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ABSTRACT
The portability of genetic tools from one organism to another is a cornerstone of synthetic
biology. The shared biological language of DNA-to-RNA-to-protein allows for expression
of polypeptide chains in phylogenetically distant organisms with little modification. The
tools and contexts are diverse, ranging from catalytic RNAs in cell-free systems to bacterial
proteins expressed in human cell lines, yet they exhibit an organizing principle: that genes
and proteins may be treated as modular units that can be moved from their native organism
to a novel one. However, protein behavior is always unpredictable; drop-in functionality is
not guaranteed.
My work characterizes how two different classes of tools behave in new contexts and
explores methods to improve their functionality: 1. CRISPR/Cas9 in human cells and 2.
quorum sensing networks in Escherichia coli.
1. The genome-editing tool CRISPR/Cas9 has facilitated easily targeted, effective, high
throughput genome editing. However, Cas9 is a bacterially derived protein and its behavior
in the complex microenvironment of the eukaryotic nucleus is not well understood. Using
transgenic human cell lines, I found that gene-silencing heterochromatin impacts Cas9’s
ability to bind and cut DNA in a site-specific manner and I investigated ways to improve
CRISPR/Cas9 function in heterochromatin.
2. Bacteria use quorum sensing to monitor population density and regulate group
behaviors such as virulence, motility, and biofilm formation. Homoserine lactone (HSL)
quorum sensing networks are of particular interest to synthetic biologists because they
can function as “wires” to connect multiple genetic circuits. However, only four of these
networks have been widely implemented in engineered systems. I selected ten quorum
sensing networks based on theirHSL production profiles and confirmed their functionality in
E. coli, significantly expanding the quorum sensing toolset available to synthetic biologists.
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Chapter 1
INTRODUCTION
1.1 Part I: Cas9 and Chromatin
1.1.1 Chromatin
Chromatin is the DNA, protein, and RNA complex that compacts and organizes genomic
DNA into eukaryotic nuclei and controls gene expression. It was first described by Walther
Flemming in 1879 after he developed staining solutions to visualize cell division.1 He
named the rod-like structures he observed during mitosis “chromatin,” meaning stainable
material.2
Chromatin can be divided into two types: 1. Euchromatin is characterized by having
an “open” or not-compacted structure often with activating chemical modifications and
associated proteins Figure 1.1. It is accessible to DNA binding proteins like RNA polymerase
and is therefore permissive to transcription; 2. Heterochromatin is characterized by a
“closed” or tightly compacted structure with silencing marks and proteins Figure 1.1. It is
generally not accessible to DNA binding proteins and thus does not allow for gene expression.
Heterochromatin can be further divided into constitutive heterochromatin and facul-
tative heterochromatin Figure 1.1. Constitutive heterochromatin is found mostly in the
pericentromeric regions of chromosomes and on the telomeres. These regions are very
stable and contain long repeat sequences with few protein coding sequences. Constitutive
heterochromatin clusters near the nuclear membrane. Facultative heterochromatin is more
dynamic than constitutive and is responsible for silencing genes and controlling differential
gene expression, as is seen in different tissue types or allele-specific silencing. It also controls
expression of genes at the appropriate times and concentrations during development of
multicellular organisms.
The basic building block of chromatin is the nucleosome, a DNA-protein complex com-
posed of 147 basepair of DNA wrapped around an octamer of histone proteins Figure 1.2 a.
Some of the amino acids in histone proteins have unstructured tails that can be chemically
modified with either activating or silencing marks. The chromatin state at a particular locus
is characterized by the presence of nucleosomes, their proximity to each other, and the
chemical modification(s) found on them. The protein complexes that affect these character-
istics are called chromatin modifying protein groups. In our work, we focus on one class of
facultative heterochromatin regulated by a class of proteins called Polycomb group (PcG)
proteins.
1
DNA methylation
Constitutive
Basal to active
Overexpression Facultative
Euchromatin Heterochromatin
Figure 1.1. Classes of human chromatin. Human chromatin can be divided into two
classes: euchromatin and heterochromatin. Euchromatin is decompacted and permissive
to RNA Polymerase and thus can have different levels of transcriptional activity.
Heterochromatin is tightly compacted and can be further divided based on the associated
proteins and histone modifications. For example, constitutive heterochromatin is found in
the pericentromeric regions, DNA methylation is associated with CpG rich regions, and
facultative heterochromatin controls expression of genes during development and
differentiation.3
1.1.2 Polycomb Group Proteins
In 1977, Pamela Lewis first identified a Drosophila gene coding for a protein called Poly-
comb.4 The following year, Ed Lewis described Polycomb as a “regulator of regulators” and
proposed it was responsible for controlling the segmentation of the bodies of Drosophila.5
A series of studies in the 1980’s revealed that two protein groups, PcG and Trithorax group
(TrxG), act antagonistically to control expression of genes responsible for body segmenta-
tion, growth, and other crucial steps during Drosophila embryonic development.6–9 It was
proposed that these gene expression states are inherited as a form of cellular memory.10
While the early work was done inDrosophila, PcG and TrxG protein homologs are found
in all metazoans. van der Lugt et al. and Coré et al. made Polycomb protein knockout lines
to demonstrate that PcG proteins regulate Hox genes in mice.11,12 In addition to controlling
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Figure 1.2. Composition of nucleosomes and the role of Polycomb group proteins in
regulating them. (a) A nucleosome is a DNA-protein complex with 147basepair of genomic
DNA wrapped around a multimer of eight histone proteins: one H3-H4-H3-H4 tetramer
and two H2A-H2B dimers. Histones have unstructured amino acid tails that can be
modified to effect the chromatin state. (b) Polycomb repressive complexes 1 and 2 (PRC1
and PRC2) modify and bind to histone tails. The EZH2 protein of PRC2 writes the histone 3
lysine 27 trimethylation (H3K27me3) silencing marks while the EED protein binds to them.
In canonical PRC1 (cPRC1), the CBX subunit binds to H3K27me3 while BMI1 writes
histone 2A lysine 119 ubiquitilation (H2AK119ub). In non-canonical PRC1 (ncPRC1),
KMD2B demethylates histone 3 lysine 36 (H3K36). (c) List of the proteins that can
compose different PRC1 and PRC2 variants. For each list, one protein from the group is
included in the complex.
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gene expression during development, they are responsible for regulating expression of
many important cellular processes like senescence, proliferation, and memory of expression
states during mitosis.10,13 Misregulation of PcG and TrxG proteins can lead to cancer.14–16
Extensive research has been done to understand their function during normal development
and how their misregulation results in disease.
1.1.3 Mechanism of Polycomb-Mediated Gene Silencing
Polycomb-mediated gene silencing is controlled by two major PcG complexes: Poly-
comb repressive complex 1 (PRC1) and Polycomb repressive complex 2 (PRC2). PRC2 can
both write and bind to the silencing mark histone 3 lysine 27 trimethylation (H3K27me3)
(Figure 1.2 b.17–20 PRC1 can also bind to H3K27me321 as well as ubiquitilate H2AK119
(Figure 1.2 b).22 In mammals, there are multiple variants of PRC1 and PRC2 (Figure 1.2 c).
Expression of different PcG variants and accessory proteins adds an additional level of gene
expression control during differentiation. PRC2 accessory proteins change PRC2 function
and are hypothesized to control differential gene expression in different tissues (for a review
of composition and expression of PcG variants see Schuettengruber et al.).
Until recently, chromatin silencing by PcG proteins was theorized to be hierarchical:
PRC2 deposits H3K27me3 followed by PRC1 recruitment and binding to H3K27me3, com-
pacting chromatin and propagating the silencing mark. However, new data suggest that
there is not a single model for PcG control of chromatin;3,23 there are examples of loci that
are silenced by only PRC124,25 or only PRC2.26 While these mechanisms are still being
investigated, it is clear that localization of PcG proteins and deposition of H3K27me3 results
in nucleosome compaction and gene silencing. This compaction blocks access to local DNA
by polymerase, activating protein groups, and nucleosome remodeling proteins, causing
heritable silencing of local chromatin.
PcG proteins also control chromatin packaging on a genomic scale. Chromatin organizes
into higher order structures of active or silenced gene expression called topologically associ-
ating domains (TADs).27 ,28 These compartments contain regions separated by megabases
on the same chromosome or regions from different chromosomes, pulled together by inter-
actions between chromatin-associated proteins. Early observations showed PcG proteins
were localized into clusters inside nuclei.29,30 It was later discovered that silent TADs con-
tain high levels of H3K27me3, the silencing mark deposited by PRC2.31,32 Furthermore,
exogenously introducing H3K27me3 results in TAD formation.33 Taken together, these
observations suggest that PcG proteins regulate higher-order chromatin compaction.34,35
While the mechanism for this compaction is not completely understood, current research
is beginning to shed more light. For example, PRC1 interacts across long distances with
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other PRC1 complexes.35–38 While PRC2 is also involved, only PRC1 is necessary to form
TADs.31,36 For a full review of the role of Polycomb in long range chromatin interactions,
see Entrevan et al.
1.1.3.1 Recruitment
While there has been significant effort in this area, it is still unclear how PcG complexes
are recruited to a target site in mammalian genomes. Drosophila contain Polycomb re-
sponse elements (PREs) that recruit PcG proteins, even in the absence of nucleosomes.39–41
However, in mammalian nuclei, the evidence is less clear and sometimes appears con-
flicting. A model for mammalian recruitment proposes that PRC2 deposits the silencing
mark H3K27me3, which both PRC1 and PRC2 bind to (reviewed in Simon et al.). PRC2
binding recruits more PRC2 complexes, propagating the silencing mark. PRC1 complexes
bind H3K27me3 and interact with each other, pulling nucleosomes closer together and
compacting the chromatin. However, there are other factors that are known to recruit PcG
proteins. For example, PcG-recruiting non-coding RNAs (ncRNAs) have been identified.43
CpG islands are also proposed as PcG protein recruiters, though some evidence suggests
that only silent CpG islands recruit Polycomb.44 Some evidence suggests ncPRC1 ubiqui-
tilation of H2A recruits both PRC1 and PRC2.22,45 However, there is also evidence that
the ubiquitilation activity of PRC1 is not required for PcG-mediated silencing.46,47 It is
likely that there are several forms of PcG recruitment in mammalian genomes, possible
utilized at different steps of development and differentiation, adding yet another level of
transcriptional control. For a full review of the current research on PcG recruitment, see
Schuettengruber et al.
In summary, human chromatin is dynamic and complex, and we are still years away
from having a full understanding of it. As synthetic biology moves into more complicated
organisms, it is crucial to appreciate this fact while not being deterred by it. We can apply our
current understanding of chromatin to investigate how exogenous tools like CRISPR/Cas9
interact with the complexity of mammalian chromatin.
1.1.4 Engineered CRISPR/Cas9 Systems and Chromatin
CRISPR/Cas9, a nucleic acid modifying system borrowed from prokaryotes, is a popular
tool for editing eukaryotic DNA. Gene editing efforts have been successful in many cases,
but the complex structure of chromatin and its variation in different cells still pose a barrier
to reliable and consistent use. Since Jinek et al. first demonstrated the programmability of
the CRISPR/Cas9 system, it has rapidly become a popular tool for rapid, high-throughput
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genome engineering.48 In 2013, Gilbert et al. showed that Cas9 is able to efficiently bind and
edit mammalian genomes.49 However, as Cas9 is bacterially derived, it remained unclear
whether Cas9 could efficiently edit target sites located in heterochromatin, the dynamic
network of non-coding RNA, scaffolding proteins, and protein-modifying enzymes that
organizes the packaging of DNA and regulates the expression of genes in eukaryotic nuclei
(subsection 1.1.1).50–52
In chapter 2, we used a transgenic cell line that allows us to control the chromatin state
at a transgenic luciferase reporter.53,54 Addition of the small molecule drug doxycyclin
(dox) initiates direct Polycomb-mediated silencing at a luciferase transgene, as confirmed
with luciferase assay and chromatin immunoprecipitation (ChIP) assay.54 We compared
Cas9 binding through chromatin immunoprecipitation (ChIP) and editing through cleavage-
induced non-homologous end-joining repair (NHEJ) in both open and closed chromatin
along a single locus. We found that Cas9 editing was completely blocked by heterochromatin
at four of nine gRNA targets and that editing was reduced at two sites. Editing at three of
the target sites showed no reduction in binding or editing,54 which suggests that inhibition
of Cas9 is discontinuous across regions of closed chromatin.
Our study added to a rapidly growing body of work that support the hypothesis that
chromatin states have a strong influence on the accessibility of DNA to Cas9 (Figure 1.3).
Several studies have found that off-target binding of non-cleaving deactivated Cas9 (dCas9)
is highly correlated with open chromatin, as characterized by DNaseI hypersensitivity.55–58
Furthermore, Cas9 off-target binding prediction tools that incorporate chromatin state
information as a parameter outperform those that do not.58 Additional studies used li-
braries of gRNAs targeted across genomes to demonstrate Cas9’s preference for regions of
open chromatin via CRISPRi-mediated transcriptional regulation59–62 or Cas9-mediated
cleavage.63,64
In a series of in vitro studies, researchers provided the first evidence of a mode of
chromatin inhibition of Cas9. Using reconstituted nucleosomes complexed with a synthetic
DNA sequence, Hinz et al.,65 Isaac et al.,66 andHorlbeck et al.59 showed that Cas9-mediated
binding and cleaving of the DNA sequence is completely blocked when it is complexed with
the nucleosome. It is important to note that this synthetic sequence associates more tightly
with nucleosomes than natural sequences.67 ,68 Utilizing transgenic cell lines, Chen et al.
showed that ectopic constitutive HP1-mediated heterochromatin compaction inhibits Cas9
binding and editing in HEK293T cells.69 They targeted the KRAB domain to two transgenes
and compared gRNA editing efficiency at each locus in the open or closed state.69 Of eight
target sites within 1500bp of the nucleation sites, none showed complete inhibition but all
showed greater than 1.5-fold reduction in editing efficiencies in the closed state compared
to open.69
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Figure 1.3. Summary of current literature on Cas9 inhibition by human chromatin. Since
Gilbert et al., many studies have demonstrated that Cas9 efficiently cuts target sites in open
chromatin.49 Overexpression can evict repressive chromatin (chapter 3) but also hamper
Cas9 activity.54 Hsu et al. provided indirect evidence of inhibition of Cas9 by DNA
methylation.74 Chen et al. and Daer et al. provided direct evidence of inhibtion of Cas9 by
constitutive69 and facultative54 heterochromatin.
There also exists conflicting evidence that suggests that Cas9 is not impeded by chromatin
compaction. Some studies have found that Cas9 is able to efficiently access target sites located
in closed chromatin.70–73 We propose that this is not conflicting evidence, but rather that
these data support the hypothesis that Cas9’s interaction with chromatin is complex, with
the level of inhibition seeming to depend on target site.
Cas9 is rapidly becoming an important tool for bioengineering applications. Therefore,
it is becoming increasingly important to solve the problem of inconsistent, site-specific
inaccessibility and varying Cas9 efficiency. The relationship between chromatin states,
gene expression, and Cas9 editing in cells warrants further investigation. To this end, in
chapter 3 we propose methods for improving Cas9 editing at previously inhibited sites
by artificially opening chromatin. In our previous work, we demonstrated that artificial
conversion of closed chromatin towards a more transcription-permissive state via siRNA-
mediated knockdown of the repressive Polycomb protein Suz12 was accompanied by an
increase in Cas9-mediated editing efficiency.54 It is difficult to control the consistency and
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magnitude of siRNA delivery. Therefore, we explored alternative methods to induce an
open, Cas9-accessible state at closed chromatin.
In chapter 3, we expanded our investigation to two methods for disrupting closed chro-
matin: a chromatin-disrupting drug (Figure 3.2) and site-directed chromatin modification
with targeted transcriptional activators (Figure 3.5). Transcription-activating fusion pro-
teins have been shown to change chromatin accessibility.72 Furthermore, Isaac et al. and
Horlbeck et al. used nucleosome-sliding enzymes to improve Cas9 cleavage of DNA com-
plexed with nucleosomes in vitro.59,66 Together, these works suggest that targeting silenced
chromatin for remodeling could improve Cas9 editing in human cells. To test this hypothesis,
we determined the effect of our global and targeted chromatin reopening approaches on
transgene expression and chromatin profile. We next analyzed Cas9 editing at a set of sites
located downstream from the nucleation site of ectopic chromatin formation. Finally, we
investigated whether chemically modified sgRNAs affect Cas9 editing in silenced chromatin.
We found that strong induction of transcription from a nearby promoter followed by cultur-
ing for several days to allow recovery of a generally permissive chromatin state improved
editing at some target sites. Preliminary data suggest our synthetic sgRNA approach could
be a promising alternative for editing in challenging loci. Our results inform a general
approach for overcoming challenges associated with site-specific Cas9 inaccessibility.
1.2 Part II: Quorum Sensing
1.2.1 Overview of Quorum Sensing Systems
Quorum sensing networks enable bacteria to monitor and respond to changes in popula-
tion density by coupling gene regulation with diffusible chemical signals from neighboring
bacteria.75 Some species of bacteria use this signaling to control group behaviors such as
virulence, biofilm formation, and motility.76 One class of these chemical signals, known as
HSLs*, are produced by a family of synthase enzymes.77–79 Accumulation of HSLs results
in activation of a regulator protein that controls expression of group behaviors. Homologous
HSL networks have been identified in over 100 species of bacteria and more networks
are regularly being discovered.80,81 Each network includes an HSL synthase protein that
catalyzes the synthesis of specific HSL signaling molecules, a regulator that is allosterically
regulated by the HSL ligand, and a promoter that typically contains a palindromic sequence
that is bound by the regulator as a monomer or homomultimer (Figure 1.4).82,83
*These chemicals have traditionally been referred to as N-acyl homoserine lactones (AHLs). However,
some synthases produce non-acyl chain homoserine lactones (HSLs) so we use the more inclusive HSL.
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Figure 1.4. General HSL signaling network. An HSL synthase protein produces the HSL
signaling molecule. The regulator protein is activated after binding to the HSL and binds to
its DNA binding domain. Binding of the HSL-regulator complex activates transcription of
genes associated with group behaviors.75,76
There are some exceptions to this network architecture. In Pantoea stewartii, the regu-
lator EsaR binds to DNA in the absence of its HSL and blocks polymerase from transcribing
downstream genes.84 Accumulation of its HSL releases EsaR and results in upregulation of
associated genes.
1.2.2 Quorum Sensing Applications
Scientists have taken advantage of the simplicity of this system to incorporate signal
processing pathways into gene circuits as genetic wires to convert an output from one
computation into an input of another. In an engineered system, the synthase protein
can be considered a “sender module” which produces the input for a “receiver module”
comprised of the regulator and the inducible promoter upstream of an output, such as
GFP.85 Engineered quorum sensing networks are used for a variety of applications including
metabolic engineering, computational circuits, and medicine. For example, Gupta et al.
used the Esa network to build a valve that can control dynamic flux to improve titers ofmyo-
inositol, glucaric acid, and shikimate.86 Chen et al. used two quorum sensing networks, Cin
and Rhl, to couple two strains that communicate to control synchronized oscillation.87 This
kind of system could be used to split production of a fermentation product across two strains
and tune growth and expression for more efficient bioproduction. Growth can be controlled
by expressing a self-lysing gene in response to a threshold population density.88 Other
examples are discussed in detail in chapter 4, including digital and analog computation,89
edge detection,90 and engineered biofilm formation.91
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1.2.3 Limits to Engineering with Quorum Sensing
Most examples of engineered quorum sensing systems use synthetic HSLs added ex-
ogenously, limiting the potential complexity of the genetic circuit. Engineered quorum
sensing systems that incorporate HSL senders can achieve more complex computation
and behavioral cooperation across populations in co-culture or on agar plates. However,
promiscuity of the synthase and regulator proteins limits potential complexity. In spite of
the natural diversity of quorum sensing networks and their utility to bioengineers, only
three—Lux, Las, and Rhl—have been extensively used in reported synthetic systems.
HSL molecules contain a variable R-group that extends from a homoserine lactone ring;
the chemistry of the R-group contributes to network diversity (Figure 1.5 and reviewed in
chapter 4).92 Variability arises from the chain length (from 3 to 18 carbons), the saturation of
the chain, and the presence of modifications such as methyl or phenol groups. In most cases,
regulator proteins bind and respond to the specific HSL produced by the synthase protein.
However, since the space of possible HSLs is limited, there are species that produce and
respond to the same HSLs. Furthermore, many synthases produce more than one HSL and
there are species which have regulator proteins without a synthase protein.93,94 This results
in overlap in signal production and responsewhichmanifests as crosstalk and eavesdropping.
There are examples of both competitive and cooperative eavesdropping.77 Pseudomonas
aeruginosa and Burkholderia cepacia coordinate virulence in co-infections.95 Others, such
as B. thailandensis and Chromobacterium violaceum, produce antibiotics to disrupt biofilm
formation of neighboring strains.96
1.2.4 Crosstalk Between Quorum Sensing Networks
As in nature, these networks exhibit crosstalk with each other in engineered systems
(Figure 1.6): synthases produce many species of HSLs (Figure 1.6b); the HSLs produced
by one synthase activates a regulator from a different system (Figure 1.6c); and regulators
bind to promoters from different systems (Figure 1.6d). The promiscuity of the most
commonly used regulator, LuxR, was explored by Canton et al. who reported LuxR-activated
expression of a GFP reporter in response to a range of HSLs.97 Others have identified
promoter crosstalk—wherein the regulator from one system can bind and activate expression
at a promoter from another system—as an additional level of crosstalk limiting the potential
complexity of genetic circuits.84,98–100
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Figure 1.5. Example structures of homoserine lactone (HSL) molecules. HSL molecules
are composed of a lactone ring with a variable R-group. The variability in HSL networks is
due to different chain length, saturation, and modification of the R-groups.
1.2.5 Progress Toward Overcoming Crosstalk
In chapter 4, we proposed that a major limitation of engineering with quorum sensing
networks is a lack of characterized orthogonal pathways, that is, networks that do not cross-
induce one another. We compiled a comprehensive list of the known synthase proteins and
the HSLs they produce. We compared the secondary structures of several regulator proteins
and suggest likely candidates for orthogonal networks.
Recently, several groups have begun characterizing and, in some cases, mutating some of
these quorum sensing networks to increase the number of systems available for engineering.
Scott et al. screened nine quorum sensing networks for potential orthogonality.88 While
most of them did not function in their chassis, they added the Rpa receiver and, with one
mutation, the Tra receiver to the quorum sensing toolbox. In a subsequent paper, they
added the RpaI synthase to the toolbox and demonstrated the functional orthogonality of the
Lux and Rpa networks.101 Chen et al. were the first to use the Cin network in an engineering
application.87 They split their circuit across two populations and used the Rhl and Cin
networks to control coordinated oscillations of fluorescent protein expression. Tashiro
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Figure 1.6. Classes of engineered quorum sensing crosstalk. (a) Synthases with narrow
HSL profiles induce only their cognate regulators. Regulators are activated by the cognate
HSL molecule. Regulators bind only to their cognate promoter. (b) Promiscuous synthase
IA induces both receivers. (c) Promiscuous regulator RB is activated by a non-cognate HSL.
(d) Promiscuous regulator RA binds at an off-target promoter pB.
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et al. evolved the promiscuous LuxR, which is known to respond to its cognate HSL, N-
(3-oxo-hexanoyl)-L-homoserine lactone (3-oxo-C6-HSL), as well as N-(3-oxo-octanoyl)-L-
homoserine lactone (3-oxo-C8-HSL) and others, to be more selective.102 First, they evolved
it to maintain wild type sensitivity to 3-oxo-C8-HSL but be 1000 times less sensitive to
its cognate HSL, 3-oxo-C6-HSL. Next, they evolved LuxR to be insensitive to 3-oxo-C8-
HSL with some reduction in sensitivity to 3-oxo-C6-HSL. While they only used synthetic
HSLs for their experiments, these mutated regulators could be used orthogonally with a
set of similarly selective synthases. Tackling the problem of promoter crosstalk, Grant et al.
mutated the LuxR promoter binding site to reduce binding of LasR and improve binding
of LuxR.103 Taken together, these works have greatly expanded the number of available
quorum sensing tools and, importantly, the number of pairs of networks that can be used
orthogonally.
1.2.6 Building a Library of Senders
This recent progress in engineering receiver modules has brought us closer to using
more than two networks in a single circuit. We propose that building a library of senders
that produce narrow profiles of HSLs will allow more complex circuits to be built. However,
as discussed above, many synthase proteins produce more than one HSL. Selective receivers
are only useful if sender inputs are equally specific. In chapter 5, we present our progress
toward building and characterizing a library of senders. We selected synthase proteins that
are known to produce one HSL and cover a wide range of tail lengths and modifications
and tested their functionality using the promiscuous LuxR regulator protein in E. coli. This
work complements the recent progress in receiver module development and will enable
researchers to engineer increasingly complex multi-strain circuits.
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Chapter 2
THE IMPACT OF CHROMATIN DYNAMICS ON
CAS9-MEDIATED GENOME EDITING IN HUMAN CELLS†
In order to efficiently edit eukaryotic genomes, it is critical to test the impact of chro-
matin dynamics on CRISPR/Cas9 function and develop strategies to adapt the system to
eukaryotic contexts. So far, research has extensively characterized the relationship between
the CRISPR endonuclease Cas9 and the composition of the RNA–DNA duplex that mediates
the system’s precision. Evidence suggests that chromatin modifications and DNA packag-
ing can block eukaryotic genome editing by custom-built DNA endonucleases like Cas9;
however, the underlying mechanism of Cas9 inhibition is unclear. Here, we demonstrate
that closed, gene-silencing-associated chromatin is a mechanism for the interference of
Cas9-mediated DNA editing. Our assays use a transgenic cell line with a drug-inducible
switch to control chromatin states (open and closed) at a single genomic locus. We show
that closed chromatin inhibits binding and editing at specific target sites and that artificial
reversal of the silenced state restores editing efficiency. These results provide new insights
to improve Cas9-mediated editing in human and other mammalian cells.
† This chapter was previously published as an article in ACS Synthetic Biology. See section F.1 for a
discussion of authorship and contributions. The original citation is Daer, R. M., et al. (2017). The Impact of
Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells. ACS Synthetic Biology 6, 428–438,
DOI: 10.1021/acssynbio.5b00299.
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2.1 Introduction
Extensive characterization and engineering is driving the CRISPR/Cas9 system to the
forefront of biomedical research, human gene therapy, and tissue regeneration.104–107
Realizing the full potential of CRISPR/Cas9 editing in eukaryotic cells will require efficient
access to target sites within chromatin, the ubiquitous DNA-protein complexes that organize
eukaryotic genomes, regulate gene expression, and render DNA less accessible to nucle-
ases.50–52 While some evidence suggests that chromatin modifications and DNA packaging
can block eukaryotic genome editing by custom-built DNA endonucleases,55,69,105,108,109
the underlying mechanism of Cas9 interference is unknown. Here, we present direct evi-
dence that closed, gene-silencing-associated chromatin inhibits Cas9-mediated DNA editing.
These results establish closed chromatin as a target for improving CRISPR/Cas9 efficiency
in human and other eukaryotic cells.
There is conflicting evidence on whether chromatin interferes with Cas9 binding and
nuclease activity in human cells. Chromatin immunoprecipitation (ChIP) mapping of dCas9,
which lacks nuclease activity, showed preferential binding at off-target sites across the human
genome with characteristics of open chromatin: high levels of DNase-hypersensitivity and
protein-coding gene sequences.55,56,58 Wu et al. reported reduced DNA cleavage at off-
target sites near closed chromatin versus on-target sites near open chromatin.55 While Cas9-
mediated editing is not completely blocked at the silenced SERPINB5 locus, which contains
methylated DNA, the reported editing frequency was only ~8%.105 Taken together, these
data suggest Cas9 may be inhibited by closed chromatin. However, Chen et al. showed that
pericentromeric heterochromatin inhibited INDEL formation.69 Perez-Pinera et al. found
that dCas9-based activators were functional at sites within closed chromatin, suggesting
binding was not prevented.71 So far, no study has compared Cas9 activity and binding at a
single site for both open and Polycomb-mediated closed chromatin.
2.2 Results and Discussion
Here, we use amodel silencing systemdeveloped inHansen et al. to control the chromatin
state at a single site, a stably integrated firefly luciferase transgene.53 We directly measured
the impact of closed chromatin on Cas9-mediated DNA editing by targeting Cas9 to sites
within the luciferase gene in unsilenced, partially silenced, and fully silenced chromatin
states. The Gal4EEDHEK293 cell line contains a doxycycline (dox)-inducible transgene that
expresses Gal4EED, which binds upstream of luciferase and recruits endogenous Polycomb
Repressive Complexes (PRCs), key regulators of facultatively closed chromatin (Figure 2.1a,
see Methods for detail).42 PRCs target hundreds of genes and play a critical role in gene
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Figure 2.1. A closed chromatin state at luciferase is regulated by doxycycline (dox) in
GAL4EED cells. (a) The GAL4EED circuit diagram illustrates how dox regulates the
expression of the Gal4EED fusion protein, which mediates accumulation of Polycomb
Repressive Complex 1 (PRC1) and closed chromatin at the luciferase reporter. (b) A
repressed expression state at luciferase is stimulated by dox in GAL4EED cells.
(c) Comparison of luciferase expression in cells that lack a Gal4EED gene (Luc14), and
GAL4EED cells before and after treatment with dox. a.u.: arbitrary units from
luminescence readings. Error bars indicate s.d. for n = 3 technical replicates.
silencing, embryonic development, stem cell maintenance and differentiation, and tumor
suppression,110–114 and thus, understanding whether differences in PRC accumulation
influence Cas9 activity is necessary for advancing biomedical applications.
GAL4EED cells grown with 1 µg/ml dox for 96h show maximal levels of repression
(Figure 2.1b). We observed that the GAL4EED cell line shows less luciferase expression
than the parental Luc14 cell line, which lacks the Gal4EED transgene, perhaps due to leaky
Gal4EED expression and a partially silenced chromatin state (Figure 2.1c). The chromatin
states in GAL4EED are stable over time and in the presence of transfected plasmids. Once
initiated by Gal4EED, the silenced state remains stable up to 96h after dox is removed and
Gal4EED expression is no longer activated.53 In our previous work, we showed that control
plasmids that express fluorescent proteins do not alter the expression levels of active or
Gal4EED-silenced luciferase.115
We constructed a series of plasmids expressing Cas9 and a short guide RNA (sgRNA)
designed to target 1 of 23 sites within Gal4UAS-TK-luciferase. Editing efficiencies were
determined using a SURVEYOR digestion assay and a Bioanalyzer (Figure 2.2a). The
target sites are distributed across 900 basepairs (bp) of the transgene located downstream
of the Gal4EED binding site (5xGal4UAS in Figure 2.2b). The sgRNAs showed a wide
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variability of INDEL frequency from zero (below detection limits) to almost 40% in Luc14
cells (Figure 2.2c).
To determine the effect of facultative closed chromatin on Cas9-mediated editing, we
compared the editing efficiencies of Cas9 in cells where the luciferase target was set to differ-
ent expression states: unsilenced (Luc14), partially silenced (GAL4EED), and fully silenced
(GAL4EED+dox) (Figure 2.1c). For this analysis, we used the five sgRNAs that showed the
highest editing efficiencies in preliminary tests (Figure 2.2c) in Luc14 cells: sg034, sg031,
sg025, sg044, and sg048. We also tested four additional sgRNAs, located farther upstream
(sg046, sg055, sg032, sg054) in order to investigate Cas9 interference closer to the initiation
site of chromatin compaction. In order to control for varying transfection and expression
levels across cell lines and conditions, we added an enhanced green fluorescent protein
(EGFP) reporter gene to the Cas9 plasmid (Figure 2.3a). In this plasmid, EGFP expression
is driven by the same promoter as Cas9, but the T2A signal allows EGFP to be translated
as a separate peptide to avoid interference with Cas9 function. We used the percentage
of GFP-positive cells (Figure 2.3b) to normalize editing efficiency values across different
experiments.
Cas9-mediated editing was reduced at target sites in fully silenced chromatin compared
to unsilenced chromatin for six of the nine sgRNAs we tested (Figure 2.3c). The greatest
significant reductions occurred within 150bp of the transcription start site downstream
of the chromatin initiation site at 5xGal4 at sites sg046 (p = 0.002), sg055 (p = 0.092),
sg032 (p = 0.008), and sg054 (p = 0.001). In the unsilenced state (Luc14), average editing
efficiencies at these sites were 7.5 to 55.1% while mutation frequencies were below detection
limits in both the partially (GAL4EED) and fully (GAL4EED+dox) silenced states. These
results suggests that editing at TSS-proximal sites is sensitive to closed chromatin. Cas9-
mediated editing in fully silenced chromatin was reduced, but not completely inhibited,
farther downstream at sg034 (p = 0.024) and sg044 (p = 0.022) compared to unsilenced
chromatin. Interestingly, editing efficiency at sg025, located between sg031 and sg044, and
sg048, located downstream of g044, is not decreased in the presence of closed chromatin.
This suggests that interference may occur in a Cas9/sgRNA-dependent manner or that the
spreading of closed chromatin from the UAS is discontinuous. Overall, our results reveal
differences in Cas9 accessibility at a greater resolution than what has been reported to date
for a single genomic locus. Furthermore, comparison of open, moderately closed, and fully
closed states at several on-target sites along a single locus allowed us to detect different
levels of interference that are the direct outcome of the formation of facultative chromatin.
Next, we tested the hypothesis that in addition to reducing editing efficiency, silenced
chromatin also affects the types of mutations that are generated at the target site. We
analyzed mutations at target site sg034 because at this location the closed state still showed
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Figure 2.3. Continued. (c) Mean editing frequencies normalized to transfection efficiency in
Luc14, GAL4EED, or GAL4EED+dox cells for Cas9 targeted to sites sg046, sg055, sg032,
sg034, sg054, sg031, sg025, sg044, and sg048. * Indicates significantly reduced editing
efficiencies at fully silenced chromatin compared to unsilenced chromatin (p < 0.025 for
3 biological replicates). Editing frequencies for target sites sg046, sg055, sg032, and sg054
for both GAL4EED or GAL4EED+dox cell types were below detection limits. Error bars
indicate s.d. for n = 3 biological replicates. (d) Summary of the data in (c). Cas9 target sites
sg046, sg032, and sg054 show a reduction in editing efficiency in both the partially and
fully silenced states compared to the unsilenced states (red arrows). Cas9 target sites sg034
and sg044 show a reduction in editing efficiency in the fully silence states compared to the
unsilenced states (yellow arrows).
detectable Cas9-mediated editing. Sequencing of cloned mutants from Cas9-edited DNA
confirmed lower editing efficiency at a target site in fully silenced chromatin compared
to unsilenced chromatin. We then compared the distribution of mutated sequences from
unsilenced- and fully silenced-chromatin samples. We detected various mutations that
were generated in the absence of a repair template by nonhomologous end joining (NHEJ)
at target site sg034. These mutations primarily consisted of deletions ranging from 1bp
to 24bp (Figure 2.4a). A small number of insertions (1 bp to 205bp) and single base
pair substitutions were also detected. DNA cloned from Cas9/sg034-treated luciferase in
the unsilenced chromatin state showed a higher frequency and broader range of affected
nucleotides compared to the fully silenced chromatin state (Figure 2.4b). The most frequent
mutation was a single base pair deletion at the Cas9 cut site in both the unsilenced and fully
silenced chromatin states (12.3% and 2.3%, respectively). This result led us to reject our
hypothesis. Themutant library sequence data indicate that Cas9-mediated editing is reduced
by ~30% in fully silenced chromatin. SURVEYOR assays showed a similar reduction, ~40%.
Therefore, the sequencing data and the SURVEYOR data provide corroborating evidence
that repressive chromatin interferes with Cas9-mediated editing at site sg034.
In order to investigate inducible chromatin and Cas9 binding, we performed chromatin
immunoprecipitation followed by quantitative PCR (ChIP-qPCR) (Figure 2.5a). First, we
used an anti-H3K27me3 antibody to map the silencing mark at luciferase. H3K27me3 is
required for the maintenance of Polycomb-mediated chromatin compaction. We detected
29- to 338-fold increases in mean H3K27me3 enrichment at luciferase in GAL4EED cells
that were treated with dox for 96h compared to untreated Luc14 cells. We also detected
4- to 93-fold increases in H3K27me3 enrichment spanning the Cas9/sgRNA target sites
in untreated GAL4EED cells relative to Luc14 cells. These data, along with the Luciferase
expression assays in Figure 2.1b, validate the dox-induced, facultative silenced chromatin at
luciferase. Previous work by Hansen et al. showed through ChIP-qPCR that upon addition
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of dox, Polycomb Group 2 (PRC2) protein EZH2, Polycomb Group 1 (PRC1) protein CBX8,
and the H3K27me3 mark accumulate at the luciferase transgene in GAL4EED cells.53 We
can conclude from their data that when Gal4EED protein binds upstream of luciferase,
PRC2 is recruited and trimethylates H3K27. H3K27me3 binds PRC1, which is associated
with nucleosome compaction and gene silencing.
Next, we used ChIP-qPCR to investigate whether interference of Cas9 activity is asso-
ciated with a decrease in Cas9 binding. We used deactivated Cas9 (dCas9), which lacks
DNA-cutting activity116 tagged with a C-terminal FLAG sequence to analyze the binding
activity of the Cas9/sgRNA complex at unsilenced, partially silenced, and fully silenced chro-
matin. Formaldehyde-cross-linked chromatinwas extracted fromdCas9/sgRNA-transfected
cells and sheared to ~700bp. ChIP was carried out in triplicate using an antibody against
the FLAG tag. We observed a 3- to 5-fold decrease in mean dCas9 enrichment at sg032 in
cells with partial or full silencing at luciferase compared to the unsilenced state (Figure 2.5c).
This result and the changes in editing efficiency we observed at sg032 (Figure 2.3c) support
a mechanism where closed chromatin blocks access of Cas9/sgRNA complexes to the target
site. In order to further investigate how Cas9 binding is associated editing efficiency, we
investigated two sites where editing was either partially affected or unaffected by the closed
chromatin state. Sg034 showed comparable editing in the unsilenced and partially silenced
states (Figure 2.3c). The ChIP-qPCR results show comparable enrichment of dCas9 in these
two states for sg034. In the fully silenced state where editing efficiency was reduced at
sg034, dCas9 enrichment was undetectable. Sg031 showed the least amount of interference
(Figure 2.3c). We detected very modest decreases in the mean editing efficiencies for the
partially and fully silenced state compared to the unsilenced state. The ChIP-qPCR data
followed a similar trend, where dCas9 enrichment was reduced but not eliminated. Perhaps
at this site, modest levels of Cas9 binding are sufficient to allow DNA editing. In summary,
these results strongly suggest that closed chromatin reduces editing efficiency by blocking
access of Cas9 to the target site.
Next, we investigated whether changes in chromatin states (illustrated in Figure 2.6a)
could enhance or restore Cas9-mediated editing. In order to induce a hyperactive expression
state, we transfected Luc14 cells with a plasmid that expressed the strong transcriptional-
activator Gal4-p65. We exposed the luciferase transgene to Cas9 editing by cotransfecting
these cells with the Cas9/sg034 plasmid. Gal4-p65 induced luciferase expression approx-
imately 6-fold compared to the basal expression level in Luc14 cells (Figure 2.6b). SUR-
VEYOR showed reduced INDEL formation at hyperactivated luciferase compared to the
basal level (p = 0.018), suggesting that dynamic chromatin remodeling through transcrip-
tional activation or competition with transcription factors interferes with Cas9-mediated
INDEL formation. Next, we investigated Cas9 efficiency after restoring the active state
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Figure 2.5. Chromatin mapping data show differential enrichment of H3K27me3 and
dCas9 at luciferase in the open, partially closed, and closed chromatin states.
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Figure 2.5. Continued. (a) Cross-linked, sheared chromatin was prepared from Luc14
(unsilenced), GAL4EED (partially silenced), or GAL4EED+dox (fully silenced) cells. An
anti-H3K27me3 antibody was used to immunoprecipitate (IP) chromatin from untreated
cells. An anti-FLAG antibody was used to IP chromatin from dCas9_gRNA-transfected
cells. Quantitative PCR (qPCR) was used to measure IP’ed DNA. Primers (described in
Methods) and amplicon sizes are shown in the illustrated maps. A primer pair located at
the constitutively active GAPDH promoter was used as a negative control to determine
off-target binding. (b) Mean H3K27me3 enrichments for Luc14 (unsilenced), GAL4EED
(partially silenced), and GAL4EED+dox (fully silenced) cells at four sites spanning the
Cas9/sgRNA target sites. Enrichment is shown as percentages of input minus IgG mock IP.
(c) Enrichments of IP DNA for dCas9 are shown for three gRNA target sites, sg032, sg034,
and sg031 in three chromatin states, unsilenced, partially silenced, and fully silenced.
Enrichments are shown as percentages of input minus background (IgG mock IP and
GAPDH) (see Methods). In (b) and (c), error bars indicate s.d. for n = 3 replicate IPs from
a single chromatin preparation. A one-tailed t test was done to compare Gal4EED or
Gal4EED+dox to Luc14 (*p < 0.5, **p < 0.01).
from a previously silenced state. GAL4EED +dox cells were treated with anti-SuZ12 siRNA
to disrupt PRC2 accumulation, or Gal4-p65 to enhance luciferase expression. SuZ12, a
member of the PRC2 complex, is required for maintaining the H3K27me3 mark.53 Anti-
SuZ12 stimulated partial reactivation compared to the basal expression state and showed
full recovery of Cas9 editing efficiency compared to the fully silenced state (p = 0.045)
(Figure 2.6b and 2.6c). Gal4-p65-treated GAL4EED+dox cells showed full reactivation of
luciferase compared to the basal expression level and partially restored the frequency of
INDEL formation (Figure 2.6b and 2.6c). These results suggest that artificial restoration of
gene expression is an effective approach for enhancing Cas9-mediated editing at a target
gene.
In conclusion, our results provide direct evidence that at a single genomic locus, Poly-
comb-mediated chromatin structure impairs Cas9-mediated DNA editing and Cas9 binding
at specific sites. Specifically, in the partially and fully repressed chromatin states, the sg032
target site is less accessible to dCas9/sgRNA binding and INDEL formation is reduced.
Similarly, at the fully repressed chromatin state, the sg034 target site is less accessible to
dCas9/sgRNA binding and INDEL formation is also reduced. Others have investigated the
Cas9/sgRNA-target binding step using dCas9 and found off-target binding to be reduced at
sites of closed chromatin.55,56,58 In vitro studies suggest that the nucleosome core particle
directly contributes to Cas9 interference. Nuclease activity on naked DNA confirmed that
Cas9/sgRNA is active in vitro.117 Experiments that used reconstituted chromatin templates
demonstrated that nucleosome-occupied regions are blocked from Cas9 binding.59,66 Our
data support these previous observations by demonstrating that closed chromatin inhibits
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Figure 2.6. Dynamic regulatory states impact Cas9-mediated editing at the luciferase
transgene. (a) Illustration of the luciferase transgene in the basal expression state and in
different, artificially regulated states. (b) Background-subtracted Luciferase expression
levels per cell were measured 96h after dox treatment (GAL4EED+dox), immediately
before transfection with Gal4-p65 plasmid DNA (+p65), or mock-transfection (vehicle
only). Luciferase expression was measured in siRNA-treated cells 336h after transfection.
a.u.: arbitrary units.
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Figure 2.6. Continued. (c) Editing efficiency for Cas9/sg034 was determined by
SURVEYOR assays. Editing was reduced in the hyperactive expression state (Luc14+p65)
compared to the Luc14 basal state (*p = 0.018) and the GAL4EED partially repressed state
(*p = 0.004). Reversal of the closed state via siRNA treatment (GAL4EED+dox+ siRNA)
was accompanied by an increase in luciferase expression and editing efficiency (p = 0.045)
compared to the fully repressed state. Editing efficiencies for Luc14, GAL4EED, and
GAL4EED+dox shown here are the same data shown in Figure 2.3c.
Cas9/sgRNA-DNA binding at an on-target site. Reduced enrichment of Cas9 is associated
with reduced INDEL formation. Taken together, our findings support a mechanism for Cas9
inhibition where chromatin compaction and nucleosome occupancy disrupt Cas9-mediated
editing by blocking accessibility of the target site.
Our findings identify repressive chromatin as a critical barrier to efficient Cas9-mediated
editing in mammalian cells. In high-throughput applications, such as generating knockout
libraries for model organisms, many target sites may be located in closed chromatin in
certain cell types. Many sgRNAs may be prone to high failure rates; thus, trial-and-error
to achieve gene editing may be impractical. Methods for opening closed chromatin, such
as transcriptional activators118 and inhibitors of heterochromatin proteins119,120 might
enhance Cas9 editing efficiency. We observed that treating cells with siRNA against the
silencing protein SuZ12 led to full recovery of editing efficiency comparable to the basal
expression state (Figure 2.6). Inducing an active state with a transactivator (Gal4p65) might
inhibit Cas9 via competition with the activator and the transcription complex. Therefore, an
effective general strategy for restoring an open, Cas9-accessible state at chromatin-regulated
target sites may be siRNA-mediated inhibition of closed chromatin. Our study with a
switchable Polycomb chromatin system53 sheds light on the impact of eukaryotic chromatin
on Cas9-mediated genome editing and opens new avenues to for enhancing Cas9 function
in the context of the human genome.
2.3 Methods
2.3.1 Plasmid DNA Construction
In order to determine transfection efficiencies using flow cytometry, we modified the vec-
tors pX330-U6-Chimeric_BB-CBh-hSpCas9107 (a gift from Feng Zhang, Addgene plasmid
#42230) and pX330A_d-Cas9-1×4116 (a gift from Takashi Yamamoto, Addgene plasmid
#63598) using the T2A peptide skipping sequence to express EGFP from the same mRNA
transcript as the Cas9 protein. PX330 or pX330A and the gBlock Gene Fragment (Integrative
36
DNA Technologies) FseI-NLS-T2A-EGFP-EcoRI containing EGFP were cut with FseI (New
England BioLabs) and FastDigest EcoRI (ThermoFisher Scientific) and ligated using T4DNA
Ligase (New England BioLabs). We named this new vector pU6-(BbsI)_CBh-Cas9-T2A-
EGFP (DNASUUnSC00746685). SgRNAs used in the study (Table A.1) were designed using
the CRISPR design tool at crispr.mit.edu.74 DNA oligos were synthesized with the over-
hangs for cloning into pX330g or pX330g_dCas9 (Integrative DNA Technology). Drop-in
of sgRNAs followed the cloning protocol described in Cong et al..107 The Gal4-p65 fusion
was expressed from plasmid CMV-Gal4p65_MV1 (DNASU UnSC00746686). Annotated
sequences of the plasmids used in this study are available online.121
2.3.2 Cell Culturing and Transfections
The Luc14 cell line carries a firefly luciferase gene (Gal4UAS-TK-luciferase), which is
stably integrated into the genome of HEK293 cells.53 A second cell line, GAL4EED, con-
tains the firefly luciferase gene (Gal4UAS-TK-luciferase) as well as a TetO-CMV-Gal4EED
transgene, which carries a Gal4 DNA-binding motif (Gal4) fused to an embryonic ectoderm
development (EED) open reading frame driven by TetO-CMV promoter.53 Expression of the
Gal4EED fusion protein-encoding sequence is silenced by a Tetracycline repressor (TetR)
(Figure 2.1a). The cell line also contains a puromycin (puro)-inducible anti-Gal4EEDmiRNA
to counter leaky transcription of TetO-CMV-Gal4EED. The removal of puro and addition of
doxycycline (dox) to cultured GAL4EED cells releases the TetR protein from TetO-CMV-
Gal4EED and allows the expression of Gal4EED. Gal4EED binds to the Gal4UAS site and
switches the chromatin state at luciferase from active to silenced through accumulation of
PRC (Figure 2.1b, Hansen et al.,53 and Haynes et al.)115).
Cells were grown in Gibco DMEM high glucose 1× (Life Technologies) with 10% Tet-free
Fetal Bovine Serum (FBS) (Omega Scientific), 0.5 µg/ml puro and 1%penicillin streptomycin
(ATCC) at 37 ◦C in a humidified 5%CO2 incubator. At time 0h, puromycin was removed and
GAL4EED cells were induced with doxycyclin (dox) (Santa Cruz Biotechnology) at 1 µg/ml.
At 72h, Luc14 cells and dox-induced GAL4EED cells were seeded in 12-well plates such
that at 96h, cells reached 90% confluency. One well from each cell type was collected for
Luciferase assay (see below). The remaining wells were used for lipid-mediated transfection.
For pX330g/sgRNA transfections, 0.5 µg plasmid was used/well, 3 µl Lipofectamine LTX,
and 1µl Plus Reagent (Life Technologies) per manufacturer’s protocol. At 144h, cells were
collected to determine transfection efficiency by flow cytometry and editing efficiency by
SURVEYOR Assay (see below).
For p65 CMV-Gal4p65_MV1 transfections, 0.5 µg of each plasmid was used/well, 3 µl
Lipofectamine LTX, and 1µl Plus Reagent (Life Technologies) per manufacturer’s protocol.
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At 144h, cells were collected for downstream analyses, including determining transfection
efficiency, and performing Luciferase Assay and SURVEYOR Assay (described below).
2.3.3 Luciferase Assay
Cells were washed with 0.5ml PBS (Irvine Scientific), detached with 0.2ml trypsin (Life
Technologies), collected with the addition of 0.5ml DMEM, and spun at 100 g. Supernatant
was aspirated and the cell pellet was resuspended in 2ml of FACS buffer (PBS with 1%
FBS) and filtered using 35µm cell strainers (Electron Microscopy Sciences). Twenty µl of
cells + FACS buffer were counted and gated using the BD Accuri C6 Flow Cytometer and
software (BD Biosciences). The luciferase assay was performed using Steady-Luc Firefly
HTS Assay Kit (Biotium) according to manufacturer’s protocol. Briefly, 100µl of cells in
FACS buffer from each sample were added to three wells of a Corning and Costar 96-well
Cell Culture Plate, black, clear bottom (Bioexpress). One hundred µl of Luciferase working
solution was added to each well. Three wells with FACS buffer (without cells) plus Luciferase
working solution were read and the highest measured value of the three wells was used as
background signal. The plate was incubated for 5min with orbital shaking and luminescence
was read using a Synergy H1 Multi-Mode Reader (Biotek). Luciferase expression per cell
was calculated as follows:
Sample Luciferase per cell = Sample Luciferase signal −
background signal
cell count× 100µl/20 µl
2.3.4 SURVEYOR Assay
Genomic DNA was extracted using a QIAamp DNA Mini Kit (Qiagen). Cas9/sgRNA
target DNA was amplified using Phusion polymerase first with external primers P197 5'–gct-
cactcattaggcacccc and P198 5'–ggcgttggtcgcttccggat. PCR products were diluted 1:1000
in water. Nested PCR was performed using primers flanking the Cas9/sgRNA target site
(Table A.2 and Table A.3). An annotated map of primers is available online (UAS-TK-luc
HEK293).121 PCRproducts were purified (GenElute PCRClean-Up, Sigma) and SURVEYOR
assay (IDT) was performed according to the manufacturer’s protocol. Briefly, 400ng of
PCR product was mixed with 1.5 µl of annealing buffer (10mM Tris-HCl (pH 8.8), 1.5mM
MgCl2, and 50mM KCl), and brought to 15µl with water. PCR products were melted and
reannealed and digested with 1 µl SURVEYOR enzyme and 1µl Enhancer for 1 h at 42 ◦C.
The concentrations of fragments in each sample were measured on an Agilent 2100 Bio-
analyzer. The ratio of uncut wildtype (WT) to cut heteroduplex DNA fragments (HDlarge,
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HDsmall) was calculated as follows:
Percent editing efficiency = 100× HDlarge +HDsmall
HDlarge +HDsmall +WT
Genomic DNA from untreated Luc14 and GAL4EED cells and genomic DNA from
Cas9/sgRNA treated cells lacking S-nuclease treatment were used as controls to distinguish
background noise from actual cut heteroduplex DNA fragments.
The editing efficiencies shown in Figures 3 and 6 were normalized by transfection effi-
ciency. At 72h post-transfection (12-well plates, ~4× 105 cells/well), cells were washed
with 0.5ml PBS (Irvine Scientific), detached with 0.2ml trypsin (Life Technologies), col-
lected with 0.5ml DMEM, and spun at 100 g for 5min. Supernatant was aspirated and the
cell pellet was resuspended in 2ml of FACS buffer (1% FBS in 1× PBS) and filtered using
35µm cell strainers (Electron Microscopy Sciences). Live cells were gated based on forward
and side scatter using the BD Accuri C6 Flow Cytometer and software (BD Biosciences).
Data was analyzed using FlowJo software. Fluorescence intensity for ten thousand live cells,
detected with settings for GFP (488nm laser, 533/30 filters), was plotted against cell count.
The GFP-expression threshold was determined using non-GFP expressing HEK293 cells.
Transfection efficiency was calculated as the percent of cells GFP-positive cells in the total
live cell population. This value was used to normalize editing efficiencies to cells containing
the Cas9/sgRNA plasmid:
Percent editing efficiency normalized to transfection efficiency =
Percent editing efficiency
transfection efficiency
Statistical Analyses. For analyses of SURVEYOR Assay data, standard deviations were
calculated for n = 3 biological replicates. The differences of means for Luc14/GAL4EED
cells and Luc14/GAL4EED+dox cells were calculated using the two sample, one-tailed
Student’s t test with a confidence of 97.5% for 2 degrees of freedom and a test statistic of
t(0.025,2) = 4.303.
2.3.5 Mutant Clone Library
The sg034 target region was PCR amplified from genomic DNA and prepared as de-
scribed above (see “SURVEYOR assay”). Thirty ng (0.072pmol) of each blunt ~630bp
PCR product was ligated with linear pJET1.2 vector (0.05 pmol ends) in a 10µl reaction
following the manufacturer’s protocol (CloneJET PCR Cloning Kit, Life Technologies) with
the following modifications: 1× ligation buffer (Roche), T4 DNA ligase (New England Bio-
labs). Reactions were incubated at room temperature (25 ◦C) for 5min, mixed with 50µl
of thawed Turbo competent DH5-alpha E. coli (New England Biolabs), and incubated on
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ice for 5min. Transformed cells were plated directly on prewarmed LB agar (100µg/ml
ampicillin) and incubated overnight at 37 ◦C to grow colonies. Liquid cultures (200µl LB
broth, 100µg/ml ampicillin) were inoculated in deep round-bottom 96-well plates with
single colonies collected via sterile, disposable pipet tips. Plasmid DNA was purified using
the Montage Plasmid Miniprep HTS 96 Kit (Millipore). Sanger sequencing was performed
using primer P163 (5'–caaaccccgcccagcgtctt). The sequence data were aligned to the pUAS-
TK-luc reference sequence in Benchling using MAFFT.122 Sequence variants were binned
manually and counted using Excel software.
2.3.6 Cross-linked chromatin immunoprecipitation (ChIP)
Luc14, GAL4EED, andGAL4EED+dox cells were electroporatedwith plasmid pX330g_-
dCas9/sg031, pX330g_dCas9/sg032, or pX330g_dCas9/sg034 using the Neon Transfection
System (Invitrogen) following manufacturers protocols. Electroporation settings were as
follows: 100µl tip, Pulse voltage 1100V, pulse width 20ms, 2 pulses, with cell density
5× 107/ml. Two transfections were plated into each 15 cm plates for each cell type. Trans-
fected cells were grown at 37 ◦C for 72h before collection for IPs.
Transfected (for dCas9 IPs) and nontransfected (for H3K27me3 IPs) were collected
by trypsin-treatment, and incubated with 20ml of 1% formaldehyde (Thermo Fisher Sci-
entific)/1× Dulbecco’s PBS for 10min at room temperature. Cross-linking was quenched
with 125mM glycine for 5min. Cross-linked cells were washed twice with cold 1× PBS
buffer + Pierce Protease Inhibitors (Thermo Fisher Scientific) for 5min with shaking. Cells
were washed again with 1× PBS buffer + Pierce Protease Inhibitors without shaking. Cells
were spun at 500 g for 5min between each wash step. To lyse cells, 70 µl of cross-linked
cells were resuspended in 112.5 µl of Cell Lysis Buffer [10mM Tris pH 8.0 (ThermoFisher),
10mM NaCl, 0.2% IGEPAL (Sigma)] plus Protease Inhibitors and incubated on ice 10min.
Lysed cells were spun for 5min at 500 g. Nuclei were resuspended and lysed in 1ml of
Nuclei Lysis Buffer [1% sodium dodecyl sulfate (SDS) (Sigma), 10mM ethylenediaminete-
tracacetic acid (EDTA) (Fisher Scientific), 50mM Tris-HCl pH 8.1 (Sigma)] plus Protease
Inhibitors and incubated on ice for 10min. Lysed nuclei were diluted with 0.5ml of ChIP
Dilution Buffer [1% Triton X-100 (Santa Cruz Biotech), 2mM EDTA, 50mM NaCl (Sigma),
20mM Tris-HCl, pH 8.0] and split into five 300µl-aliquots. Cells were disrupted using a
Qsonica Q700A Sonicator with a 5.5 in CupHorn. Sonicated chromatin was spun at 10 000 g
for 10min at 4 ◦C to remove impurities and then flash frozen at −80 ◦C. To confirm sonica-
tion efficiencies, 100 µl of sonicated chromatin was purified and resolved via electrophoresis
to confirm ~700bp fragments. For IPs, 50 µg of each chromatin preparation was diluted
to 1ml in dilution buffer [1% Triton X-100 (Santa Cruz Biotech), 2mM EDTA, 150mM
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sodium chloride (NaCl) (Sigma), 20mM Tris-HCl, pH 8.0]. Chromatin was precleared for
3 h at 4 ◦C with nutation with 20µl of washed [3× PBS buffer + BSA (5mg/ml) (Sigma)]
Magna ChIP Protein A+G (Millipore). Fifty µl (20%) of precleared chromatin was frozen
for input control. Chromatin from nontransfected cells was incubated with 5 µg of rabbit
anti-H3K27me3 07-449 (Millipore) or 5 µg of rabbit IgG (Cell Signaling 27295) at 4 ◦C for
12h with nutation. Chromatin from dCas/sgRNA plasmid-transfected cells was incubated
with 40µl of washed anti-FLAG M2 magnetic beads (M8823, Sigma) (3× with TBS (50mM
Tris HCl, 150mM NaCl, pH 7.4) or 5 µg of rabbit IgG (Cell Signaling 27295) at 4 ◦C for 12h
with nutation. Chromatin-anti-FLAG-bead complexes were washed three times with TBS
buffer. Chromatin-anti-H3K27me3 and chromatin-IgG samples were incubated with 20µl
Magna ChIP Protein A+G beads for 3 h at 4 ◦C with nutation and then washed 6 times with
10min rotating incubations with RIPA buffer [50mM HEPES pH 7.6 (Thermo Fisher Scien-
tific), 1mM EDTA, 0.7% Sodium-Deoxycholate (Sigma), 1% IGEPAL CA-630 (Sigma), 0.5M
LiCl (Sigma)] and two times with 5min rotating incubations with tris-EDTA pH 7.6 (Sigma).
Washed chromatin-antibody-bead complexes were resuspended in 100µl of elution buffer
[1% SDS, 0.1M sodium bicarbonate (Sigma), 0.1M NaCl]. Fifty µl inputs were brought up
to 100µl in elution buffer. IPs and inputs were nutated for 30min at room temperature
then incubated at 65 ◦C for 9 h to reverse cross-linking. Samples were treated for 30min
at 37 ◦C with 10µg of RNase A and then for 2 h at 62 ◦C with 10µg of Proteinase K. DNA
from IPs and inputs was purified with Genelute PCR Cleanup Kit (Sigma) and eluted in 50µl
nuclease-free water.
2.3.7 Real-Time Quantitative PCR of ChIP-Enriched DNA
Real-time quantitative PCR reactions (15 µl each) contained SYBR Green master mix,
2 µl of immunoprecipitated (IP), IgG-IP, or input template DNA, and 2.25 pmol of primers.
Input Cp values were adjusted by subtracting log2 20 from each input Cp, as 50 µl was taken
from 1ml total chromatin or ¹⁄₂₀. % IP DNA bound was calculated as 100× 2Ct input−Ct IP.
% IgG-IP bound (100×2Ct input−Ct IgGIP) was subtracted from% IP DNA bound to calculate
% IP enrichment (minus IgG mock IP) for H3K27me3 mapping. For dCas9 enrichment,
% IP enrichment (minus IgG mock IP) at site GAPDH was subtracted from % IP enrichment
(minus IgG mock IP) at Site 1 to calculate % IP enrichment (minus background).
Primer sequences for site 1 were as follows:
5'–cgaccctgcataagcttgcc (forward);
5'–ccgcgtacgtgatgttcacc (reverse).
Primer sequences for site 2 were as follows:
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5'–ggtgaacatcacgtacgcgg (forward);
5'–aataacgcgcccaacaccgg (reverse).
Primer sequences for site 3 were as follows:
5'–gcgcccgcgaacgacattta (forward);
5'–gagatgtgacgaacgtgtac (reverse).
Primer sequences for site 4 were as follows:
5'–ttgtaccagagtcctttgatcg (forward);
5'–ccgtgatggaatggaacaac (reverse).
Primer sequences for GAPDH were as follows:
5'–tactagcggttttacgggcg (forward);
5'–tcgaacaggaggagcagagagcga (reverse).
Statistical Analyses. For analyses of ChIP-qPCR Assay data, standard deviations were
calculated for n = 3 replicate IPs from single chromatin preps. The differences of means
for Luc14/GAL4EED cells and Luc14/GAL4EED+dox cells were calculated using the two
sample, one-tailed Student’s t test. For p < 0.05, confidence was 95% for 2 degrees of
freedom and a test statistic of t(0.05,2) = 2.920. For p < 0.01, confidence was 99% for
2 degrees of freedom and a test statistic of t(0.01,2) = 6.965.
2.3.8 siRNA Transfections
At time 0h, puromycin (puro) was removed and GAL4EED cells were induced with
doxycycline (dox, Santa Cruz Biotechnology) at 1 µg/ml. At 96h, dox was removed and
media with puro was used. Cells were seeded in 12-well plates such that at 96 h, cells were
at 50% confluency. One well was collected for Luciferase assay (see above). The remaining
wells were used for lipid-mediated transfection with 2.5 µl of 20 µm anti-SUZ12 siRNA
duplex (Dharmacon)/well and 1.5 µl Oligofectamine (Life Technologies) per manufacturer’s
protocol. siRNA sequence used was as follows:53
Sense: 5' A.A.G.C.U.G.U.U.A.C.C.A.A.G.C.U.C.C.G.U.–G.U.U 3';
Antisense: 5' C.A.C.G.G.A.G.C.U.U.G.G.U.A.A.C.A.G.–C.U.U.U.U 3'.
Mock transfected cells (water used in place of siRNA duplex) were used as a control. At
144h, siRNA and mock transfections were repeated. At 264h, siRNA and mock transfected
cells were transfected with Cas9/sg034 (three experimental replicates) (see above). At 336h
cells were collected to determine luciferase expression, transfection efficiency, and editing
efficiency (see above).
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Chapter 3
ENHANCING CAS9 ACTIVITY IN HETEROCHROMATIN‡
3.1 Introduction
In chapter 2, we demonstrated that compact, gene-silencing chromatin impedes Cas9
binding and editing by making the DNA less accessible to Cas9/gRNA binding (Figure 2.3
and Figure 2.5). Our investigation of the underlying mechanism showed that disruption
of chromatin through siRNA-mediated knockdown of the Polycomb complex enhanced
CRISPR editing, but that target gene overexpression impeded CRISPR activity (Figure 2.6).
Thus, further research is needed to establish chromatin manipulation as a practical tool
for gene editing. In this chapter, we test additional approaches for improving target site
accessibility in heterochromatin. To begin, we compare two general methods for inducing
an open, non-silenced state to enhance CRISPR efficiency: chromatin-disrupting inhibitor
drugs and transient expression of site-specific chromatin-modifying proteins. We explored
the mechanism of enhanced editing at artificially opened chromatin in HEK293 cells using
deep sequencing of edited DNA and chromatin immunoprecipitation (ChIP) of histone
modifications. We demonstrate modest CRISPR enhancement with pre-treatment with
a transiently expressed site-specific fusion transcriptional activator Gal4-p65. We show
co-treatment with Gal4-p65 and the small molecule chromatin inhibitor UNC1999 do not
improve Cas9 editing. In both cases, loss of H3K27me3 was observed but was only associ-
ated with the CRISPR-permissive state in pre-treatment with a transcriptional activator.
We next tested whether delivery of a pre-assembled Cas9/sgRNA ribonucleoprotein (RNP)
with a chemically modified, degradation resistent sgRNA effects targeting in closed chro-
matin. Preliminary data suggest that synthetic guide RNAs greatly improve Cas9 editing in
heterochromatin.
3.2 Sequencing the Luciferase Transgene
While testing the above described approaches for improving Cas9 editing effiency, we also
further characterized the two cell lines used in our study, Luc14 and GAL4EED. To construct
the Luc14 cell line, Hansen et al. transfected the Flp-In T-REx - 293 Cell Line (Invitrogen)
with a plasmid containing the UAS-TK-luciferase sequence 5xGAL4TKLucNeo and selected
‡ This chapter is a manuscript in preparation. See section F.2 for a discussion of authorship and contribu-
tions.
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Figure 3.1. Facultative heterochromatin inhibits Cas9 editing while open chromatin is
permissive to Cas9. The PRC2 (Polycomb repressive complex 2) holoenzyme (orange)
writes the silencing chromatin mark H3K27me3. It is composed of SUZ12 (Suppressor of
Zeste 12), EED (Embryonic ectoderm development), RbAp (Retinoblastoma-binding
protein), and EZH2 (Enhancer of zeste 2).50,52 The PRC1 (Polycomb repressive complex 1)
holoenzyme (red) reads and propogates the silencing mark H3K27me3. It is composed of
CBX8 (Chromobox protein homolog), RING1b (Ring finger protein 1b), and BMI1
(Polycomb group RING finger protein 4).50,52 Localization of PRC1 and PRC2 results in
histone (blue) compaction and gene silencing by preventing binding to the DNA by proteins
like RNA polymerase and Cas9. HATs (Histone acetyltransferases) (dark green) add
activating acetylation marks to histones, opening chromatin and activating
transcription.123 HMTs (Histone methyltransferases) (light green) add activating
methylation marks to histones, opening chromatin and activating transcription.124 These
proteins write activating marks and erase silencing marks, recruiting other chromatin
remodelers and loosening the local chromatin to allow for access to the DNA by RNA
polymerase (purple) and other DNA binding proteins like Cas9.
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Figure 3.2. Sequencing the luciferase transgene. Green bands indicate the PCR produced a
product with the expected length. Red bands indicate the expected PCR product from a
failed reaction. Purple band indicates the probable break region. Significant plasmid
features are annotated.
for stable integration.53 The Flp-In T-REx - 293 Cell Line has a single-integrated FRT site
and constitutively expresses the TetR repressor. To build the GAL4EED cell line, they
used the FRT site to integrate a dox-inducible Gal4-EED fusion protein expression plasmid
(pcDNA5/FRT/TOGAL4–EED) into the Luc14 parent cell line. They confirmed their system
behaved as expected using ChIP for the H3K27me3 silencing mark deposited after Gal4EED
recruitment to luciferase (see chapter 2 for a full discussion of the cell line and Figure 2.1
and Figure 2.5b for our data).53,54 Along with generously providing us with the Luc14 and
GAL4EED cell lines, Hansen et al. sent us the sequence map for the pUAS-TK-Luciferase
plasmid. We performed Sanger sequencing to verify the plasmid sequence and have provided
an updated sequence map online.We next used end point PCR to identify the location in
the plasmid where it broke before insertion. This data will allow us to use ChIP-qPCR to
characterize the chromatin state upstream and downstream of the gal4 initiation site. We
anchored one primer in the pUAS-TK-Luciferase to prevent false positives Because this cell
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Figure 3.3. Using chromatin inhibitors to improve Cas9 editing. We are using UNC1999, a
small molecule drug that inhibits the protein Enhancer of zeste 2 (EZH2), a component of
the Polycomb Repressive Complex 2 (PRC2).125 PRC2 is responsible for maintaining the
repressive mark H3K27me3.50,52
line contains at least four transgenes, it is likely that the plasmid elements occur multiple
times in the genome. We paired each anchor primer with primers moving farther away from
the transgene (Figure 3.2). Only one of our PCR reactions failed leading us to identify a
possible break region in the plasmid (Figure 3.2). It is important to note that we do not
know whether this PCR faied because it traversed the break point or because the product
was long and the reaction was inefficient. We did not have the original plasmid to be able to
run a positive control. Furthermore, because the pUAS-TK-Luciferase plasmid randomly
integrated, we do not know if it was inserted multiple times. In order to determine this, we
would need to sequence the genome of the cell line.
3.3 Improving Cas9 Editing with Chromatin Inhibiting Drugs
We hypothesized that treatment with with a broad acting, chromatin inhibiting drug
would allow for Cas9 to bind and edit a target site located in heterochromatin (Figure 3.3).
UNC1999 is a small molecule drug that disrupts heterochromatin in mammalian cells by
binding to the active site of the methyltransferase EZH2 to prevent the methylation at
H3K27me3, a modification that supports Polycomb complex formation and a closed chro-
matin state.125 Konze et al. demonstrated that UNC1999 effectively removed all H3K27me3
from the cell by directly inhibiting EZH2 and EZH1 in both MCF7 (a human breast cancer
cell line) and HEK293T cells.125
UNC1999 can be diluted in media and therefore can be delivered to all cells in a culture,
making it an attractive option for difficult to transfect cell lines. Konze et al. also showed
that UNC1999 is effective when fed to and injected into mice with no observed toxicity.125
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Figure 3.4. UNC1999 dose effect on Luciferase expression. (a) UNC1999 only modestly
increases Luciferase expresion at 2 µM and 10µM doses of UNC1999 over DMSO control
(Silenced +veh). Experiment was done with n = 1 biological samples. Error bars indicate
standard deviation of n = 3 technical replicates.
3.3.1 Determining UNC1999 Dose
To begin, we determined the toxicity of UNC1999 in our cells. Because Konze et al.
tested in HEK293T cells and our experiments use HEK293 cells, we started with the dose
ranges they tested. Supplemental Table C.1 shows the concentrations we tested and the
resulting toxicity determined through microscopy. For our vehicle control, we added the
volume of DMSO corresponding to the highest volume of UNC1999 in DMSO added to our
cells, 2.5 µL. We tested both cell types, Luc14 and GAL4EED, at concentrations of 1, 2, 5,
10, 20, and 50mM and looked for toxicity after 48h. We did not observe any toxicity in
the vehicle control. Cells grown in 1, 2, 5, and 10mM showed growth similar to the vehicle
control. Cells grown in 20mM showed some toxicity while 50mM was completely toxic.
We next determined if the non-toxic doses 2 µM and 10µM increased luciferase expres-
sion. After 48h, we saw very modest increases in Luciferase activity compared to vehicle
control (Figure 3.4). We did not see differences between the 2 µM and 10µM doses. Based on
these results, we decided to test whether the lower dosage, 2 µM, removed the silencing mark
H3K27me3 from our luciferase transgene via (ChIP). However, our preliminary results did
not show a reduction in H3K27me3 (data not shown). For our next experiments, we tested
the higher concentration of 10 µM.
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Figure 3.5. UNC1999 effect on Luciferase expression and H3K27me3. GAL4EED cells
were treated with doxycycline (dox) for 96h and treated with UNC1999 for 120h.
(a) UNC1999 does not increase luciferase expression over the silenced state. Luciferase
expression was measured 24h post treatment with UNC1999. Error bars indicate standard
deviation of n = 3 biological replicates. (b) ChIP assay shows that UNC1999 removes
H3K27me3 at the luciferase transgene. Error bars indicate standard deviation of n = 3
replicate pulldowns from a single chromatin prep.
3.3.2 UNC1999 Removes H3K27me3 from Previously Silenced Locus
We next tested the effect of higher doses of UNC1999 on our luciferase transgene. We
silenced the chromatin at luciferase, as described in chapter 2, Figure 2.1, by adding dox
for 96h. At 120h (24h after dox removal), we added 10µM of UNC1999 for 120h. At
264h (24h after UNC1999 removal), we measured luciferase activity and performed ChIP
assay to determine H3K27me3 occupancy. Figure 3.5 shows that while UNC1999 does
not significantly increase Luciferase activity, we see a significant decrease in H3K27me3
compared to the DMSO control (p < 0.01). We conclude that at 10 µM, UNC1999 can
effectively remove the silencing mark H3K27me3 from our silenced transgene but does not
initiate transcriptional activation. We proceeded to determine if this removal is sufficient to
improve Cas9 editing.
3.3.3 Effect of UNC1999 on Cas9 Editing
To measure whether Cas9 editing is improved at a silenced locus after treatment with
UNC1999, we followed the treatment steps described in subsection 3.3.2. At 264h, we
transfected with Cas9/sgRNA expressing plasmids with sgRNAs targeting sg046, 32, 25,
52
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Figure 3.6. UNC1999 effect on Cas9 editing. (a) Map of the luciferase transgene and the
sgRNA target sites. (b) Heat maps of the mutational frequency determined by deep
sequencing. (c) Comparison of editing efficiencies at each sgRNA target site in each
chromatin state. In (b) and (c), open chromatin (active), closed chromatin (silenced),
reopened with UNC1999 (+UNC1999), and a vehicle control (+DMSO). In (c), dots indicate
individual replicates and bars indicate the average of the three biological replicates.
and 48 (Figure 3.6a). In chapter 2 Figure 2.3 we showed that chromatin inhibited Cas9
at sg046 and sg032 target sites but not at sg025 or sg048.54 At 96h post transfection, we
collected the treated cells and assayed for Cas9 editing using deep sequencing. In Figure 3.6b
and c, we see that UNC1999 does not improve Cas9 editing. At sg046, we see significant
inhibition of editing in the vehicle control when compared to the active state (p < 0.001).
However, treatment with UNC1999 not only showed inhibition when compared to the active
state (p < 0.001), we see even greater inhibition than in the vehicle control (p < 0.001). We
see the same trend across the other three sgRNA sites. At sg032 and sg025, we see inhibition
at all treatments compared to active state (p < 0.05 for each). At sg048, we see the same
trend; editing is reduced in both the UNC1999 and DMSO treated samples (p < 0.005) but
the difference between silenced and active is not significant (p = 0.06).
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We conclude that UNC1999 treatment under these conditions is not effective in improv-
ing Cas9 editing at sites in heterochromatin. We hypothesize that removal of the H3K27me3
silencing mark is not sufficient to remove the nucleosomes occupying the locus. To confirm
this, we will perform ChIP assay using an antibody agains unmodified H3.
We also do not observe the same inhibition pattern at these sgRNA target sites we
reported in chapter 2 for our silenced state compared to the active state. For the active
chromatin state, we see a close distribution of our replicates. The error for the silenced
state is very large, and for each sgRNA site, there is one biological replicate that showed
complete inhibition. Importantly, we see a trend of inhibition in the silenced +DMSO control
state when compared to active with p < 0.05 for all sites. This is also inconsistent with
our previously reported data in which we saw inhibition at sg046 and sg032 but not at
sg025 or sg048. In those assays, we used the less sensitive Surveyor assay while in these
assays, we are using deep sequencing to detect editing efficiency. We are repeating these
experiments to determine whether this variability is due to an experimental error or if
editing in heterochromatin is noisy.
3.4 Improving Cas9 Editing with Transcriptional Activators
Our previous work demonstrated that transcriptional activators can activate on gene
expression at luciferase after silencing (Figure 2.6. However, we did not explore whether
gene activation is associated with remodeling of the local chromatin. We hypothesize that
strong polymerase recruitment using the targeted, synthetic activator, Gal4-p65, could
result in nucleosome sliding away from the transgene, allowing for Cas9 to access the target
site. In chapter 2, we tested this hypothesis for a single target site by co-transfecting a
Gal4-p65 expressing plasmid with the Cas9/sgRNA plasmid and observed that high levels of
transcriptional activation might inhibit Cas9 (Figure 2.6). We hypothesized that after initial
recruitment of Gal4-p65, Cas9 is outcompeted by the transcriptional initiation complex and
polymerase. Waiting several days post-treatment with Gal4-p65 before transfecting with
the Cas9/sgRNA plasmid might allow for nucleosome repositioning to occur followed by
plasmid dilution and slowing of transcription at the target site. To test this, we measured the
change in Luciferase activity and chromatin state 9 days after treatment with the Gal4-p65
activator. We next measured how co-treatment and pre-treatment (9 days) effects Cas9
editing at a previously silenced target site.
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Figure 3.7. Using transcriptional activators to improve Cas9 editing. We are using a
targeted transcriptional activator, Gal4-p65, to activate transcription at the previously
silenced luciferase transgene to improve Cas9 editing.
3.4.1 Gal4-p65 Activates Transcription and Modifies Chromatin at Previously Silenced
Locus
To measure the effect of our activator on heterochromatin, we induced silencing at
luciferase in GAL4EED cells as described in chapter 2 Figure 2.1 by treating with dox for
96h. At 24h after dox removal, we transfected with the Gal4-p65 plasmid. After 3 days and
9days, we collected the cells and assayed for Luciferase activity. We performed ChIP only
on samples collected after 9 days.
In Figure 3.8a, we see that Gal4-p65 causes strong and sustained re-activation of
luciferase for both 3days and 9days. This is consistent with our previous results (Fig-
ure 2.6).54
Using ChIP-qPCR, we determined the change in H3K27me3 after treatment with the
Gal4-p65 activator. Similar to treatmentwithUNC1999, we saw a significant reduction in the
amount of H3K27me3 9days post transfection with the Gal4-p65 expressing plasmid (p <
0.005) (Figure 3.8b). This suggests that Gal4-p65 is either recruiting chromatin remodelers
that are removing the nucleosomes or the silencing mark, or that strong recruitment of RNA
polymerase is responsible for the change in chromatin.
To determine whether p65 localization results in addition of active chromatin modifica-
tions, we tested for the presence of an activatingmark, H3K4me3. We saw some reduction in
the mark between active and silenced though it was not significant (p = 0.06) (Figure 3.8b).
We did observe a significant increase in the active mark between the silenced state and the
reopened state (p < 0.01).
Interestingly, our data indicate that the active and silenced state have the H3K4me3
mark (Figure 3.8b). This mark is associated with bivalent promoters and is often seen
together with H3K27me3.110 This suggests that recruitment of PRC1 and PRC2 does not
55
-500	 -300	 -100	 100	 300	 500	
Luciferase
luc PCR
bp
UAS TK
bp-50        -3       -10         1         3         50  bp
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
1.4	
Ac+ve	 Silenced	 Gal4-p65	
(9	dy)	
luc	 TBP	
0	
1	
2	
3	
4	
5	
6	
7	
8	
Silenced	 Gal4-p65	
(9	dy)	
luc	 TBP	
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
1.4	
1.6	
Lu
c1
4	
Ga
l4
+d
ox
	
Ga
l4
-p
65
	
Ga
l4
-p
65
	(9
	d
y)
	
a b
Tk-luciferase expression
Lu
c 
si
gn
al
 /
 c
el
l (
no
rm
)
E
nr
ic
hm
en
t (
%
 In
pu
t)
H3K27me3
Ac
tiv
e
Si
le
nc
ed
+G
al
4-
p6
5
+G
al
4-
p6
5 
(9
d)
l c P7
5
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
-500	 -300	 -100	 100	 300	 500	
TBP PCR
bp-5        - 0      -         0        0         bp
H3K4me3
l
1.4
1.2
1
.8
0.6
.4
0.2
0
Gal4-p65
(9d)
Silenced
E
nr
ic
hm
en
t (
%
 In
pu
t)
l -
(9d)
ilti
Tk-luciferase chromatin profile
Figure 3.8. Targeted transcriptional activator Gal4-p65 increases Luciferase expression
and modifies local chromatin. GAL4EED cells were treated with doxycycline (dox) for 96h
and transfected with the Gal4-p65 expressing plasmid. (a) Gal4-p65 increases gene
expression at the previously silenced luciferase transgene. Luciferase expression was
measureed after 3 days or 9 days. Error bars indicate standard deviation of n = 3 biological
replicates. (b) Gal4-p65 reduces H3K27me3 at the luciferase transgene. H3K4me3 is
present in each chromatin state but increased after treatment with Gal4-p65. Error bars
indicate standard deviation of n = 3 replicate pulldowns from a single chromatin prep.
result in removal of H3K4me3 at our site. Unfortunately, the literature does not point
to a single chromatin modification associated with p65. In order to determine whether
recruitment of Gal4-p65 results in the addition of an activating mark, we will need to screen
other activating marks.
3.4.2 Effect of Gal4-p65 on Cas9 Editing
To measure the effect of our activator on heterochromatin, we again silenced GAL4EED
cells with dox for 96h. At 24h after dox removal, we transfected with either the Gal4-p65
plasmid and the Cas9/sgRNA plasmid (for co-treatment) or the Gal4-p65 plasmid alone
(for pre-treatment). For co-treated samples, we collected to assay for editing efficiency 72h
post-transfection. For pre-treated samples, we transfected with the Cas9/sgRNA plasmid
9days after Gal4-p65 transfection and collected to assay for editing efficiency 72h later. We
tested four sgRNA target sites: sg046, 32, 25, and 48 (Figure 3.6a).
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Figure 3.9. Transcriptional activator effect on Cas9 editing. (a) Map of the luciferase
transgene and the sgRNA target sites. (b) Heat maps of the mutational frequency.
(c) Comparison of editing efficiencies at each sgRNA target site in each chromatin state.
In (b) and (c), open chromatin (active), closed chromatin (silenced), reopened with
Gal4-p65 after 3 days (+Gal4-p65), and opened with Gal4-p65 after 9 days (+Gal4-p65
(9d)). In (c), dots indicate individual replicates and bars indicate the average of the three
biological replicates. Note: “Active” and “Silenced” data are the same data presented in
Figure 3.6.
Active and Silenced controls in Figure 3.9b and c are the same data presented in Fig-
ure 3.6. In subsection 3.3.3 we discuss the inconsistency with these data and the data we
presented in chapter 2 Figure 2.3 and the variability observed in the Silenced controls.
For all target sites, we do not see any improvement in editing after co-treatment or
pre-treatment when compared to the silenced controls. At sites sg046 and sg048, co-
treated samples show significant reduction in editing when compared to pre-treated samples
(p < 0.01). These data support our hypothesis that inhibition of Cas9 by targeted over
expression diminishes with time.
While not significant, the Gal4-p65 pre-treatment data show a trend toward higher
editing efficiency over the silenced state. As discussed above, the silenced state data are
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noisy. However, the silenced state treated with DMSO used as the control for the UNC1999
experiments (Figure 3.6) showed significant reduction in editing when compared to the
active controls for each target site. We do not expect the low volume of DMSO added to
these cells is responsible for this reduction in editing and therefore are a suitable control for
our pre-treatment data. We compared editing efficiencies at each target site between the
silenced DMSO control and pre-treatment with Gal4-p65 (Figure 3.10). At sg046, we do
not see any improvement in editing after Gal4-p65 pretreatment (Figure 3.10b). At sg032
there is a slight increase in efficiency but the data are not significant (p = 0.07). At sg025
and sg048, we see significant editing improvements after pre-treatment (p < 0.05 for sg025
and p < 0.005 for sg048).
While more experiments are necessary, these data begin to support our hypothesis that
transient expression of transcriptional activators remodels chromatin to amoreCas9-permissive
state (Figure 3.10). However, hyperactive transcription further inhibits Cas9 editing (Fig-
ure 3.8). Further exploration should include weaker transcriptional activators to balance
chromatin reopening with moderate promoter activity.
3.5 Improving Cas9 Editing with Synthetic Guide RNAs
In adddition to artificially reopening silenced chromatin, we also tested whether increas-
ing the stability of the RNP using chemically modified sgRNAs improves Cas9 editing in
heterochromatin. The RNP is subject to degradation becasue of the single stranded RNA
extending from the complex. If the mechanism of chromatin inhibition is reducing, but not
blocking, access to target sites, increasing the stability of the RNP could keep more active
Cas9 molecules in the nucleus for longer. This would increase the number of tries over the
same time period and possibly increase the accumulation of edits.
We used synthetic sgRNAsmodified to have greater stability fromaddition of 2’-O-methyl
group and a sulfur atom substituted for an oxygen on the linking phosphodiester bonds
between the last three nucleotide on the 5’ and 3’ ends of the sgRNA (Synthego).126–128
SgRNAs modified in this way are resistant to degradation and show significantly improved
editing efficiencies compared to other RNP introduction techniques.
At this time, we only have editing efficiencies for one sgRNA site, sg032 (Figure 3.11a),
and only one biological replicate. In Figure 3.11b and c, we see that theRNP editing efficiency
is over five times greater than the active state with plasmid delivery. These preliminary data
suggest that delivery of RNP with synthetically modified sgRNAs greatly improves Cas9
editing at sites in closed chromatin.
It is important to note here that the controls we are using are not ideal and therefore
cannot say what is responsible for this improvement: the methods of Cas9 delivery (pre-
complexed RNP over plasmid) or increased stability of the modified sgRNA. When an RNP
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Figure 3.10. The effect of pre-treatment with transcriptional activator Cas9 editing
compared to DMSO control. (a) Map of the luciferase transgene and the sgRNA target sites.
(b) Heat maps of the mutational frequency. (c) Comparison of editing efficiencies at each
sgRNA target site for silenced samples treate with DMSO vehicle control (Silenced +DMSO)
or pre-treated with Gal4-p65 for 9 days (+Gal4-p65 (9d)). Dots indicate individual
replicates and bars indicate the average of the three biological replicates. Note: “Silenced
+DMSO” data are the same data presented in Figure 3.6.
is electroporated into the cell, it is immediately active. Cas9 delivery via plasmid requires
transcription, translation, RNP complex formation, and nuclear localization before editing
begins. To control for these differences, we will compare editing of RNP with modified and
unmodified sgRNAs. It is also possible that RNP delivery results in much higher protein
concentrations in the cell. For our plasmid experiments, we determine transfection efficiency
using the EGFP reported on our plasmid. To determine protein delivery efficiency, we will
performWestern blots using anti-Cas9 antibodies.
Even without knowing the mechanism, we can still conclude that RNP delivery of Cas9
with chemicallymodified sgRNAs is themost promising approach for improving Cas9 editing
in closed chromatin.
3.6 Future Work: Gene Expression and Cas9
The data reported in Figure 3.9b and c suggested that gene over-expression inhibits
Cas9 editing at some target sites. With this in mind, we designed experiments to determine
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Figure 3.11. Increased RNA stability greatly increases Cas9 editing at sites in closed
chromatin. (a) Map of the luciferase transgene and the sgRNA target sites. (b) Heat maps
of the mutational frequency. (c) Comparison of editing efficiencies at each sgRNA target site
in each chromatin state. In (b) and (c), open chromatin transfected with plasmid
expressing Cas9/sgRNA [active (plasmid)], closed chromatin transfected with plasmid
expressing Cas9/sgRNA [silenced (plasmid)], and closed chromatin electroporated with
Cas9/sgRNA ribonucleoproteins (RNPs) [silenced (RNP)]. In (c), dots indicate individual
replicates and bars indicate the average of the three biological replicates. Silenced (RNP)
includes data from a sinle experiment. Note: “Active” and “Silenced” data are the same data
presented in Figure 3.6 and Figure 3.9.
the threshold of artificial gene expression that Cas9 can tolerate. We hypothesize that while
low-levels of polymerase activity maintain an open chromatin state and allow for Cas9
access, over-expression results in competition with polymerase and observed reductions in
editing activity.
The Luc14 cell line used in these studies contains a constitutively expressed, genomic-
integrated TetR and a Frt site (section 3.2). We designed and built a vector for Frt-mediated
integration of a dox-inducible transcriptional activator system, Gal4-mCherry-p65. With this
system, we would be able to gradually increase gene expression at the luciferase transgene
and measure Cas9 inhibition.
Current progress includes construction of the integration plasmid and a kill-curve with
the selection antibiotic, hygromycin. Next steps to complete this project require generation
of the stable cell line, characterization of Luciferase expression in response to dox induction,
and measuring Cas9 editing at different expression levels. We hypothesize that in addition
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to overexpression resulting in Cas9 inhibition, distance from the transcriptional start site
will also effect sensitivity to expression levels.
3.7 Discussion
Here, we investigated methods for improving Cas9 editing at sites located in silenced
chromatin. First, we tested how artificial opening of closed chromatin effects CRISPR
editing activity. We compared two approaches: indirect activation via the disruption of
closed chromatin and fusion-mediated activation. The data presented in this chapter are
preliminary and donot conclusively demonstrate that these approaches significantly improve
Cas9 editing in silenced chromatin.
While UNC1999 effectively removed H3K27me3 from the Tk-luciferase transgene (Fig-
ure 3.5b), we did not see editing efficiencies similar to the active state (Figure 3.6b and c).
Furthermore, UNC1999 treatment did not increase Luciferase expression to levels similar
to the unsilenced state (Figure 3.5a) (Figure 4B). We hypothesize that UNC1999 removed
the silencing mark but that the histone proteins remained tightly compacted and continued
to inhibit Cas9. Future work should include screening other chromatin-inhibiting drugs
and testing combinations of drugs.
Pre-treatment with the Gal4-p65 activator shows the most promising improvement in
editing (Figure 3.10c). Co-treatment showed greater inhibition, supporting our hypothesis
that high levels of transcriptional activity can impede Cas9 editing through steric hinderence.
The work proposed in section 3.6 will test this hypothesis with consideration of the distance
from the transcriptional start site, where transcriptional initiation complexes might increase
steric competition. Future work should also include testing weaker transcriptional activators
to determine if they can initiate sufficient transcription to reopen silenced chromatin without
creating steric competition.
The key advantage of the activator Gal4-p65, or any fusion of a DNA binding domain with
a transcriptional activator, is the ability to target a single site, presumably without disrupting
the expression of other genes. Global chromatin modification by drugs like UNC1999 likely
will not be tolerated in many applications. While the fusion proteins tested in this study
are targeted to a Gal4 binding domain, they can be modified to be fused to dCas9 or other
targetable DNA binding domains making them widely applicable.72
However, there are also applications in which gene activation, even if targeted, will not be
acceptable. For example, if the target site is a global transcriptional activator or an oncogene
that initiates apoptosis, any expression could lead to further chromatin remodeling and
irreversible changes to the cell state. Chromatin remodeling without gene activation (i.e.
UNC1999 treatment) would be a better approach over targeted activation. Furthermore,
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broad-acting chromatin remodeling may be necessary for manipulating chromatin at multi-
ple sites or at sites for which DNA-binding modules cannot be designed (e.g., low complexity
sequences). Low molecular weight compounds do not require transfection and are easier to
deliver. By exploring both strategies, our work allows researchers to choose an appropriate
strategy specific to their experimental goals.
We also tested whether delivering Cas9 complexed with a chemically modified sgRNA
efficiently targets Cas9 to sites in closed chromatin. The chemicalmodification reduces degra-
dation of the protruding RNA fromCas9 increasing the stability of the RNP.126–128 Although
we currently have limited data, our synthetic guide RNA shows the greatest improvement
in editing in heterochromatin (Figure 3.11). As presented here, these experiments are not
well-controled in our current design and we cannot conclude what is responsible for the
improvement; there are several differences between our current control data set and this
treated sample. First, in our controls, we are transfecting plasmid DNA.We likely don’t have
active Cas9/sgRNA complexes until at least 24 h after transfection as we do not observe
EGFP expression until 24 h. With the synthetic guide approach, we are transfecting RNPs
which are likely immediately active when they enter the cell. Even with these limitations,
these results are very promising, andwe are performing additional experiments to determine
whether this is consistent across replicates as well as target sites.
3.8 Methods
3.8.1 Cell Lines and Plasmids
For this study, we used HEK293 cells carrying a firefly luciferase transgene (Luc14)
or the firefly luciferase transgene plus an inducible tetO-Gal4EED transgene (GAL4EED),
described previously (chapter 2).53,54 Briefly, in the GAL4EED cell line, chromatin state at
the Gal4UAS-TK-luciferase transgene can be controlled by the addition of doxycyclin (dox);
cells are open until treated with dox for 96h.54 The Gal4UAS-TK-luciferase transgene in
the Luc14 cell line remains open as there is no Gal4EED transgene. These states have been
characterized by luciferase expression assays and ChIP-qPCR.53,54
Cas9was transfected using pU6-(BbsI)_CBh-Cas9-T2A-EGFP (DNASUUnSC00746685)
built from pX330-U6-Chimeric_BB-CBh-hSpCas9 (a gift from Feng Zhang, Addgene plas-
mid #42230) (described in Daer et al.). The pU6-(BbsI)_CBh-Cas9-T2A-EGFP expresses
the human optimized Cas9 protein and EGFP from the same mRNA transcript. Guide RNAs
sg025, sg032, sg046, and sg048 were cloned into pU6-(BbsI)_CBh-Cas9-T2A-EGFP (de-
scribed in Daer et al.). Gal4-p65 transfections were done with plasmid CMV-Gal4p65_MV1
(DNASU UnSC00746686) which expresses the Gal4-mCherry-p65 fusion protein from a
CMV promoter.
62
Annotated sequences of the plasmids used in this study are available online.129
3.8.2 Cell Culturing and Transfection
Luc14 and GAL4EED were cultured using Gibco DMEM high glucose 1× (Life Technolo-
gies) with 10% Tet-free Fetal Bovine Serum (FBS) (Omega Scientific), 0.5 µg/ml puromycin
(puro) and 1% penicillin streptomycin (ATCC) and grown at 37 ◦C in a humidified 5% CO2
incubator. To induce chromatin silencing at luciferase in GAL4EED cells, puro was removed
and 1µg/ml of dox (Santa Cruz Biotechnology) was added to the media for 96h.
For transfections, cells were seeded in 12-well plates such that 24h later they were at
90% confluency. Lipid complexes were formed using 500ng plasmid, 3 µl Lipofectamine
LTX, and 1µl Plus Reagent (Life Technologies) per well and diluted in Gibco Opti-MEM
(Thermo-Fisher) to a final volume of 100µl per well. Cells were collected for analyses 72h
post transfection.
For UNC1999 treatment, powdered UNC1999 (Cayman Chemical) was dissolved in
DMSO to 10mM. Toxicity was determined using a dilution curve (data not shown). Gal4EED
cells were treated for 96h with dox to induce silencing. After 24h without dox, cells were
treated with 10mM UNC1999 by diluting 1 µl of 10mM UNC1999 per 1ml media for 72h.
Control cells were treated with 1 µl of DMSO (vehicle) per 1ml media. Cells were grown for
1 day in media without UNC1999 before Luciferase assay (described below), transfection
with Cas9/sgRNA plasmids (described above) or ChIP assay (described below).
3.8.3 Luciferase Assays
Cells were washed with PBS and collected with 0.2ml of trypsin-EDTA (0.25%) (Life
Technologies) and 0.5ml DMEM. Cells were pelleted at 200 g for 5min at room temperature,
washed with PBS, pelleted again, resuspended in 1ml of FACS buffer (1% FBS in 1× PBS),
and filtered with 35µm cell strainers (Electron Microscopy Sciences). Transfection efficien-
cies for each sample were determined by measuring the mCherry positive cells in 10 000 live
cells with the BD Accuri C6 Flow Cytometer and accompanying software (BD Biosciences).
Cell counts to normalize luciferase activity were determined by counting the number of live
cells in 20 µl from each sample by flow cytometry. Luciferase assay was performed in tripli-
cate, with 100µl of each sample diluted in 100µl D-luciferin diluted in buffer [Steady-Luc
Firefly HTS Assay Kit (Biotium)] according to manufacturer’s protocol, in CORNING and
Costar 96-well Plates, black sides, clear bottom (Bioexpress). One hundred µl of FACS buffer
with 100µl of diluted D-luciferin was used as background control. The reaction incubated
for 5min at room temperature with orbital shaking and luminescence was determined
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with a Synergy H1Multi-Mode Reader (Biotek). Luciferase activity normalized per cell was
calculated:
Luciferase
cell
= Luciferase signal −
background signal
cell count in 20µl× 100 µl20 µl
3.8.4 CRISPR Activity Assays
After 72h of growth post-transfection with pU6-(BbsI)_CBh-Cas9-T2A-EGFP (DNASU
UnSC00746685) with sgRNAs sg025, sg032, sg046, and sg048,54 cells were collected as
with 0.2ml of trypsin and 0.5ml of DMEM and spun for 5min at 500 g at room temperature.
Supernatant was discarded and cells were resuspended in 250µl of 1× PBS. To determine
transfection efficiency, 50 µl were counted by flow cytometry, gated for live cells, and the
percent of GFP positive cells was recorded. Genomic DNA was extracted from the remaining
200µl of cells using the QIAampDNAMini Kit (Qiagen) and eluted in 100µl of nuclease-free
water.
PCR of gDNA was performed using GoTaq 2× mastermix (Promega) using primers
P198/198 (sequences listed in Supplemental Table C.2) [95 ◦C for 10min; 34 x (95 ◦C for
30 s; 58 ◦C for 30 s; 72 ◦C for 120 s)]. Nested PCR was performed by diluting 2 µl of PCR
product into 500µl of water and Phusion High-Fidelity DNA Polymerase (Thermo Scientific)
(primers listed in Supplemental Table C.3). PCR reactions were purified using the Genelute
PCR Cleanup Kit (Sigma) and submitted to the Center for Computational and Integrative
Biology (CCIB) Core Facility (Massachusetts General Hospital, Cambridge, MA) according
to their requirements for sequencing.
3.8.5 Crosslinked Chromatin Immunoprecipitation
For p65 co-treatment ChIPs, Luc14s and Gal4EED + dox cells were transfected with
18µg p65 plasmid using the 100µl Neon transfection system (Invitrogen) following the
recommended protocol (1100V pulse voltage, 20ms pulse width, 2 pulses, with cell density
5× 106/ml). Cells were grown at 37 ◦C for 72h, fixed as described below, and sorted using
the BD FACSAria II cell sorter. Lysis and sonication steps were performed same day as
described below. For chromatin remodeler treatment ChIPs, Gal4EED + dox cells were
transfected with 18µg of each chromatin remodeler plasmid using the Neon transfection sys-
tem as described above. For p65 pre-treatment ChIPs, Gal4EED + dox cells were transfected
with Lipofectamine as described above and grown at 37 ◦C for 9 days.
Cells were washed and collected as described above and fixed with 1% formaldehyde
(Thermo Fisher Scientific) in 1× Dulbecco’s PBS for 10min. The reaction was quenched
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with 125mM glycine (Sigma) for 5min at room temperature with gentle rocking followed
by four washes with 1× PBS and Pierce Protease Inhibitors (Thermo Fisher Scientific), two
for 5min at room temperature and two without incubation. Cells were pelleted between
each wash at room temperature for 5minute at 500 g. During the last wash step, 10 µl of
cells were transferred to a new tube, diluted into 90µl of 1× PBS, and 20µl of cells were
counted via flow cytometry. Total number of cells were calculated for each sample. Cells
and nuclei were lysed with cell lysis buffer and nuclei lysis buffer. Chromatin was diluted in
500µl of ChIP dilution buffer [1% Triton X-100 (Santa Cruz Biotech), 2mM EDTA, 150mM
NaCl (Sigma), 20mM Tris-HCl, pH 8.0] and split into 1.5ml microcentrifuge tubes, 300 µl
per tube. Chromatin was sonicated using the Qsonica Q700A Sonicator with a 5.5 in Cup
Horn, spun for 10min at 4 ◦C at 1× 104 g, and efficiency was confirmed using the Agilent
2200 Tapestation. Sonicated chromatin from 5× 106 cells was diluted in 1.5ml siliconized,
low-binding tubes (Sigma) in ChIP dilution buffer to 1ml for each pulldown, except for
the p65 sorted experiments where chromatin from 1.5× 106 cells was used. Chromatin
was precleared by incubation with 20µl of Magna ChIP Protein A + G beads (Millipore)
(washed 3 times with 5mg/ml BSA (Sigma) in 1× PBS) for 3 h at 4 ◦C with nutation. Beads
were separated and removed using a magnetic rack (Invitrogen), 50 µl from each chromatin
prep was frozen for inputs, and chromatin was incubated with antibody [5 µl anti-Histone
H3 antibody (ab1791, Abcam); 5 µl anti-H3K27me3 antibody (07−449, Millipore); 3 µl
anti-H3K4me3 (ab8580, Abcam)] for 12h at 4 ◦C with nutation. Chromatin was incubated
with 20µl washed Magna ChIP beads for 3 h at 4 ◦C with nutation. Beads were washed at
4 ◦C 3 times, first with 1ml low salt buffer [20mM Tris-HCl, 2mM EDTA, 1% Triton X-100,
0.1% SDS (Sigma), 150mM NaCl (Sigma)], 1ml high salt buffer [20mM Tris-HCl, 2mM
EDTA, 1% Triton X-100, 0.1% SDS, 500mM NaCl], and 1ml tris-EDTA pH 7.6 (Sigma)
with 10min incubations with nutation between each wash. Beads were resuspended in
100µl elution buffer [1% SDS, 0.1M NaHCO3 (Sigma), 0.1M NaCl], inputs were thawed
and diluted with 50µl elution buffer, and all samples were incubated for 30min at room
temperature with nutation. Samples were incubated at 65 ◦C for 7 h for uncrosslinking, at
45 ◦C for 14h with 20µg of Proteinase K (Thermo-Fisher), and eluted in 50µl nuclease-free
water using the Genelute PCR Cleanup Kit (Sigma).
3.8.6 Quantitative PCR of ChIP DNA
Relative quantification of ChIP samples was performed using real-time quantitative
PCR and SYBR Green I master mix (Roche) as previously described.54 To adjust for input
dilution, log2 20 was subtracted from input Cp values.
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% IP DNA bound was calculated as 100 × 2Ct input−Ct IP. % IgG-IP bound (100 ×
2Ct input−Ct IgGIP) was subtracted from % IP DNA bound to calculate % IP enrichment for
H3K27me3 and H3K4me3 ChIP samples.
Primer sequences for site 1 were as follows:
5'–CGGCGCCATTCTATCCTCTA (forward);
5'–ATTCCGCGTACGTGATGTTC (reverse).
Primer sequences for TBP were as follows:
5'–CAGGGGTTCAGTGAGGTCG (forward);
5'–CCCTGGGTCACTGCAAAGAT (reverse).
3.8.7 RNP Electroporation
Synthetic guide RNAs and purified Cas9 protein were generous gifts from Synthego. RNP
complex formation and electroporation were performed following manufacturer protocols.
Briefly, 1 pmol of Cas9 protein and 9pmol synthetic sgRNAs were complexed together.
Cells were prepared for electroporation as described previously.54 RNP complexes were
electroporated into cells using the Neon Transfection system (Life Technologies) and the
10µL tips. Neon settings were as follows: pulse voltage 1500V; pulse width 30ms; 1 pulse;
with cell density 5× 106/ml.
3.8.8 Statistical Analyses
The percentage of edited reads was normalized to transfection efficiency for each sample.
Averages and standard deviations were calculated for each of n = 3 biological replicates.
To analyze ChIP-qPCR Assay data, averages and standard deviations were calculated for
each of n = 3 replicate IPs from a single chromatin preparation. For each cell/treatment
data set, percent IP DNA for site 1 and TBP were normaized to percent IP DNA for TBP.
The differences of means to compare cell/treatment data sets for both editing and ChIP
experiments were calculated using the two sample, one-tailed Student’s t test. For p < 0.05,
95% confidence with 2 degrees of freedom and a test statistic of t(0.05,2) = 2.920. For
p < 0.01, 99% confidence with 2 degrees of freedom and a test statistic of t(0.01,2) = 6.965.
66
References
(50) Tiwari, V. K., Cope, L., McGarvey, K. M., Ohm, J. E., and Baylin, S. B., (2008). A
novel 6C assay uncovers Polycomb-mediated higher order chromatin conformations.
Genome Research 18, 1171–1179, DOI: 10.1101/gr.073452.107.
(52) Aoto, T., Saitoh, N., Sakamoto, Y., Watanabe, S., and Nakao, M., (2008). Polycomb
group protein-associated chromatin is reproduced in post-mitotic G 1 phase and
is required for S phase progression. Journal of Biological Chemistry 283, 18905–
18915, DOI: 10.1074/jbc.M709322200.
(53) Hansen, K. H., Bracken, A. P., Pasini, D., Dietrich, N., Gehani, S. S., Monrad, A.,
Rappsilber, J., Lerdrup, M., and Helin, K., (2008). A model for transmission of the
H3K27me3 epigenetic mark. Nature Cell Biology 10, 1291–1300, DOI: 10.1038/
ncb1787.
(54) Daer, R. M., Cutts, J. P., Brafman, D. A., and Haynes, K. A., (2017). The Impact
of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells. ACS
Synthetic Biology 6, 428–438, DOI: 10.1021/acssynbio.5b00299.
(72) Polstein, L. R., Perez-pinera, P., Kocak, D. D., Vockley, M., Bledsoe, P., Song, L., Safi,
A., Crawford, G. E., Reddy, T. E., Gersbach, C. a., Carolina, N., and Surgery, O.,
(2015). Genome-wide specificity of DNA binding , gene regulation , and chromatin
remodeling by TALE- and CRISPR / Cas9-based transcriptional activators. Genome
research 25, 1158–1169, DOI: 10.1101/gr.179044.114..
(110) Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J.,
Fry, B., Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R.,
Schreiber, S. L., and Lander, E. S., (2006). A bivalent chromatin structure marks
key developmental genes in embryonic stem cells. Cell 125, 315–26, DOI: 10.1016/
j.cell.2006.02.041.
(123) Racey, L. A., and Byvoet, P., (1971). Histone acetyltransferase in chromatin. Evi-
dence for in vitro enzymatic transfer of acetate from acetyl-coenzyme A to histones.
Experimental Cell Research 64, 366–370, DOI: 10.1016/0014-4827(71)90089-9.
(124) Rea, S., Eisenhaber, F., O’Carroll, D., Strahl, B. D., Sun, Z. W., Schmid, M., Opravil,
S., Mechtler, K., Ponting, C. P., Allis, C. D., and Jenuwein, T., (2000). Regulation
of chromatin structure by site-specific histone H3 methyltransferases. Nature 406,
593–599, DOI: 10.1038/35020506.
(125) Konze, K. D., Ma, A., Li, F., Barsyte-Lovejoy, D., Parton, T., MacNevin, C. J., Liu, F.,
Gao, C., Huang, X.-p., Kuznetsova, E., Rougie, M., Jiang, A., Pattenden, S. G., Norris,
J. L., James, L. I., Roth, B. L., Brown, P. J., Frye, S. V., Arrowsmith, C. H., Hahn,
K. M., Wang, G. G., Vedadi, M., and Jin, J., (2013). An Orally Bioavailable Chemical
Probe of the Lysine Methyltransferases EZH2 and EZH1. ACS Chemical Biology 8,
1324–1334, DOI: 10.1021/cb400133j.
67
(126) Holden, K., Maures, T., Walker, J., Miano, J., Seclen, E., Christian, M., Bak, R.,
Goodwin, M., and Hazelbaker, D., Use of Synthetic sgRNAs for Highly Efficient
CRISPR Editing in Various Cell Types., Poster presented at the 2017 meeting on
Genome Engineering: The CRISPR-Cas Revolution, Cold Spring Harbor, 2017.
(127) Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld,
I., Lunstad, B. D., Kaiser, R. J., Wilkens, A. B., Bacchetta, R., Tsalenko, A., Dellinger,
D., Bruhn, L., and Porteus, M. H., (2015). Chemically modified guide RNAs enhance
CRISPR-Cas genome editing in human primary cells. Nature Biotechnology 33,
985–989, DOI: 10.1038/nbt.3290.
(128) Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E.,
Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., Uchida, N., Hendel, A., Narla,
A., Majeti, R., Weinberg, K. I., and Porteus, M. H., (2016). CRISPR/Cas9 β-globin
gene targeting in human haematopoietic stem cells. Nature 539, 384–389, DOI:
10.1038/nature20134.
(129) Daer, R. M., Barrett, C. M., and Haynes, K. A., Gal4 DNA-binding Fusion Tran-
scription Regulators. https://benchling.com/hayneslab/f_/5wovkOaK-gal4-dna-
binding-fusion-transcription-regulators/ (accessed Sept. 9, 2017).
68
Chapter 4
CAN THE NATURAL DIVERSITY OF QUORUM-SENSING
ADVANCE SYNTHETIC BIOLOGY?§
Quorum-sensing networks enable bacteria to sense and respond to chemical signals
produced by neighboring bacteria. They are widespread: over 100 morphologically and
genetically distinct species of eubacteria are known to use quorum sensing to control gene
expression. This diversity suggests the potential to use natural protein variants to engineer
parallel, input-specific, cell–cell communication pathways. However, only three distinct
signaling pathways, Lux, Las, and Rhl, have been adapted for and broadly used in engineered
systems. The paucity of unique quorum-sensing systems and their propensity for crosstalk
limits the usefulness of our current quorum-sensing toolkit. This review discusses the
need for more signaling pathways, roadblocks to using multiple pathways in parallel, and
strategies for expanding the quorum-sensing toolbox for synthetic biology.
4.1 Modules from Natural Quorum-Sensing Networks Can Be Decoupled and Integrated
into Synthetic Systems
Scientists first explored the genetic circuitry of a quorum-sensing system through basic
research of Vibrio fischeri, a symbiotic microbe that populates the light organ of the bobtail
squid, Euprymna scolopes. Researchers identified an operon called “Lux” that allowed indi-
vidual V. fischeri cells to produce a glowing phenotype by expressing Luciferase specifically
in dense bacterial populations.75 Explorations of other microbial genomes revealed dozens
of Lux homologs that are collectively known as HSL quorum-sensing networks.77–79 In
addition to bioluminescence, they found that these bacteria use quorum sensing to couple
population density with the onset of group behaviors such as virulence, biofilm formation,
sporulation, competence, and disruption of neighboring bacterial biofilms.76
Homoserine lactones networks aremore commonly known as N-acyl homoserine lactone
(AHL) quorum-sensing networks. However, our discussion includes LuxI-like synthases
that produce compounds with a homoserine lactone ring but groups other than the acyl
tail. In this review, we will consider homoserine lactone (HSL) to include AHLs as well as
non-acyl tail compounds. We will refer to HSL with an acyl tail as acyl-HSL.
§ This chapter was previously published as an article in Frontiers in Bioengineering and Biotechnology. See
Appendix D for the corrigendum. See section F.3 for a discussion of authorship and contributions. The original
citation is Davis, R. M., et al. (2015). Can the Natural Diversity of Quorum-Sensing Advance Synthetic Biology?
Frontiers in Bioengineering and Biotechnology 3, 1–10, DOI: 10.3389/fbioe.2015.00030.
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Figure 4.1. The structure of natural and artificial homoserine lactone (HSL) networks.
(a) Natural HSL quorum-sensing networks such as the luciferase expression system in
Vibrio fischeri regulate the expression of gene clusters (e.g., LuxR, I, C, D, A, and B).
(b) Quorum-sensing networks have been decoupled and used to build engineered, synthetic
systems to control the expression of any gene of interest (output). O = “Operator” binding
site for the regulator protein, p = constitutive promoter.
Homoserine lactones quorum-sensing networks generally consist of an HSL synthase
LuxI-like protein, an HSL-binding LuxR-like regulator, and promoters that are regulated by
LuxR-like/HSL complexes. The LuxI-like HSL synthase enzyme produces chemical signals
called HSLs.82,83 Most HSLs diffuse passively across the cell membrane, while some require
active transport. Quorum sensing is triggered when high external HSL concentrations
drive net influx, allowing HSLs to bind and activate a LuxR-like regulator. The activated
LuxR-like/HSL complex binds to a 20 base pair inverted repeat known as a Lux-like-box and
regulates expression of downstream genes (Figure 4.1A). Synthases from various species of
bacteria produce different HSL signals, and their corresponding regulators generally bind
their cognate HSL with varying levels of specificity.
Researchers have also identified two other families of cell–cell communication networks:
autoinducer-2 (AI-2) networks130,131 and autoinducing peptides (AIPs), also called peptide
pheromone networks.131,132 While AI-2 and AIP networks may be used in engineered
systems, the molecular components of HSL networks are simpler, more diverse, and require
little modification to function as expected when they are transferred into new host cells.
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These characteristics of the HSL family of quorum-sensing networks are well suited for
building sophisticated, multi-component, synthetic systems. Therefore, we focus primarily
on the HSL networks in this review.
Synthetic biologists and genetic engineers often use HSL quorum-sensing pathways to
engineer novel behaviors in prokaryotic microorganisms. In these engineered systems, quo-
rum-sensing pathways are used as a set of decoupled components where the HSL synthase
is the “Sender” component and the regulator and promoter are collectively the “Receiver”
component (Figure 4.1B).85 They can be employed as “genetic wires” linking the functional
elements of multi-component biological systems.133,134 The wires connect circuit compo-
nents within a cell or across a population of single or multiple strains. The Sender converts
an input stimulus into a transmittable signal, the HSL, which activates the Receiver. The
Receivermodulates expression of an output as designated by the designer (Figure 4.2A). This
input stimulus may be anything that activates a promoter, including heavy metals,135,136
specific wavelengths of light,90 biochemical signals secreted by pathogens,98,137 the hypoxic
microenvironment surrounding a tumor,138 and HSLs from tandem quorum-sensing net-
works.133 The output may be any gene controlled by a Lux-like promoter, such as a visible
reporter,90,97 ,133 cell motility,139 antimicrobial proteins,98,137 and anti-cancer drugs.138
The simplicity of these networks allows researchers to model how quorum-sensing-
controlled gene expression is regulated in response to HSL signal concentration.140–142
These models can inform how a quorum-sensing network should be implemented in a
synthetic circuit to achieve the desired behavior.140,141 Furthermore, dry lab researchers
have used modeling to demonstrate how quorum-sensing systems control group response
in the presence of noisy signal concentrations, supporting their use in synthetic biology as
robust circuit components.143,144
Incorporating quorum-sensing networks into production strains has advanced the field
of metabolic engineering. Quorum sensing has been used to synchronize gene expression
across a population to reduce cell-to-cell variability and to increase yields in engineered
strains.135,145–147 For example, by linking a Lux-based genetic oscillator with a gas phase
signal oscillator, researchers coordinated gene expression among 2.5 million cells across
5mm of space with minimal noise.135,145,146 Anesiadis et al. employed this type of circuit
in a production strain, where they engineered a cell-density-dependent switch using the Lux
system to control production of serine in an Escherichia coli knockout strain.147 Group-
controlled gene expression implemented by anHSL quorum-sensing network leads to overall
higher serine production.
Quorum-sensing networks are also used in genetic circuits to perform computation.
Tabor et al. took advantage of the diffusibility of HSL through agar to build a bacterial edge
detector using the Lux network.90 They demonstrated that stationary physical spacing of
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Figure 4.2. Homoserine lactone (HSL)-based genetic wiring supports the function of
sophisticated synthetic systems. (a) Quorum-sensing pathways used as wires to link an
input stimulus with expression of an output gene. (b) An edge detector expressed as Light L
Neighboring Dark. The absence of light (dark) allows HSL production to activate LacZ
(blue) in neighboring light-exposed cells.90 (c) Biocomputational systems implement
complex Boolean expressions by linking combinations of small molecule inputs (e.g.,
tetracycline aTc and arabinose Ara) to outputs (e.g., yellow fluorescence) using HSL
signaling.133
bacteria relative to different inputs drives controlled expression of an output. The circuit was
designed such that bacteria exposed to darkness expressed HSLs but no output (LacZ). The
circuit allowed only bacteria that were both adjacent to HSL-producers and exposed to light
to express LacZ, which resulted in a pigmented outline at the edges of a light-masked region
(Figure 4.2B). While most biocomputation is digital, Daniel et al. showed the versatility of
quorum-sensing networks by demonstrating analog computation using the Lux network;
their circuit converts logarithmic HSL input into linear fluorescent output over a large range
of HSL concentrations.89 Thus far, engineered biocomputation has used monolayers of
cells. Three-dimensional (3D) colony-printing techniques will increase the sophistication of
these systems.148 Controlled spacing of colonies based on HSL-diffusion rates could allow
engineering a temporal element into a split circuit.
In the preceding examples, the cells in each system are expressing the same circuit.
However, engineers may also coordinate gene circuits distributed among multiple popula-
tions. Brenner et al. used the Rhl and Las networks from Pseudomonas aeruginosa to build
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two strains of E. coli that form a biofilm together once both populations reach a threshold
density.91 Balagaddé et al. used components from the Lux and Las networks to engineer a
predator–prey relationship between E. coli strains.149 High predator population density
induces cell death in the prey strain, while high prey population density supports survival of
the predator strain. You et al. placed a cell death gene under the control of the Lux promoter
and built a bistable system that maintains a population density of a defined range.150 At
high cell density, the Lux network activates a cell death. At decreased cell density, the cell
death gene is inactive and the population begins to grow again. Computation may be split
across multiple strains, distributing the energy demands of a complex computation that are
too great for a single cell (Figure 4.2A).151,152 Wang et al. built a two-strain, three-input
biosensor in E. coli that produces RFP only in the presence of three heavy metal contami-
nants: arsenic, mercury, and copper.136 Cell 1 produces LuxI after exposure to arsenic and
mercury; Cell 2 expresses RFP in response to N-(3-oxo-hexanoyl)-L-homoserine lactone
(3O-C6-HSL) produced by Cell 1 and copper. Tamsir et al. linked circuits expressed in mul-
tiple cell populations using two quorum-sensing networks derived from P. aeruginosa, Rhl
and Las (Figure 4.2C).133 They implemented complex Boolean expressions using different
spatial arrangements on agar plates. Their system is built with the functionally completed
NOR operator and can implement any Boolean expression.
4.2 Crosstalk Between Quorum-Sensing Pathways Challenges the Development of Syn-
thetic Genetic Circuits
Attempts to isolate, study, and apply quorum-sensing pathways for bioengineering is
often thwarted by unexpected crosstalk. Quorum sensing is a popular tool among synthetic
biologists for designing multicellular systems, but widely utilized HSL quorum-sensing
networks are currently limited to three pathways: Lux, Las, and Rhl. These networks
all exhibit crosstalk with each other, complicating the design of complex genetic systems
implemented with quorum-sensing networks.
For instance, a single regulator can be activated bymultiple acyl-HSL-class molecules, re-
sulting in cross-activation of regulators from different species of bacteria. This phenomenon
was observed in a proof-of-concept system designed by Canton et al. wherein an output gene
for green fluorescent protein (GFP) was placed under the control of a LuxR receiver mod-
ule.97 ,100 Four chemically distinct acyl-HSLs, N -hexanoyl-L-homoserine lactone (C6-HSL),
N-heptanoyl-L-homoserine lactone (C7-HSL), N-(3-oxo-octanoyl)-L-homoserine lactone
(3O-C8-HSL) and, at higher concentrations, N-octanoyl-L-homoserine lactone (C8-HSL),
all activated expression of GFP at levels comparable to or even greater than the cognate
LuxI acyl-HSL, 3O-C6-HSL.97 Many different HSL synthases, including EsaI, ExpI, and
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AhlI, produce the same major cognate acyl-HSL as LuxI, suggesting that these pathways
would have high levels of crosstalk if built into the same network.85,153 In the report of their
predator–prey, two-strain system, Balagaddé et al. discussed low-level crosstalk between
LuxI and LasR,149 which was recently confirmed by observing LuxI and LasR interactions
in a single-strain system /.100 However, Balagadde’s system functioned such that crosstalk
was apparently below the threshold for altering intended behavior.149 Interestingly, this
type of crosstalk is also observed in nature.77 For example, two opportunistic pathogens,
Burkholderia cepacia and P. aeruginosa, are known to co-infect patients with cystic fibro-
sis.95 Each pathogen’s quorum-sensing regulators respond to the other’s HSLs, resulting in
coordination of virulence-gene expression.
Crosstalk can also occur at the level of the target, or “output,” gene; similarities between
promoter sequences and the DNA-binding domains within the regulator proteins contribute
to crosstalk between quorum-sensing pathways. The acyl-HSL-activated LuxR regulator
stimulates transcription at its cognate promoter as well as the Esa promoter, while acyl-
HSL-activated LasR, EsaR, and ExpR regulators are also capable of initiating transcription
at the Lux promoter.84,98,99 While this type of crosstalk can be avoided by using only one
regulator per strain, they will not behave as two orthogonal wires within a single cell.
4.3 Expanding the Set of Orthogonal Quorum-Sensing Pathways Enables Design of Com-
plex Genetic Circuits
Synthetic circuits may be engineered to detect specific combinations of input signals
so long as each sensing pathway functions independently (orthogonally) without unde-
sired intercommunication (crosstalk). Genetic circuits designed to respond to complex
combinations of environmental conditions must distinguish and integrate multiple distinct
input signals. Orthogonal quorum-sensing pathways are necessary to implement complex
circuits that respond to signals produced by living cells, rather than requiring synthetic,
exogenous inputs. Engineered division of labor is a major research area in metabolic engi-
neering;154,155 orthogonal quorum-sensing modules will enable further development of
cell-autonomous metabolic regulation in multi-strain bioreactor systems. Quorum-sensing
circuits could be used to engineer multi-strain, self-monitoring microbial populations that
perform energetically expensivemetabolic processes in a single culture. Multiple co-cultured
strains could be designed to monitor and maintain a target population ratio, or steps in a
metabolic process could be timed for accumulation of precursors.133
Circuit sophistication is limited by metabolic capacity, transcription and translation
resources, and crosstalk within the cell. Moon et al. pushed the bounds of single-cell compu-
tational capability by building a four input AND gate in E. coli.156 Their complex logic gate
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allows living bacterial cells to express GFP in the presence of four exogenous compounds
and no fewer. Transcription activator complexes were decoupled and placed under the
control of distinct inducible promoters that respond to the presence of soluble compounds
(arabinose, IPTG, tetracycline, and the acyl-HSL 3O-C6-HSL) in the cell culture medium.
More complex circuits could be implemented by replacing the exogenous inputs in theMoon
et al. system with quorum-sensing wires linking cells performing independent computa-
tion.156 Scaling can be achieved through modularity by building complex computational
systems with simple independent components. By designing the components in separate
strains and connecting them with orthogonal quorum-sensing wires, computational steps
can be performed independently without exhausting cellular resources.
Connecting complex circuits requires orthogonal HSL networks to independently signal
each strain’s computation. However, using even two quorum-sensing networks in parallel
is constrained by crosstalk. To our knowledge, there is no published demonstration of
three or more orthogonal quorum-sensing networks in a single system. The complexity of
multi-input integration circuits remains constrained by reliance on exogenous signals and
by the limited number of orthogonal input–output pathways.
4.4 Strategies for Minimizing Crosstalk
Promiscuous interactions between HSLs and regulators, as well as between regula-
tors and promoters, prevent many quorum-sensing systems from operating independently
and in parallel. Some have used gene-network engineering approaches to mitigate cross-
talk.91,100,133,149 For instance, Brenner et al. engineered their system to avoid crosstalk
between the Las and Rhl networks.91 They split the networks between two strains to elimi-
nate promoter–regulator crosstalk and controlled HSL synthase production via a positive
feedback loop to achieve a two-strain, biofilm-forming consortium.
Another approach to eliminate crosstalk between signaling pathways is using quorum-
sensing pathways from distinct families (the aforementioned HSL, AI-2, and AIP pathways).
Significant variance in the chemistry of the signaling molecules suggests that cross-reactivity
is unlikely: HSLs contain a lactone ring with a hydrocarbon acyl or aryl tail, AI-2 is a
furanosyl borate diester composed of two five-membered rings stabilized by a boron atom,
andAIPs are relatively large circular peptides composed of amino acids.157 ,158However, this
approachmay be limited in its flexibility since both AI-2 and AIP require active transport and
multiple proteins to generate and detect the signals. With a few exceptions, HSL networks
require only two proteins and one promoter. While AI-2 quorum sensing is limited to only
one signaling molecule, multiple AIP pathways may exist that do not have cross-reactivity.
Marchand et al. recently demonstrated modularity and orthogonality of two AIP signals
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from Staphylococcus aureus.158 In their system, E. coli was the AIP sender, producing and
secreting two AIPs, and two engineered strains of Bacillus megaterium each received one
of the signals but not the other. While the ability to use two AIPs in a single cell was not
explored, this is a promising result and further research could demonstrate orthogonality
between AIPs and HSL quorum sensing.
Directed evolution could also be used to generate regulator proteins that specifically
respond to any desired HSL. Mutational analyses and 3D protein structure data have helped
to identify key amino acid residues that govern the interaction between regulators and
acyl-HSL ligands. Using positive and negative selection, Collins et al. generated a LuxR
mutant that no longer responds to the cognate 3O-C6-HSL but gained responsiveness to N -
decanoyl-L-homoserine lactone (C10-HSL), to which wild-type LuxR does not respond.159
They then demonstrated the orthogonality of LuxR wild type versus the mutant. However,
directed evolution of regulator proteins to generate novel orthogonality is technically daunt-
ing and only generates mutants with minor changes to the wild-type binding pocket, limiting
the range of possible novel behaviors. Furthermore, they bind to and activate the same
promoter and, while this feature could be leveraged to build OR gates, they cannot be used as
orthogonal networks in the same cell without further mutagenesis to alter promoter-binding
specificity.
Finally, scientists could explore other microbial genomes for quorum-sensing homologs
that have not yet been exploited for synthetic biology. Comparative genomics has identified
dozens of HSL family (Lux-like) homologs in divergent species.80 A major advantage of
exploring wild-type homologs over directed evolution is that natural evolution has already
“discovered” functional regulators in a very broad exploration space of amino acid sequences.
Evolution has selected for regulator proteins of significantly different sizes, as opposed to
artificial selection techniques that, due to practical constraints, do not deviate significantly
from pre-existing primary structures.
4.5 The Basis of Specificity in the HSL Signaling Family
Investigations of microbial quorum-sensing pathways have revealed molecular charac-
teristics that underlie the diversity of HSL signaling pathways in different species. These
signaling pathways have been distinguished on the basis of the operator binding sites at
promoters elsewhere.160 In this review, we focus on diversity in the geometries of HSL
signaling molecules and the HSL-binding pockets within the regulator proteins.
The extensive molecular diversity of naturally occurring HSL signaling molecules sug-
gests that many functionally distinct HSLs, and thus orthogonal pathways, may exist. HSLs
vary in the R-group, an acyl or aryl tail that extends from a homoserine lactone head (Fig-
ure 4.3).79 HSL synthases have been reported to generate HSLs of varying carbon chain
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Figure 4.3. Structural diversity of homoserine lactone (HSL) signaling molecules that are
produced by bacteria. Representative variants are shown.
lengths, branching functional groups, and hydrocarbon saturation (Figure 4.4). Straight-
chain acyl R-groups vary by chain lengths (e.g., N -butyryl-L-homoserine lactone (C4-HSL)
versus C6-HSL in Figure 4.3) from 4 to 18 carbon atoms. Some acyl R-groups carry side-
group replacements at the third or fourth carbon in the chain: a carbonyl group at C3 (e.g.,
3O-C6-HSL), a hydroxyl group at C4 (e.g., N-(3-hydroxy-hexanoyl)-L-homoserine lactone
(3-OH-C6-HSL)), or a methyl group at C3 (e.g., branched-chain isovaleryl-HSL). Aryl R-
groups have a phenol group at C4 (N -(p-Coumaroyl)-L-homoserine lactone (pC-HSL)), or a
phenyl group at C4 (cinnamoyl-HSL). R-groups also differ by the degree of saturation in the
carbon chain (e.g., monounsaturated 3OH-C14:1); unsaturation results in a carbon–carbon
double bond, which changes the shape of the acyl tail, compared to the saturated form.
In some instances, a single synthase can produce two or more HSL variants. This variety
arises from the species-specific combination of acyl tails that are carried into the HSL
synthesis pathway by acyl-carrier proteins (ACPs) or aryl-CoA.163 Some HSL synthases
display promiscuity in ACP or CoA-binding affinity and can catalyze formation of several
different HSL molecules. Other HSL molecules show no overlap across species, suggesting
that the cognate regulators may have evolved to respond specifically to certain HSLs, and
orthogonal quorum-sensing systems may exist in nature.
Regulator proteins from theHSL quorum-sensing family (LuxR homologs) consist of two
major domains: an N-terminal autoinducer (HSL) binding region and a C-terminal region
that binds DNA (Figure 4.5). To visually compare the topologies of functional regions in
different regulators, we have generated scaled protein domain maps using descriptions from
the literature164–167 and annotations from protein domain-scanning databases Uniprot,168
Prosite,169 InterPro,170 and the Protein Data Bank (Figure 4.5).171 Autoinducer-binding
regions (InterPro IPR005143) contain roughly six alpha helices and six beta strands. Pub-
lished 3D structures for TraR (PDB 1L3L),165 LasR (PDB 2UV0),166 CviR (PDB 3QP6),167
77
3 4 5 6 7 8 9 10 11 13 14 15 16 17 18
1 Pn
2 Py
2 !
2 ! !
1 ! ! O !
1 OH
1 Me
6 !
3 ! !
9 O
1 O !
1 O O
1 ! ! O
9 O O
1 ! ! ! !
1 ! !
5 !
2 OH
2 O
3 ! OH ! OH O
1+ ! ! O
1 ! OH
1 O O
1 ! =
1 ! O =  =O !
1 OH
3 !
1 !
1 ! OH
1 O
1 OH =
2
1
1 ! =O OH = =O = =O =
1 =
1+ !  =
1+ ! " =
1 =OH
1 !  = !  =
1 !  = !
1 = =
1 ! !
1 = =
1 !
1 =
1 =
1 ==
Carbon Chain Length
Synthases with 
this profile 12
!
O
!
!
"
!
!  =
!
HSL Synthase
RhlI P. aeruginosa
AsaI A. salmonicida
PhzI P. aereofaciens
PcoI P. corrugata
EanI P. ananatis
CviI C. violaceum
SpnI S. marcescens AS-1
YenI Y. enterocolitica
LuxI V. fischerii
TraI A. tumefaciens 
AhlI P. carotovorum EC153
LasI P. aeruginosa
AubI Unidentified bacterium
unk. B. melitensis 16M 
R-Group Carbon Chain LengthNo. Synthases with 
HSL Profile
l
l
=Ol
l l
l l
l
l l
l
l l
llll
ll
l
l
l O
H
l O
Hl l l
l
l
l l l O l
l
l l
ll
l
O
l
l
l l
l l
l l
l
	=
! Unmodified
O Carbonyl group at C3 (3O)
OH Hydroxyl group at C3 (3OH)
Me Methyl group at C3 (3CH3)
= Monounsaturated
== Diunsaturated
=O Monounsaturated and 3O
=OH Monounsaturated and 3OH
Pn Phenol group at C3 (3-phenol)
Py Phenyl group at C3 (3-phenyl)
! Trace amounts
! Hypothetical 
l
	
l
=O
Bacterium
=
=
nmodified
rbonyl group at C3 (3O)
ydroxyl group at C3 (3OH)
ethyl group at C3 (3CH3)
onounsaturated
iunsaturated
onounsaturated and 3O
onounsaturated and 3OH
Phenol group at C3 (3-phenol)
enyl group at C  (3-phenyl)
race amounts
ypothetical
1
2
2
2
1
1
1
6
3
9
1
1
1
9
1
1
5
2
2
3
1+
1
1
1
1
1
3
1
1
1
1
2
1
1
1
1+
1+
1
1
1
1
1
1
1
1
1
1
                       5                       7                       9          1           11          12         13  14          15         16          17          18
Figure 4.4. Diversity in homoserine lactone (HSL) produced by synthases across bacterial
species. Select synthases and representative species are shown in gray boxes. Each row
represents one or several HSLs produced by one or more synthase. The number of
synthases with each HSL profile is indicated. A (1+) indicates that the exact number of
synthases is not known. A comprehensive chart with referenced literature is provided as
Supplemental Material in Figure E.1 in Appendix E. Hypothetical = cases where one of two
molecules with identical mass [i.e., 3O-C(n)-HSL and C(n + 1)-HSL] might be produced by
the bacterium, but the molecules could not be resolved with mass spectrometry. * The
hypothetical monounsaturated N-dodecanoyl-L-homoserine lactone (C12-HSL) produced
by AbaI is not shown here.
and SdiA172 reveal that a five-strand beta sheet is sandwiched between two three-helix
bundles. The C-terminal DNA-binding domains are characterized as “helix–turn–helix”
(HTH) regions (Prosite PS50043) that consist of four alpha helices. The second and third
helices within the HTH region are often identified as a conserved H–T–H motif (Prosite
PRU00411); the third helix has been characterized as the DNA recognition helix in TraR.165
When HSL molecules bind to their corresponding quorum-sensing regulator, they often
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Figure 4.5. Comparison of protein motifs in select regulators. [This figure contains an
error regarding GtaR and is correctly described in Appendix D.] The three-dimensional
(3D) structure of TraR is shown as an example of how domains and the homoserine lactone
(HSL) ligand are typically positioned in space. The underlined letters in the
b–b–a–a–b–a–b–b secondary structure motif indicate the location of highly conserved
amino acids that form hydrogen bonds with the homoserine lactone head of HSLs.
Published 3D structure data (Protein Data Bank) are listed where available (“–” = not
available). Abbreviations used are: Reg. = regulator protein, H–T–H = helix–turn–helix,
a = alpha helix, b = beta strand, h = 3/10 helix. Database entries for conserved motifs are:
autoinducer binding = IPR005143, HTH LuxR-type = PS50043. Inferred binding pockets
are patterns of secondary structures that are similar to the TraR binding pocket. Inferred
recognition helices are the second alpha helix from the C-terminus. Secondary structures
for proteins with no available 3D structure data were mapped using the Jpred prediction
tool.161 Maps were generated using DomainDraw.162
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induce multimerization of regulator proteins. This multimeric state is the active form, ca-
pable of binding an inverted DNA sequence repeat at the target promoter and inducing
transcription of downstream genes.
Analysis of the HSL-regulator binding pockets suggests that the shape, size, hydropho-
bicity, and functionalization determine the binding affinity of a regulator for a specific HSL.
This implies that comparison of knownHSL–regulator interactionsmay identify likely candi-
dates for orthogonal quorum-sensing networks. For example, it has been hypothesized that
quorum-sensing systems that produce long, straight-chain acyl-HSLs have regulators with
longer binding pockets; likewise, a system that uses acyl-HSLmolecules with branching func-
tional groups will have regulators with binding pockets that accommodate the branches.166
Thus, taking sterics into account, a quorum-sensing system that uses HSL molecules with a
relatively short hydrocarbon tail and bulky functional groups may be orthogonal to a system
that uses long-chain, non-branched HSL molecules.
Hydrophobic interactions between the HSL tail and amino acid residues within the bind-
ing pocket suggest that these binding interactions are dominated by van der Waals forces
(Figure 4.3).166 Because the HSL tail is buried within the binding pocket, the hydrophobicity
of each component also determines the entropic stability, with a predominantly hydrophobic
tail pairing stably with a predominantly hydrophobic binding pocket and less hydrophobic
tail pairing stably with a less hydrophobic binding pocket. Therefore, HSL tail and bind-
ing pocket hydrophobicity may be a predictor of orthogonality between quorum-sensing
pathways.
Pharmacophore models for HSL-regulator binding developed by Geske et al. support the
idea that functionalization of theHSLmolecule underlies binding pocket selectivity.173 Their
models are based on the response of Tra, Las, and Lux regulators to libraries of HSLs and
synthetic analogs in a system that used beta-galactosidase as the output gene. Comparison
of the atomic geometries of ligands reveals three general properties linked with HSL efficacy:
spacing of hydrophobic regions, hydrogen bond donor regions, and hydrogen bond acceptor
regions within the R-group attached to the lactone ring. For instance, TraR shows the
greatest response to a group of ligands in which the acyl tail contains one hydrogen bond
donor region followed by two hydrogen bond acceptor regions arranged in trans and ended
in a hydrophobic region.173
Conservation and divergence in the conformation of regulator N-terminal HSL-binding
regions support the idea that variation in HSL R-groups coordinates selective regulator–lig-
and interactions. Here, we explore whether motifs in the protein structures of regulators
provide insight into the underlyingmechanism ofHSL-binding selectivity. Primary sequence
alignments show 10% to 25% identity in regulator homologs166 and therefore provide very
limited information. We have attempted a more coarse-grained approach on a select set
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of well-characterized regulators by annotating secondary structures that correspond to
the TraR binding pocket. For regulators that lack published 3D structure data, we have
annotated secondary structures as hypothetical HSL-binding pockets (Figure 4.5).
The autoinducer-binding region contains two functional domains in its tertiary structure:
themultimerization surface and theHSL-binding pocket. Themultimerization surface of the
TraR homodimer consists primarily of alpha helices a1 and a6,166 plus other residues within
loops that link helices and beta strands (Figure 4.5). The HSL-binding pocket binds a single
HSL molecule in the space between a five-strand antiparallel beta sheet and a three-helix
bundle.166 In the primary structure of TraR, these secondary structures are arranged in the
order of b–b–a–a–b–a–b–b. The first and second alpha helix and the last beta strand of
this motif (underlined in Figure 4.5) contain the amino acids that form hydrogen bonds
with the homoserine lactone head of the HSL ligand. These residues are highly conserved in
LuxR protein homologs, reflecting a common binding mechanism at the non-variable head
regions of HSL molecules. In contrast, the variable acyl tail extends into the region of the
binding pocket that is formed by residues that show less conservation in LuxR homologs,
suggesting a mechanism for HSL selectivity.166
TraR and SdiA are most responsive to the ligand 3O-C8-HSL.173,174 These regulators
contain the same b–b–a–a–b–a–b–b pattern of secondary structures in their HSL-binding
pocket domains (Figure 4.5). This pair of regulators fits the attractive idea that binding
pockets with similar secondary structures may prefer the same HSL ligands. However,
comparisons of other regulators challenge this idea. While some regulators that respond to
HSLs with smaller or larger R-groups deviate from the b–b–a–a–b–a–b–b motif, there are
others, i.e., RhlR, LasR, and SinR, which contain the same motif yet respond to different
ligands: C4-HSL, N-(3-oxo-dodecanoyl)-L-homoserine lactone (3O-C12-HSL), and N-
octadecanoyl-L-homoserine lactone (C18-HSL), respectively.173,175,176 It is possible that
variations in specific residues in RhlR, LasR, and SinR account for their preferences for
different ligands. AubR contains a substitution of the third beta strand with an alpha helix
in the b–b–a–a–b–a–b–b motif, similar to LuxR and BjaR. LuxR and BjaR respond to
3O-C6-HSL97 and isovaleryl-HSL,163 respectively. Assuming that the ligand for AubR is
N-dodecanoyl-L-homoserine lactone (C12-HSL) (produced by AubI81), AubR, LuxR, and
BjaR represent another set of regulators where similarities in secondary structures do not
appear to correspond to similar ligands. Exploration of the range of HSL-responsiveness of
these regulators may provide more insight into their structure–function relationships.
Interestingly, no HSL-regulator protein-related motifs appear in GtaR. Leung et al.
reported that GtaR regulates its target promoter (a Lux promoter homolog) in response to
N-hexadecanoyl-L-homoserine lactone (C16-HSL) and cell-free growth medium collected
from HSL-producing strains.177 GatR shows sequence conservation with the TatD family of
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deoxyribonuclease proteins. Like the LuxR homologs, TatD proteins contain interspersed
beta strands and alpha helices. Here, we have annotated predicted secondary structures
within GtaR; these domains are inferred from comparisons of GatR with closely related TatD
proteins that have published 3D structures. Given its distinct arrangement of secondary
structures, GtaR might represent a unique class of HSL-responsive regulator proteins. [This
text contains an error regarding GtaR and is correctly described in Appendix D.]
4.6 Conclusion and Discussion
The informationwe present here on the diversity ofHSLmolecules and regulator proteins
is insufficient to conclude that the structures of regulator binding pockets and the atomic
geometries of the HSL ligands imply orthogonality. Regulators that respond to distinct HSL
ligands show different protein folding patterns in some cases but similar structures in others.
With limited data on regulator promiscuity, secondary structure alone cannot predict HSL
ligand preference; thus, interaction between specific amino acid residues and atoms within
the HSL molecule may need to be considered. This investigation is limited by the lack of
3D structure data for LuxR homologs.
Many gaps in knowledge remain in understanding the extent of orthogonality or interac-
tion between the homologous pathways in living cells. To date, the published functional
studies of the quorum-sensing homologs in synthetic circuits (HSL synthases, regulators,
and promoters) include just three homologous quorum-sensing pathways, or they use puri-
fied compounds to stimulate one or a few regulators. Furthermore, the available 3D structure
data for regulator proteins is sparse compared to the total number of putative regulator
homologs that have been identified via metagenomic analysis.81 More comprehensive anal-
yses to study the responses of regulator proteins to different HSLs, such as that of Geske
et al., may enable us to predict and select orthogonal pathways for use in complex syn-
thetic systems.173 For instance, E. coli could be used as a universal host to carry dozens
of decoupled sender and receiver components (Figure 4.1), derived from the genomes of
various bacterial species. Culture media from sender strains could be used to stimulate
receiver strains carrying a reporter driven by a receiver system (regulator protein and its
corresponding promoter).
The discovery of novel orthogonal quorum-sensing pathways will provide metabolic
engineers and synthetic biologists with HSL signaling wires that do not cross-react. Using
these insulated, independently functioning pathways, synthetic circuits could be designed
to detect distinct combinations of multiple input signals and scale simple single-cell com-
ponents to sophisticated multi-strain circuits. It is imperative to continue research on
quorum-sensing pathway behavior across multiple disciplines, including crystallography,
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molecular biology, microbiology, metabolic engineering, and synthetic biology, to fill critical
gaps in knowledge that have prevented us from engineering highly sophisticated biological
systems.
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Chapter 5
CHARACTERIZATION OF DIVERSE HOMOSERINE LACTONE SYNTHASES IN
ESCHERICHIA COLI USING THE LUX QUORUM SENSING REGULATOR¶
Quorum sensing is used by over 100 bacterial species to regulate group behaviors, such as
bioluminescence, virulence, and biofilm formation, by sending and receiving smallmolecules
called HSLs. Bioengineers have incorporated quorum sensing networks into genetic circuits
using HSLs as chemical wires to connect logical operations. However, the development of
higher-order genetic circuitry is inhibited by crosstalk, in which one QS network responds
to HSLs produced by a different network. We selected ten synthases with narrow yet diverse
HSL production profiles to employ as our sender devices. Here, we use decoupled sender
and receiver systems to demonstrate the sensitivity of one receiver, the commonly used
Lux system, to HSLs from ten distinct synthases. This work represents the most extensive
comparison of QS networks to date and greatly expands the bacterial signaling toolkit.
5.1 Introduction
As described in chapter 1 and chapter 4, there are many examples of researchers incorpo-
rating quorum sensing networks into genetic circuits with increasing complexity. However,
in almost all cases, they use synthetic HSL molecules as the input. To continue pushing the
complexity of these engineered systems, researchers will need to spread components across
cells, which will require multiple, non-overlapping quorum sensing networks. There are
multiple levels of crosstalk between quorum sensing networks: synthase, regulator, and
promoter (Figure 1.6). This works addresses crosstalk due to synthase promiscuity: when a
synthase produces multiple HSLs (Figure 5.1). Recent efforts have led to identification and
engineering of regulators that respond to narrow ranges of HSL molecules (discussed in
chapter 1).87 ,88,102 In order to implement these tools in biological circuits, we will require
complementary synthases with narrow HSL production profiles.
We aimed to expand the quorum sensing toolbox by characterizing synthases novel to
engineered systems. Here we have characterized ten HSL synthases by their induction of a
popular receiver, BBa_F2620 in a commonly used lab chassis, Escherichia coli BL21. Each
synthase selected produces a narrow profile of HSLs while the set covers a wide variety
of tail lengths and modifications. We have submitted these parts to the iGEM Registry of
Standard Biological Parts so they can be accessed by anyone interested in utilizing them.
¶ This chapter is a manuscript in preparation. See section F.4 for a discussion of authorship and contribu-
tions.
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Figure 5.1. Synthase crosstalk in engineered systems. Synthases that produce narrow HSL
profiles induce regulators with complementary narrow response profiles. Promiscuous
synthases cross-induce multiple receivers resulting in network crosstalk. Figure modified
from Figure 1.6 in chapter 1.
5.2 Justification for Sender Media over Synthetic HSLs
Inducing with synthetic HSLs is a useful method for testing functionality of a receiver
and initial screening of potential orthogonality88,97 and has also been used to induce cir-
cuits containing quorum sensing regulators (discussed in chapter 4). However, circuits
utilizing quorum sensing networks for practical applications depend on induction with
HSLs produced by a synthase protein and not exogenously added synthetic HSLs. The HSL
profile of a synthase depends on the promiscuity of the enzyme for other substrates and the
availability of the on and off-target substrates. Thus, inducing with a single HSL, even if it is
the primary HSL produced by a synthase, will not provide the full picture of how a receiver
responds to a sender profile composed of multiple HSL species.
Synthase proteins catalyze the production of HSL molecules by facilitating lactone ring
formation from S-adenosyl methionine and attaching a tail to the lactone ring from one of
two donors. The most commonly observed donors are acyl carrier proteins (ACPs), while a
few synthases are known to accept from coenzyme A (CoA). ACP and CoA are involved in
many important pathways including fatty acid biosynthesis and degradation and thus carry
a wide variety of tails with different lengths, modifications, and levels of saturation.
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Table 5.1. Fatty Acid Biosynthesis Enzymes from Escherichia coli
Protein Gene
ACP Acyl carrier protein181 acpP
ACC Acetyl-CoA carboxylase182 acca–d
FabD ACP S-malonyltransferase183 fabD
FabH 3-oxoacyl-ACP synthase III184 fabH
FabG 3-oxoacyl-ACP reductase185 fabG
FabA 3-hydroxyacyl-ACP dehydratase179,186 fabA
FabZ 3-hydroxyacyl-ACP dehydratase179 fabZ
FabI Enoyl-ACP reductase I184 fabI
FabB 3-oxoacyl-ACP synthase I187 ,188 fabB
FabF 3-oxoacyl-ACP synthase II187 ,188 fabF
In E. coli, ACPs comprise 0.25% of all soluble protein, but the availability of an ACP
species with a particular tail within that population depends on the set of enzymes listed in
Table 5.1178 These enzymes are responsible for modifying and lengthening the tails on ACPs.
In Figure 5.2 we show the synthesis pathway for the commonly used LuxI precursor HSL,
3-oxo-C6-HSL. As shown in chapter 4 Figure 4.4, HSLs can bemuchmore complex, with tails
as long as 18 carbons with varying degrees of saturation and types of modifications. Each of
these modifications requires an additional enzymatic step, and thus the population of acyl-
ACPs varies across bacterial species and growth conditions. InE. coli there aremany enzymes
involved in modifying ACPs (Figure 5.2 and Table 5.1). Most of the reactions catalyzed
by these enzymes are bidirectional, and their activities depend on the concentrations of
the products, allowing for self-regulation of the biosynthesis pathway. Further pathway
control comes from high levels of competition for substrates between enzymes and negative
feedback of enzymes by acyl-ACPs.178 Furthermore, many of these enzymes have reduced
specificity for longer-chain substrates. FabA and FabZ, which catalyze the dehydration
of ACP chains by introducing a cis unsaturated bond at C2, have a ~5−fold reduction in
specificity for chains longer than ten carbons.179 Because of this, long-tail ACPs are found
at much lower concentrations in E. coli.180 It is possible that synthases which depend on
long-tail ACPs for synthesis of HSLs will produce them at low levels or will show higher
levels of promiscuity in the absence of their preferred substrate.
Previous work provides evidence for the dependence of synthase behavior on the chassis.
In Figure 5.3, we present data we estimated or extracted from three published studies by
Gould et al., Beck von Bodman et al., and Ortori et al. Gould et al. expressed LasI in E.
coli, measured HSL expression profiles, and found that LasI produced multiple HSLs in E.
coli, suggesting LasI can use multiple acyl-[acp] subtrates (Figure 5.3a and c).189 Ortori
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et al. characterized the LasI HSL production profile in Pseudomonas aeruginosa but, as
the multiple quorum sensing networks in this species are interdependent, it is difficult to
determine which HSLs are produced by which synthase. They generated knockout strains
but their data suggest that LasI does not function properly without RhlI and vise versa. While
we cannot say from their data which HSLs are produced by LasI in P. aeruginosa, we can
conclude that LasI generates a different profile of HSLs when expressed in E. coli. In E. coli,
20% of the HSL molecules produced by LasI were not measured in any of the wildtype (WT)
or knockout conditions in P. aeruginosa (Figure 5.3a and c).189,191 These include six HSL
molecules, with N -(3-oxo-undecanoyl)-L-homoserine lactone (3-oxo-C11-HSL) measured
above 10% and small amounts of 3-oxo-C6-HSL, 3-oxo-C8-HSL, N-(3-oxo-nonanoyl)-L-
homoserine lactone (3-oxo-C9-HSL), C12-HSL, and N-(3-oxo-tridecanoyl)-L-homoserine
lactone (3-oxo-C13-HSL) (Figure 5.3a and c). These data suggest that not only does LasI
have promiscuous substrate specificity, the species-dependent population of available acyl-
[acp] species influences the LasI HSL production profile. In contrast, EsaI expressed only
3-oxo-C6-HSL in both E. coli189 and in its native species Erwinia stewartii (Figure 5.3b
and c).84
Taken together, these data suggest that in order to understand the relationship between a
sender module and a receiver module, they must be tested together in the chassis of interest.
This is the approach we take in this study.
5.3 Initial Synthase Screen
We began by measuring the degree to which a small set of senders induced the Biobrick
part Bba_F2620, designed and thoroughly characterized by Canton et al.97 Canton et al.
measured how a LuxR receiver responds to induction by synthetic HSLs.97 In contrast,
we chose to measure the LuxR receiver response to HSLs produced by bacteria expressing
HSL synthase proteins (discussed above). F2620 constitutively expresses the LuxR regula-
tor protein and contains the inducible pLux promoter.97 We cloned EGFP (BBa_E0240)
downstream of pLux so that upon addition of a compatible HSL, LuxR will bind the pLux
promoter and induce EGFP expression. As discussed above, in contrast to Canton et al.,
we induced F2620 with media from E. coli BL21 expressing HSL synthases from a sender
plasmid (Figure 5.4a). The Lux system is known for its promiscuity and is often used to test
for the presence of HSLs in bacterial supernatants and therefore is a suitable receiver for
testing sender functionality. We built a modular sender vector into which we could easily
clone different synthase genes (Figure 5.4a). It also contains the pTet promoter, BBa_R0040,
which will allow users to switch to a drug-inducible system by using a chassis with the TetR
protein.192 Using this vector, we constructed a small library of senders, LuxI from Vibrio
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Figure 5.3. Homoserine lactone (HSL) profiles of synthase proteins depend on host
(chassis). Data estimated from Gould et al. and extracted from Beck von Bodman et al.,
Ortori et al. (a) LasI expressed in Escherichia coli produces HSLs not measured in
LasI-expressing Pseudomonas aeruginosa. (b) EsaI produces the same single HSL,
3-oxo-C6-HSL in E. coli and its native organism, Erwinia stewartii. * Indicates HSLs
measured in E. coli but not in P. aeruginosa.
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HSL species LasIα WTβ ΔRhlIβ ΔLasIβ EsaIα WT!
E. coli P. aeruginosaP. aeruginosaP. aeruginosa E. coli E. stewartii
C4 n.m 73.79 n.m 92.26 n.m n.m
3-OH-C4 n.m 1.18 n.m 3.87 n.m n.m
C6 n.m 4.85 n.m 3.87 n.m n.m
3-oxo-C6 ~1.09* n.m n.m n.m 100.00 100.00
3-oxo-C8 ~2.72* n.m n.m n.m n.m n.m
3-oxo-C9 ~1.09* n.m n.m n.m n.m n.m
3-oxo-C10 ~27.21 0.39 n.m n.m n.m n.m
3-oxo-C11 ~10.88* n.m n.m n.m n.m n.m
C12 ~1.09* n.m. n.m n.m n.m n.m
3-OH-C12 ~2.72 0.66 100.00 n.m n.m n.m
3-oxo-C12 ~43.54 18.09 n.m n.m n.m n.m
3-oxo-C13 ~2.72* n.m. n.m n.m n.m n.m
3-oxo-C14 ~8.16 1.05 n.m n.m n.m n.m
c
α data estimated from Gould, 2006
β data extracted from Ortori, 2011! data extracted from von Bodman, 1995
Figure 5.3. Continued. (c) Estimated and extracted values from Gould et al. and Beck von
Bodman et al., Ortori et al. expressed as precentages of total HSLs measured by solid-phase
extraction (SPE) liquid chromatography tandem mass spectrometry LC/MS/MS,189 fast
atom bombardment (FAB) MS-MS,190 or LC-MS/MS.191 * Indicates HSLs measured in E.
coli but not in P. aeruginosa.
fischeri, LasI and RhlI from P. aeruginosa, and EsaI from E. stewartii (Figure 5.4b). We
transformed a common lab chassis, E.coli BL21 with F2620_EGFP for our receiver device
and with each of the sender plasmids for our senders. We grew the senders and receivers
separately, collected and filtered sender media containing HSLs, and induced our receiver
device with dilutions of sender media (Figure 5.4c). We measured GFP and optical density
(OD) over time for each dilution using a plate reader.
In order to understand how each sender behaves with F2620, we measured GFP produc-
tion over time for several dilutions of media containing HSLs produced by our synthases.
We calculated the rate of GFP production for each concentration and fit those values with
the Hill function. In Figure 5.5a–d, we have plotted the Hill functions for each of the
synthases inducing F2620. As expected, the LuxI sender efficiently induces F2620 (Fig-
ure 5.5a). Consistent with previously published studies in E. coli, LasI did not induce LuxR
(Figure 5.5b).149 As shown in Figure 5.3a and c, LasI expressed in E. coli produced mostly
long-chain 3-oxo HSLs.189 Canton et al. did not test any of these HSL species but Balagaddé
et al. was able to build a predator-prey system based on orthogonality between the Las and
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Figure 5.4. Continued. (a) Modular sender plasmid used in this study. BsmBI cloning sites
downstream of the pTet promoter and strong ribosome binding site (RBS) allow for drop-in
of any synthase gene. Downstream from the cloning site is a second RBS and an mCherry
gene for expression of a fluorescent reporter off the same mRNA transcript. (b) Chart of the
synthases used in these experiments with the HSL profiles they are known to express in
their native organism as well as Escherichia coli when available. n.d. no data available.
(c) Cartoon of our experimental approach. E. coli BL21 expressing synthase proteins
(senders) or F2620 (receiver) were grown separately. Senders were pelleted and the media
containing HSLs was removed, filtered, and diluted. Receivers were grown with the filtered
and diluted sender media and optical density (OD) and GFP expression were measured to
determine rates of induction for each concentration of sender media.
Lux networks.149 RhlI did induce F2620 but only at higher concentrations (Figure 5.5c).
We expect RhlI to produce mostly C4-HSL which Canton et al. found only induced F2620
at high concentrations.97 However, Ortori et al. found that P. auruginosa only expressing
RhlI produced small amounts of C6-HSL and 3-oxo-C6-HSL.191 This suggests that RhlI
is capable of catalyzing the formation of these HSL species which are known to induce
LuxR.97 We hypothesize that RhlI produces C6-HSL and 3-oxo-C6-HSL at high enough
concentrations in E. coli BL21 to induce F2620. EsaI, which produces the same HSL as
LuxI, also induces F2620 (Figure 5.5d).
The Hill function provides us with additional information about the interactions between
F2620 and each synthase. Figure 5.5e shows a heatmap comparing the Hill function values
from our data set. Each of these values describes a different facet of the relationship between
sender and receiver. GFPmax tells us the maximum GFP expression F2620 produced. The
heat map quickly shows us that LuxI induces the highest expression levels but not much
higher than RhlI and EsaI. We also see that LasI did not induce above background. Vmax
tells us themaximum production rate. For a receiver device, this is the fastest rate a synthase
can turn the receiver on. All of the synthases but LasI can quickly switch F2620 to an active
expression state. Kd tells us the concentration of diluted media that corresponds to the
half-maximal GFP production rate. This can be thought of as how sensitive the receiver
is to the synthase media. The higher the value, the less sensitive the receiver is to that
synthase. Interestingly, even though LuxI induces F2620 to express the highest levels of
GFP, it requires higher concentrations of sender media to do so. It is possible that EsaI is
more efficient at catalyzing the formation of HSLs. Finally, n tells us how fast the switching
from uninduced to induced happens as concentrations of synthase media increase. In this
context, an n greater than 1 could mean that the regulator is unstable at low concentrations
of synthase media but is stabilized by binding an HSL molecule. Below that concentration,
regulator protein is degraded and there is little induction. Once the concentration threshold
is crossed, stabilized regulator accumulates and induces GFP production.
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Figure 5.5. Synthases induce LuxR receiver device.
99
Figure 5.5. Continued. (a) LuxI induces the LuxR receiver device. (b) LasI does not induce
LuxR above background. (c) RhlI induces LuxR but at a relatively lower level than LuxI and
EsaI. (d) EsaI induces the LuxR receiver device similarly to LuxI. (e) Heat map of values
from Hill equations fit to data in (a) through (d). GFPmax is the maximum level of GFP
expression measured. Vmax is the maximum GFP production rate. Kd is the concentration
corresponding to half-maximal GFP production rate. n is cooperativity of the regulator and
HSL molecules. GFP production rate = maximum value from the derivative of each dilution
curve. Dilution curves (not shown) were normalized to OD. Error bars in (a) through (d)
indicate s.d. of three biological replicates.
Presenting the data in this way allows readers to make comparative decisions about
which synthase might be most appropriate for a specific application. For example, onemight
want very fast, concentration-sensitive switching with low total expression of the output to
prevent stress on the chassis. One could quickly compare each sender and select a synthase
with relatively high Vmax, low n, and low GFPmax. The success of these preliminary sender
experiments encouraged us to expand our sender library.
5.4 Designing the Senders
We hypothesized that by building a library of senders with narrow HSL profiles, each
producing one or two unique HSLs, we would enable genetic engineers to build complex
circuits utilizingmultiple quorum sensing networks without crosstalk. Several recent studies
have engineered or identified receivermodules that respond to non-overlappingHSL profiles.
In order to fully take advantage of these new tools, we will need senders that produce
complementary non-overlapping profiles. For example, Tashiro et al. evolved LuxR to
respond only to either 3-oxo-C6-HSL or 3-oxo-C8-HSL.102 Complementary senders would
include one synthase that produces 3-oxo-C6-HSL but not 3-oxo-C8-HSL and a second that
produces 3-oxo-C8-HSL but not 3-oxo-C6-HSL.
With these goals in mind, we selected ten synthase proteins to characterize. We consid-
ered the length of the acyl chain, the chain saturation, and the number of different HSLs
produced by a single sender. As described in chapter 4, we searched the literature for all
known synthases and the HSL profiles they produce (Appendix E Figure E.1). From these,
we selected the following HSL synthases: RpaI, BraI, RhlI, BjaI, EsaI, LuxI, AubI, LasI,
and CerI. As shown in Figure 5.6a, this synthase set produces a wide range of HSLs with
chain lengths from 3 to 18 carbons and modifications such as phenol, phenyl, carbonyl, and
methyl groups. We include Lux as it is the most commonly used network and the cognate
sender to our F2620 receiver device. Also including EsaI may seem redundant as they both
produce 3-oxo-C6-HSL as their major HSL. However, Gould et al. showed that EsaI only
100
produces 3-oxo-C6-HSL in E. coli and therefore may have a narrower HSL profile than
LuxI. We also included SinI despite its promiscuity because of the unique HSLs it catalyzes,
including the unsaturated 3-oxo-7,8-cis-C16-HSL and the long chain C18-HSL.193
As discussed above, it is possible that some of these synthase proteins will produce
different HSL profiles in E. coli than their native species. Figure 5.6b shows the predicted
ACP substrates for each of theHSLs produced by the seven synthases that use ACP substrates
(RpaI, BraI, and BjaI use coenzyme A substrates Lindemann et al.). Figure 5.6c shows the
fatty acid synthesis pathway for E. coli. Colored boxes indicate when each substrate is
produced in the pathway. It is clear from this chart that longer chain HSLs require many
more enzymatic steps. For example, catalyzing the formation of N-(3-oxo-dodecanoyl)-L-
homoserine lactone (3-oxo-C12-HSL) from 3-oxo-C6-HSL requires 12 additional steps
while C18-HSL requires 27 additional steps. It is possible that synthases that produce longer
chain HSLs will produce lower concentrations than the shorter chain enzymes or that their
activity will be more promiscuous as is seen with LasI (Figure 5.3a).
5.5 Testing the Senders: Plate Reader Experiments
For these experiments, we modified the modular sender vector to have the cloning sites
EcoRI and XbaI (Figure 5.7. We followed the same approach illustrated in Figure 5.4c,
inducing F2620_EGFP with dilutions of sender media but induced at higher concentrations
than in the previous experiments.
We found that F2620 had ameasurable response to all but one of our senders (Figure 5.8.
We can conclude from these data that we successfully expressed all senders but SinI in E. coli
BL21. Consistent with our previous results, RhlI, LuxI, and EsaI induce LuxR. LuxR is highly
responsive even at low doses to those synthases as well as BraI and BjaI suggesting these
enzymes are functional in our chassis. LasI, AubI, CerI, and RpaI show induction above
background at all doses but LuxR is less sensitive to these synthases at low concentrations.
This could be due to LuxR insensitivity to theHSLs produced or low activity of these enzymes
in our chassis. To determine whether senders SinI, AubI, CerI, RpaI, and LasI are functional,
we will need to test these senders inducing their cognate receiver or a promiscuous receiver
sensitive to longer chain HSLs.
In our earlier data (Figure 5.5b), we did not see induction by LasI. However, in these
experiments, we see induction at our highest tested concentration, 50%. Balagaddé et
al. demonstrated functional orthogonality between the the Las and Lux networks. This
suggests that complete orthogonality is not necessary for functional orthogonality. If only
high concentrations of sender media are able to induce a receiver module, adjustments to
synthase expression levels by changing promoter and RBS strengths could be sufficient to
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Table 5.2. Homoserine lactone (HSL) Production Profiles and acyl carrier protein (ACP)
Substrates for the Synthases Used in this Study
Synthase HSL Species ACP Species Substrate
RpaI
[CoA substrate]
BraI
[CoA substrate]
RhlI
N-C4-enoyl-[acp]
BjaI
[CoA substrate]
EsaI
3-oxo-C6-enoyl-[acp]
LuxI
3-oxo-C6-enoyl-[acp]
N-C8-enoyl-[acp]
SinI
N-C8-enoyl-[acp]
N-C12-enoyl-[acp]
3-oxo-C14-enoyl-[acp]
N-C16-enoyl-[acp]
3-oxo-7-cis-C14-enoyl-[acp]
N-C18-enoyl-[acp]
AubI
N-C12-enoyl-[acp]
LasI
3-oxo-C12-enoyl-[acp]
CerI
7-cis-C14-enoyl-[acp]
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Figure 5.7. Updated modular sender vector. This sender vector was updated from the
vector shown in Figure 5.4 a. It includes XbaI and EcoRI restriction sites to clone in the
variable synthase proteins.
prevent crosstalk. Additionally, low level expression of a lactonase could be used to prevent
accumulation of the HSLs.
Recently, Scott et al. found that RpaI did not induce LuxR and built a network based
on their orthogonality.101 This further supports the hypothesis that full orthogonality is
not necessary for functional orthogonality. Importantly, Scott et al., built their system in
Salmonella typhimurium. It is also possible that RpaI does not produce the same HSL
profile in the two chassis. These data further emphasize the importance of testing quorum
sensing networks under relevant conditions for each application.
We attempted to fit Hill functions to each sender inducing the LuxR receiver device
(Figure 5.9). However, with only four doses, 0%, 10%, 25%, or 50% (Figure 5.8), the
resulting Hill equations are not representative of the behavior of the device. For senders
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Figure 5.8. Induction of F2620 LuxR receiver device with ten synthases. (a) GFP control
plasmid (green) and LuxR receiver grown in the absence of sender media (grey). LuxR
receiver device GFP production over time grown in 10% (purple), 25% (blue), or 50% (red)
dilutions of sender media for each of ten sender devices. Dotted green line and grey line on
each graph indicates the maximum GFP expression seen in the corresponding control in the
Control graph. Bars indicate standard deviation of three biological replicates. (b) Heat map
shows relative GFPmax of the LuxR receiver induced by each sender at three concentrations.
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Figure 5.9. Dose response curves for ten senders inducing LuxR receiver. Hill functions
were fit to the maximum induction rates (Vmax) for each media dilution for each sender
inducing the LuxR receiver device. Insufficient data points resulted in unreliable fit curves.
BraI, RhlI, BjaI, EsaI, and LuxI, the receiver is at close toVmax at the lowest tested dilution of
10%. Several dilutions below 10% should be tested to better understand the dose responses.
For senders RpaI, AubI, LasI, and CerI, the tested dilutions do not reach a production rate
plateau, suggesting these should be tested at higher concentrations.
5.6 Designing the Receivers
To complement our sender library, we also began the design work for constructing a
library of receivers. We decided to base our receivers on the Biobrick part F2620 with
some important changes. First, F2620 has very leaky expression of GFP in the absence
of sender media (data not shown). We suspect this is due to two reasons: read-through
by polymerase on the plasmid and LuxR regulator over-expression. The organization of
the genes could allow for read through from the strong constitutive Tet promoter across
the two transcriptional terminators. To address this issue, we reversed the order of the
pTet_Receiver_T_T and pInd_GFP_T_T (Figure 5.10). LuxR and most other quorum
sensing regulators are unstable and degraded in the absence of a compatible HSL.194 In the
presence of 3-oxo-C6-HSL, LuxR dimerizes and can bind its cognate DNA domain. However,
it is possible that over-expression of the Lux regulator protein allows the LuxR dimer to
form in the absence of the HSL and activate the promoter, resulting in high background
GFP expression. We therefore decided to use the RBS B0032 from the Biobrick registry
which is weaker RBS than used in F2620 Figure 5.10.195
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Figure 5.10. Modular receiver vector. The modular receiver vector has BbsI cloning sites to
drop in inducible promoters and EcoRI and XbaI cloning sites to drop in the receiver genes.
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For our initial screening and induction characterization experiments, we want constitu-
tive expression of all genes. Looking ahead to future applications of these parts, we provide
the option of independently inducible senders and receivers. We chose to make the senders
tetracycline (tet) inducible under control of the pTet promoter and the receiver regulator
IPTG inducible using the pLac promoter.192
We retained the HSL-inducible promoter structure used in F2620 for our new receivers.
Specifically, including the 20 bp palindromic regulator binding site upstreamof theV. fischeri
Lux promoter -35 region.
Receiver construction and characterization is ongoing in our lab. Preliminary results
confirm this receiver design is functional for other quorum sensing networks. Future work
will include induction tests with each new receiver and our library of senders.
Scott et al. built a similar library of receivers including LuxR, LasR, RhlR, Tra, Rpa,
Ahy, Sma, Cer, and Exp, but found that several of them were not functional in E. coli. They
hypothesized that the regulators were unable to properly interact with the E. coli sigma
factor. They found that mutating one amino acid in the Tra regulator resulted in a functional
TraR receiver in E. coli. After initial testing of our receiver library, we will similarly do
protein alignments on any regulators that do not respond to their cognate senders.
5.7 Preliminary Receiver Tests Confirm Sender Functionality
To validate the design of our receivers, we constructed a LasR device and tested its
response to the long chain synthases SinI, AubI, CerI, RpaI, and LasI. In Figure 5.11 we
see that LasI and AubI induces LasR at both low and high concentrations validating our
receiver design and LasI and AubI functionality in our chassis. LasR sensitivity to RpaI
and CerI is similar to LuxR: we see induction at high concentration at ~50% of LasI-LasR
induction but little induction at low concentrations. We can confirm that these synthases
are functional in E. coli but we will need to induce their cognate receiver to understand if
they are producing low levels or if they are potentially functionally orthogonal to both LuxR
and LasR. Finally, SinI shows induction of LasI above background at high concentrations
but these data suggest that SinI is not very functional in E. coli.
5.8 Methods
5.8.1 Construction of the LuxR Receiver
An inducible LuxR receiver, F2620_EGFP, was built from with the plasmids BBa_-
F2620 and BBa_E0240 (both gifts from iGEM Headquarters). BBa_F2620 contains the
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Figure 5.11. LasR receiver is sensitive to long chain synthases. The LasR receiver device
was induced with purified media from senders SinI, AubI, CerI, RpaI, and LasI. Heat map
represents GFP expression (A.U.) minus background (LasR with negative sender media) at
8 h post induction.
promoter p(TetR) controlling expression of the LuxR regulator and the LuxR-HSL regulated
promoter p(LuxR). BBa_E0240 contains an RBS, GFP, and two transcriptional terminators.
BBa_F2620 was cut downstream of p(LuxR) with SpeI (Thermo Fisher Scientific) and PstI
(Thermo Fisher Scientific). The RBS-GFP-Terminator insert was cut from BBa_E0240 with
XbaI (Thermo Fisher Scientific) and PstI and ligated into BBa_F2620.
5.8.2 Construction of the Modular Sender Vector
The modular sender vector was constructed from the vector pSB1A3 (a gift from iGEM
Headquarters). Using Phusion-based PCR, an insert was constructed that allows formodular
cloning of synthase sequences into the vector via the standard BioBrick cloning method.
The insert contains the promoter p(TetR) (BBa_R0040), followed by a multiple cloning site
(EcoRI, NotI, XbaI, and SpeI), a strong ribosome binding site (BBa_B0034), an mCherry
open reading frame (BBa_J06504), and two terminators (BBa_B0010 and BBa_B0012).
The insert was constructed by using Phusion polymerase (New England Biolabs) to amplify
the RBS-mCherry-terminators insert from the plasmid BBa_J06702 (a gift from iGEM
Headquarters). The promoter sequence was ligated with the remainder of the construct
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using T4 ligase (New England Biolabs). This final insert was cloned into the pSB1A3 vector
using the restriction enzymes EcoRI and PstI (Thermo Fisher Scientific). This vector was
used as the negative sender plasmid.
5.8.3 Cloning of HSL Synthase Homologs
The coding regions for the following HSL synthases were synthesized as double-stranded
oligos (IDT) with an EcoRI binding site upstream and a XbaI cut site downstream: AubI,
BjaI, BraI, CerI, EsaI, LasI, LuxI, RhlI, RpaI, and SinI. The Modular Sender Vector and each
HSL synthase oligo were cut with EcoRI and XbaI (Thermo Fisher Scientific) and ligated
using T4 ligase (New England Biolabs). Plasmids containing synthases not already in the
iGEM registry were submitted with the following identification keys: AubI BBa_K2033000,
BjaI BBa_K2033002, BraI BBa_K2033004, CerI BBa_K2033006, SinI BBa_K2033008.
The negative sender vector is the
5.8.4 Microplate Reader Induction Assay
Microplate reader induction assays were used to determine RFP 580nm to 610nm, GFP
485nm to 515nm, and absorbance (OD600) of E. coli BL21 (New England Biolabs) cells
induced with media expressed by sender construct cells.
5.8.4.1 Receiver Culture Preparation
Single colonies of E. coli BL21 cells transformed with F2620_EGFP or GFP positive
plasmid (pTrc99A vector expressing GFP from the pLac promoter) were inoculated in 3ml
of LB broth [25 g Acros LB broth Lennox granules (Sigma) in 1000mL water] with 5 µg/ml
ampicillin (VWR) and grown for 16h at 37 ◦C with shaking. OD600 values of the F2620
receiver and GFP positive control cultures were recorded. New cultures from each of culture
were seeded toOD600 = 0.05 and grown at 37 ◦C with shakingOD600 = 0.8. Cultures were
spun at 4500 g for 5min. Supernatants were discarded and cells were resuspended in fresh
LB with ampicillin to obtain final culture concentrations of OD600 = 0.8.
5.8.4.2 Sender Media Preparation
Single colonies of E. coli BL21 cells transformed with sender plasmids or negative sender
plasmid were inoculated in 3ml of LB with 5 µg/ml ampicillin (VWR) and grown for 16h
at 37 ◦C with shaking. Sender and negative sender cultures were spun at 4500 g for 5min.
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Table 5.3. Culture and Media Dilutions for Plate Reader Assays
Sender
Dilution
Spent media (µL)
Sender Negative Sender Total Receiver Culture (µL)
0% 0 150 150 150
10% 30 120 150 150
25% 75 75 150 150
50% 150 0 150 150
Supernatants were filtered with 0.22 µm nylon filters (VWR International) to remove any
remaining cells.
5.8.4.3 Plate Reader Setup
Corning Black Costar Clear Bottom 96 Well Plates (Fisher Scientific) were loaded with a
total volume of 300µl per well with a final OD600 of 0.4. Varying concentrations of sender
and negative sender media were used to ensure the same total volume of spent media per
well (Table 5.3). In addition to a total of 150 µl spent media, 150 µl of working receiver stock
was added per well.
Plates were run on a Biotek Synergy H1 Microplate Reader, measuring RFP, GFP, and
OD600 every 10min for 8 h at 37 ◦C with shaking. Automatic gain adjustment was set to
scale to the lowest detected well values for each measurement.
5.8.5 Induction Curve and Heat Map Analysis
Triplicate GFP signal (A.U.) for each sample (by sender type and concentration) was
divide by triplicate OD600 measurements at each time point. Mean GFP/OD600 was
calculated and plotted against time from 0min to 240min using Microsoft Excel 2016
(error = standard deviation). Logarithmic curves of best fit were added to each data set (by
sender type and concentration).
To generate the heatmap, maximummean GFP/OD600 for each sample type (by sender
and concentration) was determined regardless of time, although inmost cases the maximum
value was at the final time point. Maximummean GFP/OD600 values were conditionally
formatted to visually indicate lowest to highest values colorimetrically.
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5.8.6 Hill Function Analysis
For each sender type and concentration, the slope of the line tangent to the curve was
determined at 60min from the equations given for logarithmic curves of best fit determined
in the induction curve analysis (described above). This time point was chosen as the cultures
had all reached mid-log phase at this point. These slope values represent the rate of GFP
production V for each concentration of sender media by sender media type. GFP production
rate was plotted against log10 sender media percentages using GraphPad Prism software.
GraphPad Prism was used to determine theHillSlope, Vmax, and Kd values. A non-linear
regression analysis was used to graphmedia dilution vs. normalized response with a variable
slope.
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Chapter 6
DISCUSSION
6.1 Improving Cas9 Editing in Heterochromatin
The CRISPR/Cas9 system is a powerful tool that allows genetic engineers to make pre-
cise modifications to virtually any genomic locus.48 The list of applications continues to
grow, from high-throughput mammalian genome editing to targeted transcriptional control
to in vivo chromosomal tracking.49,61,196 Until recently, however, it was unclear whether
the bacterially-derived Cas9 protein could efficiently target loci in heterochromatin, the
DNA-protein complex that controls gene expression and nuclear organization in eukaryotic
cells.50–52 Our work presented in chapter 2 demonstrated that facultative heterochromatin
inhibits Cas9 binding and editing at some sites and is supported by other recent publica-
tions.54,69 To continue advancing its applications in eukaryotic genomes, we will need to
identify methods for improving Cas9 activity in heterochromatin.
In chapter 3we investigated strategies for enhancing Cas9 editing at target sites located in
silenced chromatin. We used a small molecule drug and a targeted transcriptional activator
to artificially reopen silenced chromatin (Figure 3.3). We found that the drug UNC1999
removed the silencingmarkwithout increasing target gene expression (Figure 3.5). However,
our preliminary data do not indicate that it effectively improves Cas9 editing (Figure 3.6). We
next tested whether targeting a strong transcriptional activator, Gal4-p65, to our transgene
pushes the chromatin to a more permissive state, allowing Cas9 editing to occur (Figure 3.7).
We found that co-treatment and pre-treatment with the Gal4-p65 activator increases target
gene expression and removes the silencing mark (Figure 3.8). Our preliminary data show
that pre-treatment with our targeted transcriptional activator improves Cas9 editing at
some of the sgRNA sites tested (Figure 3.9 and Figure 3.10). However, co-treatment did not
improve editing and showed significantly reduced editing when compared to the preteated
cells (Figure 3.9). In section 3.6, we propose experiments to determine how hyperactive
gene expression affects Cas9 activity. Future work will include further characterization of
the effect of transcriptional activators and chromatin-modifying drugs on Cas9 editing.
Finally, we found that delivery of Cas9 complexed with a degradation-resistent synthetic
sgRNA greatly increased editing in silenced chromatin, even over editing at the active state.
These early results are very promising and our future work will determine whether this
approach will provide consistent improvement of editing across many target sites. While
our data show editing improvement, we cannot conclude what is responsible for the in-
creased editing. We hypothesize that several factors contribute to Cas9 editing efficiency in
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chromatin. Our data suggest that heterochromatin inhibits, but does block, Cas9 editing.
We propose that subtle factors which impact Cas9 activity, such as RNP stability, time, and
sgRNA binding efficiency, are amplified when the Cas9 target site is occluded. This would
explain how tightly clustered target sites show different levels of inhibition by heterochro-
matin (Figure 2.3). We hypothesize that sites that are not sensitive to heterochromatin have
increased stability and binding affinity. Future work will involve computational prediction
of gRNA stability to identify correlation with sensitivity to chromatin state.
Taken together, the work presented in chapter 2 and chapter 3 advances the field of
genetic engineering by providing methods for improving Cas9 targeting in difficult-to-access
sites in heterochromatin.
6.2 Quorum Sensing
Quorum sensing networks have been widely implemented in engineered circuits as
genetic wires that use small molecules, commonly HSLs, to signal information.92 The full
potential of these networks has been hampered by crosstalk among them. To overcome this
limitation, we must identify and characterize orthogonal networks. Nature has provided us
with over 100quorumsensing networks, but only four have been extensively used in synthetic
biology. A series of recent publications has greatly expanding the number of receiver devices
available to genetic engineers: Scott et al. and Chen et al. built and characterized RpaR, TraR,
and CinR devices;87 ,88 Tashiro et al. mutated the promiscuous LuxR receiver to respond
to a single HSL, either 3-oxo-C6-HSL or 3-oxo-C8-HSL;102 Grant et al. reduced off-target
binding of the LasR regulator to the LuxR binding domain.103 Our work to build a library
of senders with narrow HSL profiles complements these efforts and enables researchers
to build more complex networks with minimal crosstalk. Our data presentation allows for
direct comparison of sender devices based on parameters such as sensitivity, total output,
and rate of induction.
All but one of the synthases we tested induced our LuxR receiver device, including
LasI and RpaI. Previous studies have demonstrated the orthogonality of LasI/LuxR and
RpaI/LuxR and implemented circuits without crosstalk.101,149We hypothesize that quorum
sensing networks do not need to be completely orthogonal in order to be functionally
orthogonal. In our study, LuxR was insensitive to LasI and RpaI at low concentrations.
Synthase expression could be controlled by usingweak promoters and ribosome binding sites
and by limiting HSL accumulation with lactonases to avoid crosstalk in a circuit. In addition
to these two synthases, AubI, CerI, and SinI induced LuxR at high concentrations but not
at lower concentrations. We propose these senders as potential functionally-orthogonal
synthases to the LuxR receiver.
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Our work also demonstrates the importance of testing quorum sensing networks in the
chassis of interest. Published mass spectrometry data show that LasI produces a different
HSL profile in Escherichia coli than in its native organism Pseudomonas aeruginosa.189,191
Furthermore, the RpaI/LuxR orthogonality observed by Scott et al. can also be explained
by having using different species for our experiments.101 Scott et al. used Salmonella
typhimurium whereas we used E. coli BL21. As discussed above, the abundance and
diversity of acyl carrier proteins and, in the case of RpaI, coenzyme A species will likely
determine the HSL expression profile for each sender. It is possible that RpaI produces
different ratios of HSLs in S. typhimurium and E. coli BL21. This can be determined using
mass spectrometry189–191
In addition to expanding the set of functionally orthogonal quorum sensing networks,
our work also allows for greater diversity of device behaviors. We observed a wide range of
sensitivities and production levels in the nine of ten synthases that induced the LuxR receiver.
By reporting theirHill function parameters, we allow researchers to directly compare senders
and select those which fit the profile for their application, enabling the design of more
complex circuits. These parameters can be incorporated into a computational model of
a circuit in order to determine the possible circuit behaviors and inform identification of
networks to test.
In addition to synthetic biology and engineering, our library of senders has applica-
tions in medicine. P. aeruginsa has been found in the microenvironment of certain breast
cancers.197 Zhao et al. and Balhouse et al. found that the major HSL produced by the Las
quorum sensing network in P. auruginosa can inhibit tumor growth.197 ,198 Researchers
can express additional senders in the BSL1 E. coli and screen for tumor suppression activity.
Complete characterization of this library will require testing of how each sender induces
our library of receivers as well as measuring its HSL profile in E. coli BL21 by mass spec-
trometry. As described in chapter 5, receiver devices are under construction and we are
gathering induction data for more sender/receiver pairs. Mass spectrometry will confirm
whether our senders have narrow HSL profiles and are capable of selectively inducing a
single receiver device. In tandem with the newly published selective receivers, our work
will significantly expand the number and diversity of engineering-ready sender and receiver
devices.
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APPENDIX A
SUPPORTING INFORMATION FOR THE IMPACT OF CHROMATIN DYNAMICS
ON CAS9-MEDIATED GENOME EDITING IN HUMAN CELLS
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This appendix was previously published as supporting information for Davis et al.92
Figure A.1. Chromatin mapping data show differential enrichment of dCas9/sg034 at
luciferase in the open, partially closed, and closed chromatin states. Cross-linked, sheared
chromatin was prepared from Luc14 (unsilenced), GAL4EED (partially silenced), or
GAL4EED+dox (fully silenced) cells. An anti-FLAG antibody was used to IP chromatin
from dCas9_gRNA-transfected cells. Quantitative PCR (qPCR) was used to measure IP’ed
DNA. Primer set Site 1 described in Methods. A primer pair located at the constitutively
active GAPDH promoter was used as a negative control to determine off-target binding.
Enrichment shown as percentages of input minus background (IgG mock IP and GAPDH).
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Table A.1. List of sgRNAs
sgRNA
name
Target Sequence Distance from
translational
start site (bp)
Editing
efficiency
Off-
target
score*
sg023 ATAAATAACGCGCCCAACAC 276 21.74 92
sg025 TTGGAAACAAACACTACGGT 372 25.08 84
sg029 CATAGCTTCTGCCAACCGAA 184 15.47 86
sg030 TTCATTATAAATGTCGTTCG 316 22.72 86
sg031 CGAGGTGAACATCACGTACG 157 38.59 92
sg032 CCTCTAGAGGATGGAACCGC 62 16.03 91
sg033 GGCTATGAAGAGATACGCCC 100 19.28 89
sg034 AAGAGATACGCCCTGGTTCC 107 25.14 78
sg036 CGCTGGAGAGCAACTGCATA 79 6.01 76
sg040 CAAGCTTATGCAGGGTCGCT -22 15.55 91
sg041 ATAATAATTTTCTGGATTAT 435 9.83 38
sg042 GGATTCTAAAACGGATTACC 472 14.18 92
sg043 TGTACATCGACTGAAATCCC 479 12.35 82
sg044 GTCACATCTCATCTACCTCC 518 20.96 66
sg045 GCAGGGTCGCTCGGTGTTCG -31 10.38 88
sg046 CCTGCATAAGCTTGCCACCA -3 3.86 74
sg048 GGATCTACTGGGTTACCTAA 614 24.38 88
sg051 AATCCAGAAAATTATTATCA 451 11.39 34
sg052 AATCCATGATAATAATTTTC 443 0.00 34
sg053 CAAAAACATAAAGAAAGGCC 28 7.74 35
sg054 TCTGTAAAAGCAATTGTTCC 114 16.09 37
sg055 CGGGCCTTTCTTTATGTTTT 16 8.78 42
sg056 TTTTGGCAATCAAATCATTC 694 0.00 35
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Table A.2. List of Primers for Nested PCR of Genomic DNA from Cas9/sgRNA Treated
Samples
sgRNA name Forward primer Reverse primer
sg023 P149 P215
sg025 P159 P215
sg029 P149 P174
sg030 P159 P215
sg031 P149 P174
sg032 P149 P174
sg033 P149 P176
sg034 P163 P215
sg036 P149 P174
sg040 P163 P160
sg041 P175 P214
sg042 P213 P214
sg043 P213 P214
sg044 P213 P214
sg045 P151 P160
sg046 P153 P160
sg048 P213 P214
sg051 P175 P214
sg052 P175 P214
sg053 P153 P160
sg054 P149 P162
sg055 P153 P160
sg056 P216 P217
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Table A.3. List of Primers with Their Sequences
Primer name Sequence
P149 AAGGTGACGCGTGTGGCCTC
P151 TCGCCCGGGGATCCGACTAG
P153 GCAAATGCAGTCGGGGCGGC
P159 CGCCCTGGTTCCTGGAACAA
P160 TCTGCCAACCGAACGGACAT
P162 TAAATGTCGTTCGCGGGCGC
P163 CAAACCCCGCCCAGCGTCTT
P174 GCGCCCAACACCGGCATAAA
P175 TCTTTATGCCGGTGTTGGGC
P176 AAACACTACGGTAGGCTGCG
P213 CGCAGCCTACCGTAGTGTTT
P214 CCGTGATGGAATGGAACAAC
P215 GACTGAAATCCCTGGTAATCCG
P216 CGGATTACCAGGGATTTCAGTC
Table A.4. List of Primers for ChIP-qPCR
qPCR target site Primer name Primer sequence
Site 1 F P313 CGACCCTGCATAAGCTTGCC
Site 1 R P311 CCGCGTACGTGATGTTCACC
Site 2 F P173 GGTGAACATCACGTACGCGG
Site 2 R P323 AATAACGCGCCCAACACCGG
Site 3 F P331 GCGCCCGCGAACGACATTTA
Site 3 R P329 GAGATGTGACGAACGTGTAC
Site 4 F P316 TTGTACCAGAGTCCTTTGATCG
Site 4 R P214 CCGTGATGGAATGGAACAAC
GAPDH F P333 TACTAGCGGTTTTACGGGCG
GAPDH R P334 TCGAACAGGAGGAGCAGAGAGCGA
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APPENDIX B
CHROMATIN IMMUNOPRECIPITATION ASSAY DEVELOPMENT
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B.1 Introduction to ChIP Assay
B.1.1 Brief History of the ChIP Assay
In the 1970’s, researchers were experimenting with different methods of crosslinking
to understand protein-protein interactions.199 They would covalently link proteins, either
through chemical crosslinking or other methods, and deduce which proteins were closely
interacting or binding to each other.
In the mid 1980’s, Gilmour et al. were the first to crosslink DNA and protein and use
an antibody to pull down a specific protein. They used UV to covalently link the DNA and
protein to map RNA polymerase to E coli genome in 1984200 and then to the Drosophila
genome the following year.201 However, as PCR was only invented the year before,202 early
ChIP assays used hybridization probes to detect the precipitated DNA sequences. Soon after,
Solomon et al. used formaldehyde to crosslink and pulldown.203
After the development and subsequent commercialization of real time PCR in 1993 and
1996 respectively,204 it was applied to quantifying ChIP’d DNA.205 With the development
of more antibodies, especially those directed to histone modifications, ChIP was becoming a
popular tool to understand the relationship of proteins and genomes.205 However, genome-
wide mapping of proteins was more relevant so most published ChIP data utilized ChIP-chip
where the DNA was hybridized to microarrays with many target sequences.206 Finally,
with the development of deep sequencing technology, true genome-wide mapping became
possible with ChIP-seq, which was demonstrated in parallel by four different labs.207–210
ChIP assay allows us to answer two questions: 1. Where in the genome is my protein
bound and 2. How much of my protein is bound there? For question 1, we can ask if it is
bound at a particular location or set of locations by using ChIP paired with quantitative PCR
(qPCR). Alternatively, we can see all of the locations our protein is bound by using ChIP
paired with deep sequencing or ChIP paired with a microarray. For question 2, the above
assays are quantitative. In order to be able to perform a ChIP, you will need a ChIP-grade
antibody against your protein of interest.
ChIP assays have a reputation for being challenging because they require extensive
optimization, are sensitive to protocol deviations, and are tedious and long relative to most
protocols. Here, I will introduce the steps of the assay, describe the optimization I performed,
and include the detailed protocol optimized for our lab.
B.2 Overview of ChIP Steps
As shown in Figure B.1, ChIP is composed of several steps across multiple days. I have
chosen to break the protocol into 9 steps, each illustrated as a separate tube in Figure B.1.
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Step 0: Step 1 can be performed on adherent cells in the flask they’ve been grown in.
However, some people prefer to collect the cells before fixation. Therefore, I have included
a Step 0 for possible cell preparation.
Step 1: Fixation. This can be done chemically with something like formaldehyde. In
this step, any DNA-protein or protein-protein complexes are chemically fixed together.
Notably, for some applications, such as identifying histones, you do not need to fix. In this
case, you would not sonicate, but would fragment the chromatin using enzymatic digestion.
Optimization discussed further in subsection B.4.1.
Step 2: Lyse cells and nuclei to release the chromatin, which contains the gDNA fixed to
all the associated proteins.
Step 3: Separate the chromatin by centrifugation and remove cellular debris.
Step 4: Fragment the chromatin via sonication. This step requires significant optimiza-
tion to ensure the DNA fragments are of appropriate size for your downstream assays. You
must also ensure that you did not over-sonicate and destroy the epitopes on the proteins.
Optimization discussed further in subsection B.4.2.
Step 5: Incubate your sonicated chromatin with an antibody against your protein of
interest.
Step 6: Incubate your antibody-chromatin sample with a secondary antibody against
your primary antibody from step 5. It should be appropriate for the animal your primary
antibody was produced in and conjugated to something that allows you to separate it from
the rest of the sample. I used secondary antibodies conjugated to magnetic beads.
Step 7: Isolate your secondary antibody, which is bound to your primary antibody, which
is bound to your protein of interest. Some of your protein of interest will likely be bound to
DNA.
Step 8: Wash everything else away. ChIP wash steps are very diverse and thus you should
try a few methods to identify a wash sequence that removes enough background without
washing away your signal. It is important to make sure your wash buffers do not contain
anything that will denature proteins.
Step 9: The only DNA that should be present in your sample is that which was closely
associated with your protein of interest. Before you can identify and quantify it, you must
remove the antibodies, protein, and beads by reversing the crosslinking and treating with a
proteinase. Some people purify the DNA using columns while others do phenyl-chloroform
extractions.
Now your DNA is ready to be characterized.
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Figure B.1. Steps in chromatin immunoprecipitation.
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ATGTGCCTGGATGCATCGTACG
GTGCGCTAGACTGCTACGTA
CTAGCTGCTCGATACGATCGC
…..................…..................…..................…..................
ChIP-seq ChIP-qPCR
What sequences are here?
Where in the genome does my 
protein bind?
Is my sequence here?
Does my protein bind at this site?
IP’d DNA
Sequence
Map 
sequences 
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genome
Design primers to amplify site of interest
IP’d DNA
Run qPCR with IP’d DNA and primer set(s)
a b
Figure B.2. Steps to identify and quantify immunoprecipitated DNA. (a) Overview of using
deep sequencing to identify and map all the sites the protein of interest was bound.
(b) Overview of using quantitative real time PCR (qPCR) to identify whether the protein of
interest was bound at a specific location in the genome.
B.3 Identify and Quantify DNA
After purifying the DNA, you are ready to identify and quantify it. This can be done in a
number of ways, the most common two being deep sequencing and qPCR. ChIP followed by
deep sequencing, also called ChIP-seq, will tell you all of the DNA sequences in your sample
as well as how frequently they occur Figure B.2 a. Those sequences are computationally
mapped back to a reference genome using a series of algorithms. ChIP followed by qPCR
(Chip-qPCR) tells you whether your protein was bound to a specific sequence Figure B.2 b.
You first design qPCR primers that amplify the genomic region or regions of interest. This
step takes considerable optimization, as discussed in subsection B.4.3. Next, you perform
qPCR to determine if your target sequence was pulled down and howmuch of it was present.
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B.4 Optimization
While developing the ChIP assay in my lab, I did considerable optimization. Below are
some of the optimization steps and subsequent data collected during this time.
B.4.1 Fixation
Fixation is the step where proteins bound to DNA are chemical fixed together. There are
different fixation agents that can be used. Some chemicals fix proteins to DNA while others
fix proteins to proteins. They can be used together to pull down a protein associated with a
protein bound to DNA. The concentration and fixation time should be optimized for each
cell type and application. In my work, I used formaldehyde, which has a fixation length of
2Å to 3Å.211 Figure B.3 illustrates some of the issues that can arise from improper fixation.
B.4.2 Digestion
There are several methods you can employ to digest chromatin after fixation. I tested
two ways: MNase digestion and sonication.
B.4.2.1 MNase Digestion
MNase digestion was used during optimization of NChIP, which does not involve fixation.
MNase is an endonuclease that will digest any DNA that isn’t protected by nucleosomes.
The leftover, undigested DNA can be analyzed by sequencing or qPCR. Figure B.4 shows the
agarose gel for different amounts of MNase enzyme amounts. Unlike with sonication, the
digested fragments are quantized: each band corresponds to an integer times the length of
DNA wrapped around a single nucleosome, 147 basepair.
B.4.2.2 Sonication
Extensive sonication optimization was done by my colleague, Josh Cutts. He recom-
mended the intensity setting sonication power for the machine we used. He also advised me
on how to perform this optimization experiment.
To determine the appropriate number of cycles before I saw sufficient digestion of my
sample, I prepared chromatin samples and sonicated between 15 and 135 cycles, taking an
aliquot every 15 cycles to analyze. I uncrosslinked the chromatin and ran the DNA on an
Agilent TapeStation. Figure B.5 shows the resulting chromatograph. The chromatin looks
appropriately sheared between 60 and 75 cycles at these settings.
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Under-fixation
Not long enough, too weak
Associated proteins aren’t 
chemical linked to DNA
Result: Bound proteins 
aren’t pulled down
b
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Over-fixation
Too long, too strong
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Result: Pull down unrelated 
proteins
Figure B.3. Issues with fixation. (a) Results of over-fixing. (b) Results of under-fixing.
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Figure B.4. Digestion of Luc14 chromatin with MNase. Ladder included on the right.
Unt = untreated with nuclease. U = units of nuclease. N = nucleosome(s).
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Figure B.5. Chromatograph of sonicated chromatin. Chromatin was sonicated for an
increasing number of rounds and run on a bioanalyzer to determine size and amount of
DNA.
B.4.3 Quantitative PCR
In order to determine the chromatin state at my target site, I wanted to perform qPCR
on my immunoprecipitated DNA. We use Sybr green dye without probes so I first needed to
design primer sets against my target sequence and confirm on-target amplification, single
product, and primer efficiencies.
B.4.3.1 Design
My first step is to design the primers. Because I have such specific requirements for the
sequence I want to amplify, I design primer sets manually, selecting sequences between
20bp to 25bp with melting temperatures between 60 ◦C to 63 ◦C and no more than 3 ◦C
apart. The primers walk across the indicated sequence range in Figure B.6 a. After designing
primer sets, I checked to see if they would amplify any off-target genomic sequences using
the NCBI PrimerBLAST tool. Figure B.6 b shows a chart with all of the primer sets and some
important sequence characteristics.
B.4.3.2 End-Point PCR
My next step is to perform end-point PCR and run the amplicons on an agarose gel
(Figure B.7). This allowsme to quickly exclude any primer sets that have additional products.
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Primer	pair	
designation
5'	of	F	
primer	pos	
rel	to	TSS
F	primer F	Primer	GC% R	primer
R	primer	
GC%
Amplicon	
length
Ampllicon	
GC% Position
1 -430 P197 60 P351 65 144 47.92 Upstream	of	5xGal
2 -306 P350 65 P353 65 117 63.25 5xGal
3 -306 P350 65 P352 65 148 62.84 5xGal
4 -209 P165 65 P166 60 126 58.73 Upstream	and	TK	promoter
5 -140 P163 65 P358 55 135 60 TK	promoter
6 -140 P163 65 P349 60 137 60.58 TK	promoter
7 -129 P359 55 P358 55 124 58.87 TK	promoter
8 -129 P359 55 P349 60 126 59.52 TK	promoter
9 -114 P357 50 P358 55 109 60.55 TK	promoter
10 -114 P357 50 P349 60 111 61.26 TK	promoter
11 -99 P153 70 P349 60 96 62.5 TK	promoter
12 -99 P153 70 P358 55 94 61.7 TK	promoter
13 -75 P355 55 P356 55 144 54.86 TK	promoter
14 -33 P149 65 P150 60 132 78.3 across	TSS
15 -3 P313 60 P150 60 102 76.1 across	TSS
16 -3 P313 60 P348 60 141 51.77 across	TSS
17 +12 P308 60 P348 60 126 50.79 just	downstream	of	TSS
18 +18 P227 60 P311 60 145 49.66 just	downstream	of	TSS
19 +23 P309 65 P311 60 140 51.43 just	downstream	of	TSS
20 +31 P360 55 P361 50 135 49.63 just	downstream	of	TSS
21 +31 P360 55 P311 60 132 50.76 just	downstream	of	TSS
5xGal4UAS TK Luciferase
700600500400300200100-200 0-100-300 1600
Distance from translational start site (bp)
a
b
Figure B.6. Primer design steps. (a) qPCR primers were within the region indicated on the
luciferase transgene map. (b) Primer sets designed for this study.
As you can see in Figure B.7, we can exclude primer sets 3, 11, 12, and 14. However, it is
important to note that this will not resolve any primer pairs that have multiple amplicons of
similar lengths as those will appear as a single band on the gel.
B.4.3.3 qPCR Dilution Curve
The next step is running qPCR with primers, Sybr, and different dilutions of template
DNA, in this case gDNA from Luc14 cells (Figure B.8 a). This test will tell us the sensitivity
and efficiency of the primer sets. We also include a melt curve step in our qPCR protocol
so we can determine if there are any off-target amplicons and significant primer dimer in
the no-template control. While this has higher resolution than the agarose gel step, it still
will not tell us if there are multiple amplicons with very similar melting temperatures. The
only way to determine this for certain is to clone the amplicons into a plasmid and sequence
them.
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Figure B.7. Agarose gel of end-point PCR products. Primer sets 3, 11, 12, and 14 have
multiple products and are thus excluded from further characterization.
Figure B.8 b illustrates part of the concept behind the dilution curve. For primer sets
with 100% efficiency and an amplification factor of 2, each round will double the number
of amplicons. As it is unlikely that any designed primer set will have 100% efficiency, we
calculate the actual efficiency to determine whether the set is appropriate to use for an
application as sensitive as qPCR. With a set of known dilutions of starting gDNA, one can
calculate the primer efficiency and the amplification factor by graphing the log base 10 of
the dilution against the Cp value:
Amplification factor = 10
−1
slope
Efficiency = (Amplificationfactor − 1)× 100
Efficiency should be between 90% to 110%.
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Figure B.8 illustrates some example curves for different gDNA dilutions. Figure B.8 a
shows a primer pair that is not sensitive enough for our application. For ChIP assay, we will
be precipitating low concentrations of DNA and thus need very sensitive primers. The three
lowest dilutions show the same Cp value of 40, meaning we did not detect a difference in
concentration for those three dilutions. Figure B.8 b shows a primer set that is too efficient,
meaning it more than doubles the number of amplicons with each cycle. This is apparent
after calculating the amplification factor and efficiency. The amplification factor is greater
than 2 (2.23) and the efficiency is 123%, outside of our recommended range of 90% to 110%.
Figure B.8 c shows a primer set that is under efficient, with amplification factor below 2 and
efficiency of 82%. In Figure B.8 d we see three examples of sensitive primers with efficiencies
within the acceptable range.
As mentioned above, this step not only tells us the efficiency and sensitivity, but also give
a higher-resolution look at any off target amplicons and no-template control amplicons. For
off target amplicons, we look for single curves in the melt curve analysis. If we see multiple
curves, this means that our primer set is producing multiple products and Cp value will
not reflect the concentration of only our desired product; our results will skew to reporting
incorrectly higher amounts of starting DNA. For the no-template control, we look to the
reported Cp value as well as the melt curve analysis. Interpretation of these results can be a
bit more nuanced, depending on the researcher. For some, any product in the no template
control is enough to reject a primer set. For others, it may be acceptable to use a primer set
that gives a product in the no-template control. For example, say a primer set gives a great
dilution curve, with near-perfect efficiency and high sensitivity. The melt curve analysis
shows a single product around 86 ◦C. The no-template control has a Cp value of 40 and a
peak in the melt-curve at 54 ◦C. One could conclude that primer dimer occurs only when
no template is present and that any results obtained with only a single peak 86 ◦C in the
melt curve reflect the concentration of the desired product. Any results with two peaks or a
single peak at 54 ◦C should be discarded. In my case, I decided to be more lenient with the
no template control products because, with the luciferase transgene, there are not many
primer sets that meet the other requirements.
B.4.3.4 End-Point PCR with Target-Negative DNA
As I have mentioned above, these tests will not tell you for certain whether you have
a single product. It is possible that you have multiple products with overlapping size and
melting temperature. For most situations, in order to know for certain that you have a
single product, you will need to clone and sequence the PCR products. However, because
I am amplifying a transgene and I have the parent cell line that has the identical gDNA
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Figure B.8. qPCR dilution curve design. (a) General plate layout for a dilution curve to
determine qPCR primer set efficiency. (b) Example curves for different dilutions of gDNA
template.
161
Low sensitivity
20
25
30
35
40
45
-3 -2 -1 0 1 2 3
P350/P353
log10(ng gDNA)
C p
y = -2.868x + 30.588
R² = 0.96436
20
22
24
26
28
30
32
34
36
38
-3 -2 -1 0 1 2 3
P197/P351
y = -3.8424x + 30.787
R² = 0.99739
20
22
24
26
28
30
32
34
36
38
-2 -1 0 1 2 3
P163/P349
log10(ng gDNA)
C p
log10(ng gDNA)
C p
Over-efficient Under-efficient
Slope: -2.868
Amplification factor: 2.23
Efficiency: 123%
Slope: -3.8424
Amplification factor: 1.82
Efficiency: 82%
y = -3.3938x + 27.563
R² = 0.99134
20
22
24
26
28
30
32
34
36
38
-3 -2 -1 0 1 2 3
P227/P311
y = -3.1879x + 27.358
R² = 0.9912
20
22
24
26
28
30
32
34
36
-3 -2 -1 0 1 2 3
P309/P311
y = -3.263x + 28.595
R² = 0.9934
20
22
24
26
28
30
32
34
36
38
-3 -2 -1 0 1 2 3
P360/P361
log10(ng gDNA)
C p
Slope: -3.263
Amplification factor: 2.03
Efficiency: 103%
log10(ng gDNA)
C p
log10(ng gDNA)
C p
Slope: -3.3938
Amplification factor: 1.97
Efficiency: 97%
Slope: -3.1879
Amplification factor: 2.06
Efficiency: 106%
d
Great efficiency, high sensitivity
a b c
Figure B.9. Subset of primer set dilution curves. (a) This primer set does not detect the
lowest dilutions of gDNA and are therefore not sensitive enough. (b) This primer set is over
efficient, which means with each cycle, it more than doubles the number of amplicons. This
is indicated by the amplification factor of 2.23. (c) This primer set is under efficient. This
means with each amplification, it does not double the number of amplicons, as indicated by
the amplification factor of 1.82. (d) These three primer sets have ideal efficiency (between
90percent to 110percent) and are sensitive to the lowest dilution of gDNA.
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Primer	#
5'	of	F	
primer	
pos	rel	
to	TSS
F	
primer
R	
primer
Amplico
n	length
Ampllico
n	GC% Position
Taq
endpoint	
PCR	gel	
results	(no.	
of	bands)
Efficiency
Extra	
product	
Sybr
Sensitivity	(Cp	
at	lowest	
dilution)
Neg	ctrl
1 -430 P197 P351 144 47.92 Upstream	of	5xGal 1 123.19% no high	(35)
2 -306 P350 P353 117 63.25 5xGal 1 - no
v	low	(40,	40,	
40)
3 -209 P165 P166 126 58.73
Upstream	and	TK	
promoter 1 110.56% no high	(34.5)
4 -140 P163 P358 135 60 TK	promoter 1 87.85% no low	(40)
5 -140 P163 P349 137 60.58 TK	promoter 1 82.08% no low	(no	value)
6 -129 P359 P358 124 58.87 TK	promoter 1 - no low	(40,	40)
7 -129 P359 P349 126 59.52 TK	promoter 1 67.28% no
low	(40,	no	
val)
8 -114 P357 P358 109 60.55 TK	promoter 1 - yes -
9 -114 P357 P349 111 61.26 TK	promoter 1 68.01% no low	(40,	40)
10 -75 P355 P356 144 54.86 TK	promoter 1 76.22% no low	(40,	40)
11 -3 P313 P150 102 76.1 across	TSS 1 - yes -
12 -3 P313 P348 141 51.77 across	TSS 1 weird probably -
13 +12 P308 P348 126 50.79 >TSS 1 - yes - peak
14 +18 P227 P311 145 49.66 >TSS 1 97.09% no high	(35.5) maybe
15 +23 P309 P311 140 51.43 >TSS 1 105.91% no high	(33.78)
16 +31 P360 P361 135 49.63 >TSS 1 102.52% no high	(35.16) peak
17 +31 P360 P311 132 50.76 >TSS 1 107.36% no 33	then 0 no
Figure B.10. Summary of results after dilution curve test. This chart includes details about
each primer pair as well as a summary of the results from the tests performed.
missing only the luciferase transgene, I can perform end-point PCR with my primers using
the parent cell line gDNA as my template. If I have a product the same band size as my
expected amplicon, then I cannot be sure that this amplicon is not present when I amplify
gDNA containing the luciferase transgene. Figure B.11 shows my end-point PCR results for
the subset of primers that showed promising results from the above experiments. Primer
sets 1-9 are shown as well as three internal control primer sets. The internal control primers
show strong amplification, as expected. Worryingly, many of my luciferase-specific primer
sets show small products when no luciferase DNA is present, most obviously primer sets 2,
3, and 4.
Figure B.12 includes the summary of the results for the subset of the primer sets that
passed the initial Taq screen for multiple products. From the original 21 designed primer
sets (Figure B.6 b), I am confident in using one primer set, 8. This is not a common outcome
but this should demonstrate the importance of testing your primers before proceeding to
qPCR.
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Figure B.11. Agarose gel of PCR with luciferase-negative gDNA. End point PCR of primer
sets 1-9 with gDNA from the parent cell line for Luc14. Primer pairs for internal control
genomic targets GAPDH, 16S, and TBP are also included.
Primer	#
smallish	
amplicon	
from	
HEK293	
gDNA?
5'	of	F	
primer	
pos	rel	
to	TSS
F	
primer
R	
primer
Amplico
n	length Position Efficiency
Extra	
product	
Sybr
Sensitivity	
(Cp	at	lowest	
dilution)
Neg	ctrl
1 no -430 P197 P351 144 Upstream	of	5xGal 123.19% no high	(35) no
2 yes -209 P165 P166 126 Upstream	and	TK 110.56% no high	(34.5) yes
3 yes -140 P163 P358 135 TK	promoter 87.85% no low	(40) yes
4 yes -140 P163 P349 137 TK	promoter 82.08% no low	(no	value) yes
5 no -75 P355 P356 144 TK	promoter 76.22% no low	(40,	40) no	
6 yes +18 P227 P311 145 just	dstream	of	TSS 97.09% no high	(35.5) maybe
7 yes +23 P309 P311 140 just	dstream	of	TSS 105.91% no high	(33.78) maybe
8 no +31 P360 P361 135 just	dstream	of	TSS 102.52% no high	(35.16) no
9 yes +31 P360 P311 132 just	dstream	of	TSS 107.36% no 33	then	no	val no
Figure B.12. Summary of results after all optimization tests. This chart includes details
about each primer pair as well as a summary of the results from all the tests described in
this section.
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APPENDIX C
SUPPLEMENTAL MATERIAL FOR CHAPTER 3:
ENHANCING CAS9 ACTIVITY IN HETEROCHROMATIN
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Table C.1. UNC1999 Kill Curve
Concentration (µM) Toxicity
0 vehicle None
1 None
2 None
5 None
10 None
20 Some
50 Toxic
Table C.2. List of Primers for PCR of Genomic DNA from Cas9/sgRNA Treated Samples
Forward Primer Reverse Primer
Name Sequence Name Sequence
P197 ctcactcattaggcacccc P198 cgttggtcgcttccggat
Table C.3. List of Primers for Nested PCR of Genomic DNA from Cas9/sgRNA Treated
Samples
gRNA RNA Site Forward Primer Reverse Primer
g046 5'–CCTGCATAAGCTTGCCA | CCA tgg–3' P355 P311
g032 5'–CCTCTAGAGGATGGAAC | CGC tgg–3' P163 P348
g025 5'–cct ACC | GTAGTGTTTGTTTCCAA–3' P332 P330
3'–TTGGAAACAAACACTAC | GGT agg–5'
g048 5'–GGATCTACTGGGTTACC | TAA ggg–3' P314 P318
Table C.4. Sequences for Primers for Nested PCR of Genomic DNA from Cas9/sgRNA
Treated Samples
Primer Name Sequence
P163 CAAACCCCGCCCAGCGTCTTA
P311 CCGCGTACGTGATGTTCACC
P314 CGTTCGTCACATCTCATCTACC
P318 TCCGGAATGATTTGATTGCC
P330 TAGATGAGATGTGACGAACGTG
P332 CGCCCGCGAACGACATTTATAATG
P348 TTGTTCCAGGAACCAGGGCG
P355 TCCGAGGTCCACTTCGCATA
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APPENDIX D
CORRIGENDUM: CAN THE NATURAL DIVERSITY OF
QUORUM-SENSING ADVANCE SYNTHETIC BIOLOGY?
168
A corrigendum on Davis, R. M., et al. (2015). Can the Natural Diversity of Quorum-
Sensing Advance Synthetic Biology? Frontiers in Bioengineering and Biotechnology 3,
1–10, DOI: 10.3389/fbioe.2015.00030.
The geneWP_023917333was incorrectly used to generate theGtaRproteinmotifmap in Fig-
ure 5 of the original publication, which led us to publish erroneous conclusions about GtaR
structure and function. At the time thismanuscript was published, the geneWP_023917333
was incorrectly titled “LuxR family transcriptional regulator Rhodobacter capsulatus” in
the NCBI database. Analysis of the correct GtaR protein sequence (WP_013066073) does
not show “sequence conservation with TatD family of deoxyribonuclease proteins” nor does
it lead us to conclude that GtaR “might represent a unique class of HSL-responsive regulator
proteins.”
Analysis of the correct protein sequence (WP_013066073) shows GtaR contains the
same b–b–a–a–b–a–b–b motif as RhlR, LasR, and SinR. All four regulator proteins, RhlR,
LasR, GtaR, and SinR, respond to different ligands: C4-HSL, 3O-C12-HSL, C16-HSL,
and C18-HSL, respectively.173,175–177 We surmise that variations in specific residues may
account for the regulator proteins’ preferences for different ligands.
The GtaR C-terminus does not match the HTH LuxR-type motif (Prosite PS50043) origi-
nally annotated in Figure 5 but does match an “HTH_LuxR” DNA binding motif designated
as SMART motif SM00421213,214 at amino acids 140–197. This motif is present in all the
regulators analyzed. Figure 5 now illustrates HTH LuxR regions (SMART SM00421) instead
of PS50043. Furthermore, in the original publication the protein motif maps were switched
between LasR and AubR, and the SidA map was scaled incorrectly. We have corrected these
errors in a new version of Figure 5, shown here.
This appendixwas previously published as a corrigendum in Frontiers in Bioengineering andBiotechnology.
See chapter 4 for the article it corrects.92 The original citation is Davis, R. M., et al. (2015). Corrigendum:
Can the Natural Diversity of Quorum-Sensing Advance Synthetic Biology? Frontiers in Bioengineering and
Biotechnology 3, DOI: 10.3389/fbioe.2015.00099.
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Reg. Species PDB HSL ligand
RpaR R. palustris - 3-phenol
RhlR P. aeruginosa - C4
BjaR B. diazoefficiens - isovaleryl
CviR C. violaceum 3QP6 C6
LuxR V. fischeri - 3O-C6
TraR A. tumefaciens 1L3L 3O-C8
SdiA E. coli 2AVX 3O-C8
AubR unknown - C12
LasR P. aeruginosa 2UV0 3O-C12
GtaR R. capsulatus - C16
SinR S. meliloti (1021) - C18
TraR
3O-C8-HSL
Autoinducer
binding
Multimerization
surface
HTH LuxR-type
Recognition helix
Binding pocket
n Autoinducer binding n HTH LuxR
n Binding pocket n H-T-H motif
Inferred binding pocket n Recognition helix
n Multimerization surface Inferred recognition helix
n Unassigned
243
a			 				 		a			 			b b a a a a b			 		a	 a
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a						 			a b b a a b			 			a		 			b				 		b a	
242
a			 				 			a		 				 	b b a a a a b					b a
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a			 				 			a		 				 	 b					 	b		 				a h b	a					a					 			b				 	b a	
a			 				 	a				 				b b a a a a b			 	b a
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a a b b a a b				 				a					 		b		 b a
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a			 		 a b b a a b a				b					 		b a	
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267
a a b b a a b a				 			b				 	b a
239
a b b a a b a					b			 			b a
203
Figure D.1. Comparison of protein motifs in select regulators. The three-dimensional (3D)
structure of TraR is shown as an example of how domains and the homoserine lactone
(HSL) ligand are typically positioned in space. The underlined letters in the
b–b–a–a–b–a–b–b secondary structure motif indicate the location of highly conserved
amino acids that form hydrogen bonds with the homoserine lactone head of HSLs.
Published 3D structure data (Protein Data Bank) are listed where available (“–” = not
available). Abbreviations used are: Reg. = regulator protein, H–T–H = helix–turn–helix,
a = alpha helix, b = beta strand, h = 3/10 helix. Database entries for conserved motifs are:
autoinducer binding = IPR005143, HTH LuxR = SM00421.213,214 Inferred binding
pockets are patterns of secondary structures that are similar to the TraR binding pocket.
Inferred recognition helices are the second alpha helix from the C-terminus. Secondary
structures for proteins with no available 3D structure data were mapped using the Jpred
prediction tool.161 Maps were generated using DomainDraw.162
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APPENDIX E
SUPPLEMENTARY MATERIAL FOR CHAPTER 4:
DIVERSITY IN HOMOSERINE LACTONES PRODUCED BY
SYNTHASES ACROSS BACTERIAL SPECIES.
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This chart was previously published as supplementary material to Davis et al.92 It
expands on Figure 4.4 in chapter 4.
Figure E.1. Diversity in homoserine lactone (HSL) produced by synthases across bacterial
species. Select synthases and representative species are shown in gray boxes. Each row
represents one or several HSLs produced by one or more synthase. The number of
synthases with each HSL profile is indicated. A (1+) indicates that the exact number of
synthases is not known. Hypothetical = cases where one of two molecules with identical
mass [i.e., 3O-C(n)-HSL and C(n + 1)-HSL] might be produced by the bacterium, but the
molecules could not be resolved with mass spectrometry. * The hypothetical
monounsaturated N -dodecanoyl-L-homoserine lactone (C12-HSL) produced by AbaI is not
shown here.
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Carbon Chain Length
Species Synthase(s) Ref(s) 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Rhodopseudomonas palustris RpaI Lindemann 2011 Pn
Silicibacter pomeroyi unknown Schaefer 2008 Pn
Bradyrhizobium strain BTAiL BtaI, BraI Lindemann 2011, Ahlgren 2011 Py
Pseudomonas aeruginosa RhlI Fuqua 2002  
Aeromonas salmonicida AsaI Miller 2001  
A. hydrophila ahyI Khajanchi 2011    
Serratia sp. ATC 39006, marcescens MG1 SmaI/SwrI Galloway 2011    
Halomonas anticariensis HanI Tahrioui 2011, Llamas 2005     ¢    
Xenorhabdus nematophilus 19061 unknown Dickschat 2010 OH
B. japonicum BjaI Lindemann 2011 Me
P. chlororaphis PhzI Miller 2001  
P. corrugata PcoI Licciardello 2007  
Pantoea ananatis EanI Tahrioui 2011, Morohoshi 2007  
Chromobacterium violaceum CviI Mcclean 1997  
Serratia marcescens AS-1 SpnI Galloway 2011  
Yersinia enterocolitica YenI Miller 2001  
Burkholderia cenocepacia CciI Malott 2005    
Rhizobium leguminosarum RhiI Rodelas 1999, Schripsema 1996, Miller 2001    
Ralstonia solanacearum SolI Rodelas 1999, Schripsema 1996, Miller 2001    
Erwinia carotovora ExpI Galloway 2011 ¢
P. syringae AhlI Dulla 2009 ¢
Sodalis glossinidius SogI Pontes 2008 ¢
P. agglomerans EagI Miller 2001 ¢
E. chrysanthemi ExpI Miller 2001 ¢
E. stewartii EsaI Miller 2001 ¢
Y. pseudotuberculosis YpsI Miller 2001 ¢
Pectobacterium carotovorum ATCC390048 CarI Põllumaa 2012 ¢
P. atrosepticum SCRI1043 ExpI Põllumaa 2012 ¢
Vibrio fischeri LuxI Eberhard 1981 ¢  
P. putida PpuI Galloway 2011, Wagner-Döbler 2005 ¢ ¢ ¢
Azospirillum lipoferum B518 AlpI Vial 2006     ¢
P. carotovorum SCC3193 ExpI Põllumaa 2012 ¢ ¢
P. carotovorum 71 AhlI Põllumaa 2012 ¢ ¢
Burkholderia sp. CBMB40 unknown Dickschat 2010        
E. psidii unknown Dickschat 2010    
B. cepacia CepI Lewenza 1999  
B. thailandensis BtaI1 Chandler 2009  
S. liquefaciens SwrI Miller 2001  
Y. pseudotuberculosis YtbI Miller 2001  
Roseobacter litoralis DSM 7001T unknown Wagner-Döbler 2005  
B. thailandensis BtaI3 Chandler 2009 OH
B. phytofirmans PsJN unknown Dickschat 2010 OH
Agrobacterium tumefaciens TraI Moré 1996 ¢
P. carotovorum EC153 AhlI Põllumaa 2012 ¢
B. pseudomallei bpmiI 1, 2, 3 Ulrich 2004   n   n ¢
B. vietnamiensis uncharacterized Conway 2002     ¢  
A. lipoferum TVV3 unknown Vial 2006   n
A. lipoferum TVV3 AlpI Vial 2006 ¢ ¢
Dinoroseobacter shibae DFL 16 unknown Wagner-Döbler 2005   =
Sinorhizobium meliloti Rm1021 SinI Marketon 2002     ¢ =  =¢  
B. thailandensis BtaI2 Chandler 2009 OH
B. vietnamiensis BviI Conway 2002  
A. lipoferum TVV3 unknown Vial 2006  
B. pseudomallei 008 unknown Dickschat 2010  
Gymnopilus intermedius NCI1051 GinI Iida 2008     =
Rhodospirillum rubrum unknown Mastroleo 2013     OH
V. anguillarum VanI Miller 2001 ¢
R. gallaeciencis T5 unknown Wagner-Döbler 2005 OH =
Unidentified soil bacterium AubI Nasuno 2012  
Brucella melitensis 16M unknown Dickschat 2010  
P. aeruginosa LasI Fuqua 2002 ¢
Acinetobacter baumannii AbaI Niu 2008 OH =¢ = =¢ =
R. sphaeroides CerI Miller 2001   =¢ =
Roseovarius tolerans EL 52, 78, 83, 90, 164, 171, 172T, 222 unknown(s) Wagner-Döbler 2005 =
R. tolerans EL 78, 90 unknown(s) Wagner-Döbler 2005   =
R. leguminosarum bv. viciae 8401 CinI Miller 2001, Dickschat 2010  .¢.=
R. tolerans EL 164 unknown Wagner-Döbler 2005 =n
R. tolerans EL 171 unknown Wagner-Döbler 2005   =   =
Jannaschia helgolandensis HEL 10T, 26 unknown Wagner-Döbler 2005   =  
R. capsulatus GtaI Schaefer 2002 = =
R. mucosus DFL 24 unknown Wagner-Döbler 2005    
P. denitrificans unknown Schaefer 2002 = =
Oceanibulbus indolifex unknown Wagner-Döbler 2005  
Staleya guttiformis LM 09 unknown Wagner-Döbler 2005 =
D. shibae DFL 27, 30, 31 unknown Wagner-Döbler 2005   =
R. mucosus DFL 35 unknown Wagner-Döbler 2005 =
D. shibae DFL 27, 30, 31, 36 unknown Wagner-Döbler 2005 =
==
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Figure E.1. Continued.
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